%PDF-1.3
%âãÏÓ
1 0 obj
<<
/Type/ExtGState
/OPM 1
>>
endobj
2 0 obj
<<
/SM 0.01
/Type/ExtGState
/FL 1
>>
endobj
3 0 obj
<<
/OP true
/Type/ExtGState
>>
endobj
4 0 obj
<<
/OP false
/Type/ExtGState
>>
endobj
5 0 obj
<<
/Length 9334
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
/GS2 gs
q
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
9 0 0 9 14.1732 672.0087 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364)Tj
ET
0 0 0 0 k
14.173 538.7789 473.386 110.354 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
17 0 0 17 39.1434 637.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(CAP)74(A)55(CID)35(AD DIA)54(GN\356STICA DEL GDx VCC P)74(ARA EL)]TJ
4.56563 -1.05882 TD
[(DIA)55(GN\356STICO DEL GLA)50(UCOMA)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
15 0 0 15 56.3835 587.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(DIA)55(GNOSTIC ABILITY OF GDx VCC FOR GLA)49(UCOMA)]TJ
10.18743 -1.06667 TD
0 Tw
[(DIA)55(GNOSIS)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 45.4909 543.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(BORQ)10(UE E)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 100.3443 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(1)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 104.4693 543.5247 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(,)Tj
0.52488 0 Td
0 Tc
0.025 Tw
(FERRERAS A)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 176.8309 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 180.9559 543.5247 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(,)Tj
0.52486 0 Td
0 Tc
0.025 Tw
(POLO V)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 226.4137 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 230.5387 543.5247 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(,)Tj
0.5249 0 Td
0 Tc
0.025 Tw
[(LARR)40(OSA JM)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 304.2887 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 308.4137 543.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.52491 0 Td
0.025 Tw
[(P)92(ABLO LE)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 365.6959 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 369.8209 543.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.52491 0 Td
0.025 Tw
[(HONR)40(UBIA FM)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 452.1163 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
0 0 0 0 k
14.173 31.181 473.386 118.156 re
f
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 142.086 m
133.228 142.086 l
S
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 131.9149 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Recibido:)-250(3/9/07. Aceptado: 14/5/08.)]TJ
0 -1.12499 TD
(Servicio de Oftalmolog\222a. Hospital Universitario Miguel Servet. Instituto Aragon\216s de Ciencias de la Salud. Zaragoza. Espa\226a.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
6 0 0 6 14.1732 116.555 Tm
0 Tr
0 0 0 1 k
0 Tc
(1)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 21.1732 113.915 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(Licenciado en Medicina. )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
6 0 0 6 14.1732 107.555 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 21.1732 104.915 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(Doctor en Medicina. )Tj
-0.875 -2.25 TD
0 Tw
(Correspondencia:)Tj
0 -1.125 TD
0.025 Tw
(Enrique Borque Rodr\222guez-Maim\227n)Tj
T*
(Consultas Oftalmolog\222a Hospital Universitario Miguel Servet)Tj
T*
(Isabel la Cat\227lica, 1-3)Tj
T*
(50009 Zaragoza)Tj
T*
0 Tw
(Espa\226a)Tj
T*
0.025 Tw
(E-mail: eborque@gmail.com)Tj
ET
0 0 0 0 k
14.173 170.596 226.772 342.9919 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 95.0622 504.7111 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(RESUMEN)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 480.411 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(Objeti)10(v)9(o:)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 62.4247 480.411 Tm
0 Tr
0 0 0 1 k
0 Tc
0.102 Tw
[(Ev)25(aluar la capacidad diagn\227stica de los)]TJ
-4.3865 -1.10454 TD
0.093 Tw
(distintos par\207metros que ofrece el GDx VCC para)Tj
0 -1.10453 TD
0.025 Tw
(discriminar entre ojos sanos y glaucomatosos. )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 443.9612 Tm
0 Tr
0 0 0 1 k
0 Tc
0.197 Tw
(Material y m\216todos:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 118.0965 443.9612 Tm
0 Tr
0 0 0 1 k
0 Tc
0.197 Tw
(Se seleccionaron de forma)Tj
-9.44757 -1.10454 TD
0.083 Tw
[(prospecti)25(v)25(a y consecuti)24(v)25(a 417 ojos de 417 pacien-)]TJ
T*
0.001 Tw
[(tes. Fueron di)25(vididos en 60 controles, 218 hiperten-)]TJ
0 -1.10455 TD
0.201 Tw
(sos oculares, 68 glaucomas preperim\216tricos y 71)Tj
0 -1.10454 TD
0.007 Tw
(glaucomas se)Tj
5.35069 0.00001 TD
(g\234n la presi\227n intraocular)Tj
10.22589 0 TD
-0.0001 Tc
(,)Tj
0.50649 0 Td
0 Tc
(la morfolo)Tj
4.19978 0 TD
(-)Tj
-20.28284 -1.10455 TD
0.134 Tw
(g\222a papilar y los resultados en la perimetr\222a auto-)Tj
0 -1.10454 TD
0.077 Tw
[(matizada con)40(v)15(encional A todos ellos se les realiz\227)]TJ
T*
-0.002 Tw
(una polarimetr\222a l\207ser con el GDx VCC. Se compa-)Tj
0 -1.10455 TD
0.053 Tw
[(raron los par\207metros de la capa de f)20(ibras nerviosas)]TJ
0 -1.10454 TD
-0.037 Tw
(de la retina (CFNR) del GDx-VCC entre los grupos.)Tj
T*
-0.018 Tw
[(Se calcularon las curv)25(as R)40(OC entre el grupo normal)]TJ
-0.0001 Tc
(y)'
1.01572 0 Td
0 Tc
0.266 Tw
(de glaucomas. Se consideraron como mejores)Tj
-1.01572 -1.10454 TD
0.145 Tw
[(par\207metros aquellos con mejor \207rea bajo la curv)25(a)]TJ
0 -1.10455 TD
0.058 Tw
[(R)40(OC y el mejor balance de sensibilidad/especif)19(ici-)]TJ
0 -1.10454 TD
0 Tw
(dad.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 261.7112 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Resultados: )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 75.5987 261.7112 Tm
0 Tr
0 0 0 1 k
0 Tc
0.335 Tw
(La mayor\222a de los par\207metros del)Tj
-5.58414 -1.10454 TD
0.058 Tw
(GDx-VCC mostraron diferencias entre el grupo de)Tj
0 -1.10455 TD
0.081 Tw
(glaucomas y el resto de los grupos. Algunos par\207-)Tj
0 -1.10454 TD
0.234 Tw
(metros fueron tambi\216n diferentes al comparar el)Tj
T*
-0.022 Tw
(grupo normal y el de glaucomas preperim\216tricos. El)Tj
T*
0.088 Tw
(mejor de ellos fue el indicador de f)Tj
14.55858 0.00001 TD
(ibras nerviosas)Tj
-14.55858 -1.10455 TD
0.138 Tw
(\(NFI; \207rea bajo la curv)Tj
9.63325 0.00001 TD
-0.0001 Tc
(a)Tj
0.83201 0 Td
0 Tc
[(R)40(OC: 0,876\). El NFI, el)]TJ
-10.46526 -1.10455 TD
0.03 Tw
(\207rea inferior normalizada y el \207rea superior norma-)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9.6 0 0 12 384.1655 671.8343 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(AR)40(T\352CULO ORIGIN)19(AL)]TJ
ET
0 0 0 0 k
260.787 172.7999 226.772 340.788 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 339.1405 504.7111 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(ABSTRA)55(CT)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 480.411 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(Pur)10(pose:)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 306.745 480.411 Tm
0 Tr
0 0 0 1 k
0 Tc
0.106 Tw
[(T)80(o assess the diagnostic ability of scan-)]TJ
-4.17796 -1.10454 TD
0.08 Tw
[(ning laser polarimetry (GDx VCC) to dif)25(ferentiate)]TJ
0 -1.10453 TD
0.025 Tw
[(between normal and glaucomatous e)15(yes.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 443.9612 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(Methods:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 310.9099 443.9612 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0.298 Tw
(417 e)Tj
2.45158 0.00001 TD
[(yes of 417 consecuti)25(v)15(e subjects)]TJ
-7.00817 -1.10455 TD
0.222 Tw
[(were prospecti)25(v)15(ely selected. The)14(y were classif)20(ied)]TJ
0 -1.10454 TD
0.221 Tw
[(into 60 health)5(y controls, 218 ocular h)5(ypertensi)24(v)15(e)]TJ
0 -1.10455 TD
0.144 Tw
[(e)15(yes, 68 glaucoma suspects, and 71 glaucomatous)]TJ
0 -1.10454 TD
0 Tc
(e)Tj
0.42396 0 TD
-0.005 Tc
0.013 Tw
(yes, depending on intraocular pressure, optic nerv)Tj
19.74781 0 TD
0 Tc
(e)Tj
-20.17176 -1.10455 TD
-0.005 Tc
-0.012 Tw
(head morphology and standard automated perimetry)Tj
0 -1.10454 TD
0.076 Tw
(results. All underwent a scanning laser polarimetry)Tj
T*
0.002 Tc
0.368 Tw
[(with the GDx VCC. Retinal nerv)15(e f)20(iber layer)]TJ
0 -1.10455 TD
-0.005 Tc
0.066 Tw
((RNFL) parameters of the GDx-VCC were compa-)Tj
0 -1.10454 TD
0.035 Tw
(red among the four groups. Recei)Tj
13.37268 0.00001 TD
[(v)15(er operating cha-)]TJ
-13.37268 -1.10455 TD
0.071 Tw
[(racteristic \(R)40(OC\) curv)14(es were plotted between nor-)]TJ
0 -1.10454 TD
0.213 Tw
[(mal and glaucomatous e)15(yes. The best parameters)]TJ
T*
0.101 Tw
[(were def)20(ined according to the area under the R)39(OC)]TJ
0 -1.10455 TD
0.025 Tw
[(curv)15(e and the best sensiti)25(vity/specif)19(icity balance.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 273.8612 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Results:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 302.751 273.8612 Tm
0 Tr
0 0 0 1 k
0 Tc
0.122 Tw
[(Most parameters of GDx-VCC e)15(xhibited)]TJ
-3.81487 -1.10454 TD
0.21 Tw
[(dif)25(ferences between the glaucoma group and the)]TJ
T*
0.061 Tw
(rest of the groups. Some parameters were also dif-)Tj
0 -1.10455 TD
0.077 Tw
[(ferent between health)5(y patients and glaucoma sus-)]TJ
0 -1.10454 TD
0.053 Tw
(pects. The best parameter w)Tj
11.3891 0 TD
[(as the nerv)15(e f)19(iber indi-)]TJ
-11.3891 -1.10455 TD
0.005 Tw
(cator \(NFI; area under the R)Tj
11.28468 0 TD
[(OC curv)15(e: 0.876\). NFI,)]TJ
-11.28468 -1.10455 TD
0.148 Tw
(superior normalized area, and inferior normalized)Tj
T*
0.208 Tw
(area yielded the highest sensiti)Tj
13.07835 0.00001 TD
(vities at 85% and)Tj
-13.07835 -1.10455 TD
0.025 Tw
[(90% f)20(ix)14(ed specif)20(icity)65(.)]TJ
ET
Q

endstream
endobj
6 0 obj
<<
/Length 9612
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
14.173 7.5279 29.435 12.314 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 14.1732 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(358)Tj
ET
0 0 0 0 k
137.36 10.6629 228.784 9.179 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.0444 14.3792 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 14.1732 672.6915 Tm
0 0 0 1 k
(BORQUE E, et al.)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
0 0 0 0 k
14.173 29.7619 473.386 460.997 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 75.4019 481.8819 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(INTR)30(ODUCCI\356N)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 457.5819 Tm
0 Tr
0 0 0 1 k
0 Tc
0.136 Tw
(El glaucoma primario de \207ngulo abierto es una)Tj
-0.97758 -1.10455 TD
0.023 Tw
(neuropat\222a \227ptica multif)Tj
9.64408 0 TD
(actorial en la que se produ)Tj
10.63877 0 TD
(-)Tj
-20.28285 -1.10455 TD
-0.0001 Tc
(ce)Tj
1.12947 0 Td
0 Tc
-0.008 Tw
(una p\216rdida progresi)Tj
8.17682 0 TD
(v)Tj
0.4751 0 TD
-0.0001 Tc
(a)Tj
0.68559 0 Td
0 Tc
(de los axones de las c\216lu-)Tj
-10.46698 -1.10455 TD
0.085 Tw
[(las g)5(anglionares. El da\226o en la capa de f)20(ibras ner)-1(-)]TJ
T*
0.077 Tw
(viosas de la retina (CFNR) se sigue habitualmente)Tj
0 -1.10454 TD
-0.0001 Tc
(de)Tj
1.27214 0 Td
0 Tc
0.078 Tw
(una serie de cambios estructurales en la cabeza)Tj
-1.27214 -1.10454 TD
-0.0001 Tc
(del)Tj
1.49432 0 Td
0 Tc
0.023 Tw
(nervio \227ptico y de defectos caracter\222sticos en el)Tj
-1.49432 -1.10454 TD
0.025 Tw
(campo visual (1,2).)Tj
0.97758 -1.10454 TD
0.043 Tw
(Algunos estudios han sugerido que las alteracio-)Tj
-0.97758 -1.10454 TD
0.217 Tw
(nes en la CFNR pueden detectarse hasta 6 a\226os)Tj
0 -1.10455 TD
0.05 Tw
(antes de la aparici\227n de defectos consistentes en el)Tj
T*
0.006 Tw
[(campo visual (3). Con el f)20(in de superar la subjeti)25(vi)-1(-)]TJ
T*
-0.03 Tw
[(dad en la v)25(aloraci\227n de los m\216todos tradicionales de)]TJ
T*
-0.031 Tw
[(e)25(v)25(aluaci\227n de la CFNR, como las fotograf\222as mono-)]TJ
0 -1.10454 TD
0.014 Tw
(crom\207ticas (4,5), en los \234ltimos a\226os han aparecido)Tj
0 -1.10455 TD
0 Tw
(di)Tj
0.75294 0.00001 TD
0.231 Tw
[(v)15(ersos equipos capaces de obtener im\207genes y)]TJ
-0.75294 -1.10455 TD
0.02 Tw
[(datos cuantitati)25(v)20(os de la CFNR de forma objeti)24(v)25(a y)]TJ
0 -1.10454 TD
0.034 Tw
(reproducible. Una de estas tecnolog\222as es la polari-)Tj
T*
0.024 Tw
[(metr\222a l\207ser (GDx) cuya \234ltima v)15(ersi\227n comerciali-)]TJ
T*
0.006 Tc
0.368 Tw
(zada incluye un compensador corneal v)Tj
17.85669 0.00001 TD
0 Tw
(ariable)Tj
-17.85669 -1.10455 TD
0 Tc
0.026 Tw
((VCC) de la birrefringencia del polo anterior (6-8).)Tj
0 -1.10454 TD
0.0132 Tc
(El)Tj
1.54031 0 Td
0.013 Tc
0.362 Tw
(GDx-VCC estima el espesor de la CFNR)Tj
-1.54031 -1.10455 TD
0 Tc
0.067 Tw
(midiendo el retardo en el haz de un l\207ser polariza)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
-0.037 Tw
[(do, inducido por los microt\234b)20(ulos birrefringentes de)]TJ
T*
0.205 Tw
(los axones de las c\216lulas g)Tj
11.54296 0.00001 TD
(anglionares (9,10). El)Tj
-11.54296 -1.10455 TD
0.006 Tw
(GDx-VCC analiza una franja de la CFNR peripapi)Tj
20.28285 0.00001 TD
(-)Tj
-20.28285 -1.10456 TD
0.01 Tw
[(lar y ofrece al cl\222nico di)25(v)15(ersos mapas y par\207metros,)]TJ
0 -1.10454 TD
0.309 Tw
(tanto globales como relati)Tj
11.26086 0.00001 TD
(v)Tj
0.48023 0.00001 TD
(os, e incluye los de)Tj
-11.7411 -1.1046 TD
-0.01 Tw
(mayor importancia en el informe resumido que pre-)Tj
0 -1.1045 TD
-0.002 Tw
(senta. En este informe tambi\216n se incluye el indica)Tj
20.28284 0.00001 TD
(-)Tj
-20.2828 -1.1045 TD
0.011 Tw
(dor de f)Tj
3.1123 0 TD
(ibras nerviosas (NFI) y los par\207metros rela)Tj
17.1705 0.00001 TD
(-)Tj
-20.2828 -1.1046 TD
0.009 Tw
[(ti)25(v)19(os a la curv)25(a que representa el espesor de la capa)]TJ
0 -1.1045 TD
0.02 Tc
0.425 Tw
(de f)Tj
2.0121 0 TD
(ibras nerviosas, curv)Tj
9.49176 0.00001 TD
0.0199 Tc
(a)Tj
1.15908 0 Td
0.02 Tc
(TSNIT \(promedio)Tj
-12.663 -1.1046 TD
0 Tc
0.3 Tw
[(TSNIT)74(, promedio superior)39(, promedio inferior)40(, y)]TJ
0 -1.1045 TD
0.192 Tw
(desviaci\227n est\207ndar TSNIT\), que se basan en un)Tj
T*
0.006 Tw
(c\207lculo que el aparato establece de forma autom\207ti)Tj
20.28285 0.00001 TD
(-)Tj
2.13662 40.99231 TD
-0.019 Tw
(ca en un c\222rculo alrededor de la papila. El NFI es un)Tj
0 -1.10454 TD
0.009 Tw
(par\207metro global basado en el mapa de espesor que)Tj
T*
0.038 Tw
(se calcula a partir de redes neuronales denominado)Tj
0 -1.10455 TD
0.044 Tw
[(Support V)111(ector Machine (SVM). Los resultados de)]TJ
0 -1.10453 TD
-0.026 Tw
(los par\207metros TSNIT se comparan con una base de)Tj
0 -1.10454 TD
0.038 Tw
(datos normalizada que el aparato incorpora en fun-)Tj
T*
0.047 Tw
[(ci\227n de la edad y grupo \216tnico, para ser estratif)20(ica)-1(-)]TJ
0 -1.10455 TD
0.025 Tw
[(dos por ni)25(v)15(eles de probabilidad.)]TJ
0.97758 -1.10455 TD
0.276 Tw
[(Di)25(v)15(ersos f)9(actores pueden modif)20(icar la v)25(alidez)]TJ
-0.97758 -1.10454 TD
0.115 Tw
[(interna y e)15(xterna de un estudio de precisi\227n diag-)]TJ
0 -1.10455 TD
0.203 Tw
[(n\227stica. Debido a ello, se desarroll\227 la iniciati)25(v)25(a)]TJ
T*
0.315 Tw
[(ST)93(ARD \(Standards for Reporting of Diagnostic)]TJ
0 -1.10454 TD
0.02 Tc
0.362 Tw
[(Accurac)15(y\) \(11\). El prop\227sito de la iniciati)25(v)25(a)]TJ
0 -1.10455 TD
0 Tc
0.194 Tw
[(ST)93(ARD es mejorar la calidad de los estudios de)]TJ
T*
0.157 Tw
(capacidad diagn\227stica. Por ello, el dise\226o de este)Tj
T*
-0.012 Tw
[(estudio se realiz\227 de acuerdo a los 25 puntos def)20(ini-)]TJ
T*
0.025 Tw
[(dos en la iniciati)25(v)25(a ST)92(ARD.)]TJ
0.97758 -1.10455 TD
0.268 Tw
[(El objeti)25(v)20(o del presente estudio es e)24(v)25(aluar la)]TJ
-0.97758 -1.10454 TD
0.175 Tw
(capacidad diagn\227stica de los distintos par\207metros)Tj
T*
-0.01 Tw
(que ofrece el GDx-VCC para discriminar entre ojos)Tj
T*
0.034 Tw
[(sanos, hipertensos oculares \(HT)18(O\), glaucomas pre-)]TJ
T*
0.025 Tw
(perim\216tricos y glaucomatosos.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 265.4756 189.7978 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(SUJET)18(OS, MA)95(TERIAL Y M\203T)17(ODOS)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 271.5408 165.4978 Tm
0 Tr
0 0 0 1 k
0 Tc
0.053 Tw
(El dise\226o del estudio fue aceptado por el comit\216)Tj
-0.97758 -1.10454 TD
0.068 Tw
[(de \216tica del hospital, todos los participantes f)20(irma)-1(-)]TJ
T*
0.094 Tw
(ron el consentimiento informado y la metodolog\222a)Tj
0 -1.10455 TD
0.016 Tw
(del estudio se realiz\227 siguiendo las directrices de la)Tj
T*
0.025 Tw
(Declaraci\227n del Helsinki (1964). )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 81.5978 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Sujetos)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 271.5408 57.2978 Tm
0 Tr
0 0 0 1 k
0 Tc
0.013 Tw
(De enero de 2006 a diciembre del 2006 se prese-)Tj
-0.97758 -1.10455 TD
0.071 Tw
(leccionaron un total de 440 sujetos de forma pros-)Tj
0 -1.10454 TD
-0.012 Tw
[(pecti)25(v)25(a y consecuti)24(v)25(a a partir de las consultas e)15(xter-)]TJ
ET
0 0 0 0 k
14.173 516.176 226.772 132.957 re
f
BT
/F2 1 Tf
11 0 0 11 14.1732 641.6219 Tm
0 0 0 1 k
0.03 Tw
(lizada presentaron las sensibilidades m\207s altas para)Tj
0 -1.10455 TD
0.025 Tw
[(especif)20(icidades f)19(ijadas en el 85% y 90%.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 617.3218 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Conclusiones:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 82.8897 617.3218 Tm
0 Tr
0 0 0 1 k
0 Tc
0.053 Tw
(La mayor\222a de los par\207metros de la)Tj
-6.24695 -1.10455 TD
-0.0001 Tc
(CFNR)Tj
3.03925 0 Td
0 Tc
0.178 Tw
(medidos con el GDx-VCC ofrecieron una)Tj
-3.03925 -1.10455 TD
0.098 Tw
[(b)20(uena capacidad para el diagn\227stico del glaucoma)]TJ
T*
0.2 Tw
(de \207ngulo abierto. El mejor par\207metro del GDx-)Tj
0 -1.10454 TD
0.095 Tw
(VCC para diferenciar entre normales y glaucomas)Tj
0 -1.10453 TD
0.025 Tw
(fue el NFI.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 532.272 Tm
0 Tr
0 0 0 1 k
0 Tc
0.369 Tw
[(P)10(alabras cla)25(v)10(e:)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 96.3348 532.272 Tm
0 Tr
0 0 0 1 k
0 Tc
0.369 Tw
[(Polarimetr\222a l\207ser)40(, GDx VCC,)]TJ
-7.46924 -1.10455 TD
0.025 Tw
(glaucoma, diagn\227stico.)Tj
ET
0 0 0 0 k
260.787 513.8129 226.772 135.32 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Conclusions:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 327.5766 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.322 Tw
(Most RNFL parameters measured)Tj
-6.07175 -1.10455 TD
0.097 Tw
[(with the GDx-VCC pro)15(vided good diagnostic abi-)]TJ
T*
0.09 Tw
(lity for open-angle glaucoma. The best GDx-VCC)Tj
T*
0.258 Tw
[(parameter in dif)25(ferentiating between normal and)]TJ
T*
0.286 Tw
[(glaucomatous e)15(yes w)9(as the NF)1(I )]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
11 0 0 11 418.9089 593.0219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.286 Tw
[(\(Ar)37(c)15(h Soc Esp)]TJ
-14.37468 -1.10455 TD
0.025 Tw
(Oftalmol 2008; 83: 357-364\).)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 556.572 Tm
0 Tr
0 0 0 1 k
0 Tc
0.028 Tw
[(K)25(ey w)10(ords:)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 317.8351 556.572 Tm
0 Tr
0 0 0 1 k
0 Tc
0.028 Tw
[(Laser polarimetry)65(, GDx VCC, glauco-)]TJ
-5.18615 -1.10455 TD
0.025 Tw
(ma, diagnosis.)Tj
ET
0 J 0 j 10 M []0 d 1 w 
0 0 0 1 K
14.173 503.984 m
487.559 503.984 l
S
Q

endstream
endobj
7 0 obj
<<
/Length 10303
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 14.1732 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.093 Tw
(nas del servicio de oftalmolog\222a del Hospital Uni-)Tj
0 -1.10455 TD
0.238 Tw
[(v)15(ersitario Miguel Serv)15(et de Zaragoza. T)79(odos los)]TJ
T*
-0.034 Tw
(pacientes hab\222an sido remitidos desde los centros de)Tj
T*
0.336 Tw
(especialidades dependientes de nuestro Hospital)Tj
T*
0.007 Tw
[(con el objeti)25(v)20(o de realizar un diagn\227stico precoz de)]TJ
T*
0.26 Tw
(la enfermedad en sujetos sospechosos o para el)Tj
0 -1.10454 TD
0.144 Tw
[(se)15(guimiento o tratamiento de sujetos glaucomato-)]TJ
0 -1.10453 TD
0.038 Tw
(sos. En 11 de ellos fue imposible obtener al menos)Tj
0 -1.10455 TD
0.114 Tw
[(una de las pruebas f)20(iables o de calidad suf)19(iciente,)]TJ
T*
0.121 Tw
[(cinco no f)20(irmaron el consentimiento informado, y)]TJ
T*
0.078 Tw
(siete no acudieron a todas las citas para completar)Tj
T*
-0.034 Tw
[(el protocolo e)15(xploratorio. Finalmente, se incluyeron)]TJ
T*
0.04 Tw
(417 sujetos de raza cauc\207sica. Se consider\227 para el)Tj
0 -1.10454 TD
-0.035 Tw
(estudio un ojo de cada sujeto. La elecci\227n se hizo de)Tj
T*
0.047 Tw
[(forma aleatoria, salv)20(o que s\227lo uno de los dos ojos)]TJ
T*
0.025 Tw
(cumpliera los criterios de inclusi\227n.)Tj
0.97758 -1.10454 TD
(T)Tj
0.53101 0 TD
-0.016 Tw
(odos los sujetos, con independencia de su grupo)Tj
-1.50859 -1.10455 TD
-0.018 Tw
(de clasif)Tj
3.32155 0.00001 TD
(icaci\227n, cumplieron unos criterios de inclu)Tj
16.9613 0 TD
(-)Tj
-20.28285 -1.10455 TD
0.069 Tw
(si\227n que fueron: edad entre 18 y 80 a\226os, agudeza)Tj
T*
0.241 Tw
(visual superior a 20/30 en la escala de Snellen,)Tj
0 -1.10454 TD
0.07 Tw
(defecto refracti)Tj
6.123 0.00001 TD
(v)Tj
0.48023 0 TD
-0.0001 Tc
(o)Tj
0.82006 0 Td
0 Tc
(inferior a 5 dioptr\222as de esfera y)Tj
-7.42329 -1.10455 TD
0.089 Tw
(de 3 dioptr\222as de cilindro, medios \227pticos transpa)Tj
20.28285 0.00001 TD
(-)Tj
-20.28285 -1.10455 TD
0.016 Tw
(rentes \(color u opalescencia nuclear)Tj
14.34825 0.00001 TD
-0.0001 Tc
(,)Tj
0.51578 0 Td
0 Tc
(cortical o sub-)Tj
-14.86404 -1.10455 TD
0.142 Tw
[(capsular posterior del cristalino <1 se)15(g\234n la Lens)]TJ
0 -1.10453 TD
0.089 Tw
(Opacities Classif)Tj
6.87225 0 TD
(ication System III\) \(12\) y acepta)Tj
13.41058 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.094 Tw
(ci\227n del consentimiento informado. Se e)Tj
16.61731 0.00001 TD
0 Tw
(xcluyeron)Tj
-16.61731 -1.10455 TD
0.136 Tw
[(aquellos indi)25(viduos con antecedentes de cirug\222a o)]TJ
0 -1.10454 TD
0.103 Tw
[(traumatismos oculares gra)20(v)15(es, enfermedades sist\216)-1(-)]TJ
T*
0.034 Tw
(micas de repercusi\227n oft\207lmica, o imposibilidad de)Tj
T*
0.089 Tw
(realizar o v)Tj
4.65029 0.00001 TD
(alorar cualquiera de las pruebas inclui)Tj
15.63256 0.00001 TD
(-)Tj
-20.28285 -1.10455 TD
0.025 Tw
(das en el protocolo e)Tj
8.35954 0 TD
0 Tw
(xploratorio.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 240.6721 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Pr)Tj
1.03686 0 TD
0.025 Tw
(otocolo exploratorio)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 216.3721 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(A)Tj
0.97096 0 Td
0 Tc
-0.001 Tw
[(todos los sujetos se les realiz\227 una e)15(xploraci\227n)]TJ
-1.94854 -1.10454 TD
0.107 Tw
(oftalmol\227gica completa, que incluy\227 biomicrosco)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.104 Tw
(p\222a con l\207mpara de hendidura, gonioscop\222a, medi)Tj
20.28285 0.00001 TD
(-)Tj
-20.28285 -1.10456 TD
0.25 Tw
[(ci\227n de los ni)25(v)15(eles de presi\227n intraocular (PIO))]TJ
0 -1.10454 TD
0.086 Tw
(basal mediante tonometr\222a de aplanaci\227n de Gold)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10454 TD
0.147 Tw
(mann \(media de tres tomas en d\222as diferentes sin)Tj
0 -1.10455 TD
0.205 Tw
(tratamiento hipotensor\), paquimetr\222a corneal cen-)Tj
0 -1.10454 TD
0.14 Tw
(tral \(DGH T)Tj
5.15157 0.00001 TD
0 Tw
(echnology)Tj
4.10059 0.00001 TD
(,)Tj
0.63978 0 Td
0.14 Tw
(modelo DGH 500, Exton,)Tj
-9.8919 -1.1046 TD
0.161 Tw
[(P)92(A, USA\), e)25(v)25(aluaci\227n del fondo de ojo mediante)]TJ
0 -1.1045 TD
0.058 Tw
(oftalmoscop\222a indirecta y en l\207mpara de hendidura)Tj
T*
0.056 Tw
(\(con lente V)Tj
4.9255 0 TD
(olk de 78 dioptr\222as\), estereofotograf\222as)Tj
-4.9255 -1.1046 TD
0.058 Tw
[(de la papila, perimetr\222a automatizada con)40(v)15(encional)]TJ
0 -1.1045 TD
-0.0003 Tc
(\(P)Tj
0.7969 0 TD
0 Tc
0.025 Tw
(A\) y una polarimetr\222a l\207ser con el GDx-VCC.)Tj
0.1807 -1.1046 TD
0.032 Tw
[(La e)25(v)25(aluaci\227n cl\222nica del nervio \227ptico fue reali-)]TJ
-0.9776 -1.1045 TD
0.043 Tw
(zada con estereofotograf)Tj
9.89278 0.00001 TD
(ias papilares por dos espe-)Tj
-9.8928 -1.1045 TD
0.04 Tw
(cialistas en glaucoma enmascarados con respecto a)Tj
22.41947 55.22724 TD
-0.03 Tw
(la historia cl\222nica del sujeto. Las discrepancias entre)Tj
0 -1.10455 TD
0.352 Tw
[(observ)25(adores fueron resueltas por consenso. Se)]TJ
T*
0.126 Tw
[(def)20(ini\227 la apariencia del nervio \227ptico compatible)]TJ
T*
0.12 Tw
[(con glaucoma como la e)15(xistencia de un adelg)5(aza)-1(-)]TJ
T*
0.238 Tw
(miento del anillo neurorretiniano, focal o difuso)Tj
T*
0.025 Tw
[(con aumento de la e)15(xca)19(v)25(aci\227n o ambas (13).)]TJ
0.97758 -1.10454 TD
0.176 Tw
[(La P)92(A se realiz\227 con el Analizador de Campo)]TJ
-0.97758 -1.10453 TD
0.241 Tw
[(\307Humphre)15(y 750\310 \(Zeiss-Humphre)15(y)65(, Dublin, CA,)]TJ
0 -1.10455 TD
-0.021 Tw
[(EEUU\) \(estrate)15(gia 24-2 SIT)92(A Standard\). Los defec-)]TJ
T*
0.135 Tw
[(tos perim\216tricos fueron def)20(inidos por la presencia)]TJ
T*
0.072 Tw
(de un grupo de al menos tres puntos alterados con)Tj
T*
0.005 Tw
[(un ni)25(v)15(el de probabilidad menor a 5% o un grupo de)]TJ
T*
0.04 Tw
[(al menos dos puntos alterados con un ni)25(v)15(el de pro-)]TJ
0 -1.10454 TD
0.198 Tw
[(babilidad menor a 1% \(se e)15(xcluyeron los puntos)]TJ
T*
0.074 Tw
[(situados en los polos de la mancha cie)15(g)5(a\) \(14\) y/o)]TJ
T*
0.268 Tw
(desviaci\227n est\207ndar de la media (DSM) con un)Tj
T*
0 Tw
(ni)Tj
0.75293 0.00001 TD
(v)Tj
0.48511 0 TD
0.069 Tw
(el de probabilidad menor al 5%; y/o prueba del)Tj
-1.23804 -1.10455 TD
0.108 Tw
(hemicampo glaucomatoso fuera de l\222mites norma)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.051 Tw
[(les. Se realizaron al menos dos P)92(As para disminuir)]TJ
T*
0.076 Tw
(el efecto aprendizaje, y si alguna de ellas no cum-)Tj
0 -1.10454 TD
0.056 Tw
(pli\227 los criterios de v)Tj
8.63946 0.00001 TD
(alidez def)Tj
3.94966 0 TD
(inidos por el propio)Tj
-12.58913 -1.10455 TD
0.093 Tw
(per\222metro \(f)Tj
4.88536 0.00001 TD
(alsos positi)Tj
4.5399 0 TD
(v)Tj
0.48023 0 TD
(os, f)Tj
1.80479 0.00001 TD
[(alsos ne)15(g)5(ati)24(v)20(os y p\216r-)]TJ
-11.71027 -1.10455 TD
0.025 Tw
(dida de f)Tj
3.52852 0.00001 TD
(ijaci\227n\), la prueba fue repetida.)Tj
-2.55094 -1.10455 TD
0.096 Tw
(Las medidas de la CFNR peripapilar se realiza-)Tj
-0.97758 -1.10453 TD
0.363 Tw
(ron con el polar\222metro l\207ser GDx-VCC \(Laser)Tj
0 -1.10455 TD
0.374 Tw
(Diagnostic T)Tj
5.49754 0.00001 TD
(echnologies, Inc., San Die)Tj
11.60467 0 TD
(go, CA,)Tj
-17.10221 -1.10455 TD
-0.035 Tw
[(EEUU\). El e)15(xamen se realiz\227 bajo midriasis por dos)]TJ
0 -1.10454 TD
-0.004 Tw
[(t\216cnicos e)15(xperimentados. En un primer paso el apa-)]TJ
T*
-0.032 Tw
[(rato compens\227 la birrefringencia del se)15(gmento ante-)]TJ
T*
0.192 Tw
(rior con el m\216todo descrito por Zhou y W)Tj
18.11731 0.00001 TD
0 Tw
(einreb)Tj
-18.11731 -1.10455 TD
0.016 Tw
((15), bas\207ndose en el patr\227n de retardo de la re)Tj
18.83778 0 TD
0 Tw
(gi\227n)Tj
-18.83778 -1.10455 TD
0.023 Tw
[(macular (magnitud y eje). T)80(odos los e)15(x\207menes fue)-1(-)]TJ
T*
-0.026 Tw
(ron de alta calidad (mayor de 7) centrados en el ner-)Tj
0 -1.10454 TD
0.092 Tw
(vio \227ptico, con im\207genes perfectamente enfocadas)Tj
-0.0001 Tc
(e)'
0.70914 0 Td
0 Tc
0.015 Tw
(iluminadas de manera uniforme sin artef)Tj
16.2539 0 TD
(actos por)Tj
-16.96304 -1.10455 TD
0.114 Tw
[(mo)15(vimiento. En caso de no cumplir los requisitos)]TJ
0 -1.10454 TD
0.025 Tw
(de calidad la prueba fue repetida.)Tj
0.97758 -1.10455 TD
0.334 Tw
(El softw)Tj
3.68415 0.00001 TD
(are del GDx-VCC \(v)Tj
9.34395 0.00001 TD
(ersi\227n 5.4.1.35\))Tj
-14.00567 -1.10456 TD
0.074 Tw
[(bas\207ndose en los v)25(alores de retardo dentro del c\222r-)]TJ
0 -1.10454 TD
0.188 Tw
(culo de c\207lculo peripapilar ofrece los par\207metros)Tj
0 -1.10453 TD
0 Tw
(TSNIT)Tj
2.7583 0.00001 TD
-0.0001 Tc
(.)Tj
0.81722 0 Td
0 Tc
0.317 Tw
(Otros par\207metros analizados en nuestro)Tj
-3.57552 -1.10456 TD
0.113 Tw
[(estudio fueron: NFI, radio superior)40(, radio inferior)39(,)]TJ
0 -1.10454 TD
0.03 Tw
(superior/nasal, modulaci\227n m\207xima, m\207ximo supe)Tj
20.28283 0.00001 TD
(-)Tj
-20.28283 -1.10456 TD
0.013 Tw
[(rior)40(, m\207ximo inferior)39(, modulaci\227n de la elipse, \207rea)]TJ
0 -1.10455 TD
0.343 Tw
(normalizada superior)Tj
8.77139 0.00001 TD
-0.0001 Tc
(,)Tj
0.84317 0 Td
0 Tc
(\207rea normalizada inferior)Tj
10.75104 0.00001 TD
(,)Tj
-20.3656 -1.10455 TD
0.25 Tw
(temporal/nasal, inferior/nasal, inte)Tj
14.20124 0.00001 TD
(gral total, inte)Tj
6.0816 0.00001 TD
(-)Tj
-20.28283 -1.10456 TD
0.016 Tw
[(gral superior)40(, inferior)39(, promedio temporal y prome-)]TJ
0 -1.10454 TD
0.038 Tw
(dio nasal. El percentil 95 fue usado como punto de)Tj
0 -1.10455 TD
0.032 Tw
[(corte para clasif)20(icar la CFNR como dentro de l\222mi-)]TJ
T*
-0.017 Tw
(tes normales \(v)Tj
6.04996 0.00001 TD
[(alor de 0 a 30\) o en la frontera \(v)25(alo-)]TJ
-6.04996 -1.10455 TD
-0.002 Tw
(res de 31-50\). El 99% de conf)Tj
11.93246 0.00001 TD
(ianza fue usado como)Tj
ET
0 0 0 0 k
461.93 8.5039 25.629 11.338 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 469.559 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
(359)Tj
ET
0 0 0 0 k
137.614 10.57 228.784 9.178 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.2989 14.2856 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 345.0473 672.6915 Tm
0 0 0 1 k
(Diagn\227stico del glaucoma con el GDx-VCC)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
Q

endstream
endobj
8 0 obj
<<
/Length 9727
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 14.1732 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.026 Tw
[(punto de corte para v)25(alores fuera de l\222mites norma-)]TJ
0 -1.10455 TD
0.025 Tw
(les (51-100).)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 593.0219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Clasif)25(icaci\227n en grupos)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 568.7219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.037 Tw
[(Los sujetos incluidos fueron clasif)20(icados en cua-)]TJ
-0.97758 -1.10453 TD
0.218 Tw
[(tro grupos diagn\227sticos: normal o control, HT)18(O,)]TJ
0 -1.10455 TD
0.025 Tw
(glaucomas preperim\216tricos y glaucoma.)Tj
0.97758 -1.10455 TD
0.168 Tw
[<D1>-500(Grupo control (60 ojos): Exploraci\227n oftal-)]TJ
-0.97758 -1.10455 TD
0.021 Tw
(mol\227gica normal, PIO menor de 21 mmHg, morfo-)Tj
T*
0.025 Tw
[(log\222a del nervio \227ptico normal y P)92(A normal.)]TJ
0.97758 -1.10455 TD
-0.01 Tc
0.032 Tw
[<D1>-490(Grupo de HT)18(O (218 ojos): PIO mayor o igual)]TJ
-0.97758 -1.10454 TD
-0.0101 Tc
(a)Tj
0.64938 0 Td
(21)Tj
1.1953 0 Td
-0.01 Tc
-0.024 Tw
[(mmHg, morfolog\222a papilar normal y P)92(A normal. )]TJ
-0.8671 -1.10454 TD
0 Tc
0.001 Tw
[<D1>-500(Grupo de glaucoma preperim\216trico (68 ojos):)]TJ
-0.97758 -1.10454 TD
-0.0001 Tc
(PIO)Tj
1.89322 0 Td
0 Tc
0.033 Tw
(mayor o igual a 21 mmHg, morfolog\222a papilar)Tj
-1.89322 -1.10454 TD
0.025 Tw
(compatible con glaucoma y P)Tj
11.83804 0.00001 TD
-0.0001 Tc
(A)Tj
0.99682 0 Td
0 Tc
0 Tw
(normal. )Tj
-11.85728 -1.10455 TD
<D1>Tj
1.5 0 TD
0.033 Tw
(Grupo de glaucomas (71 ojos): nervio \227ptico)Tj
-2.47758 -1.10455 TD
0.025 Tw
[(compatible con glaucoma y P)92(A alterada.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 386.472 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(An\207lisis estad\222stico)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 362.172 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.036 Tw
[(P)15(ara realizar los c\207lculos y an\207lisis estad\222sticos se)]TJ
-0.97758 -1.10453 TD
0.011 Tw
(utilizaron los programas estad\222sticos SPSS \(v)Tj
18.17225 0 TD
0 Tw
(ersi\227n)Tj
-18.17225 -1.10455 TD
0.128 Tw
(15.0; SPSS Inc., Chicago, IL, EEUU\) y MedCalc)Tj
0 -1.10454 TD
0.025 Tw
[(\(v)15(ersi\227n 9.3.2.0 MedCalc Softw)9(are, Belgium\).)]TJ
0.97758 -1.10454 TD
-0.018 Tw
[(Se realiz\227 un an\207lisis de la v)25(arianza \(ANO)49(V)135(A\) de)]TJ
-0.97758 -1.10454 TD
0.053 Tw
(los par\207metros del GDx-VCC entre los cuatro gru-)Tj
T*
0.169 Tw
(pos diagn\227sticos con la correcci\227n de Bonferroni)Tj
0 -1.10455 TD
0.025 Tw
(para m\234ltiples comparaciones. )Tj
0.97758 -1.10455 TD
-0.005 Tc
-0.005 Tw
(Entre los grupos de sujetos normales y glaucoma-)Tj
-0.97758 -1.10455 TD
0.041 Tw
[(tosos se calcularon las curv)25(as R)39(OC \(recei)25(v)15(er opera-)]TJ
0 -1.10454 TD
0.043 Tw
(ting characteristic\) para cada uno de los par\207metros)Tj
T*
-0.026 Tw
(de la CFNR. La curv)Tj
8.13301 0 TD
-0.0051 Tc
(a)Tj
0.65739 0 Td
(R)Tj
0.62222 0 TD
(OC)Tj
1.59729 0 Td
-0.005 Tc
(es una representaci\227n de)Tj
-11.00991 -1.10455 TD
0.071 Tw
[(la tasa de f)10(alsos positi)24(v)20(os \(1-especif)20(icidad\) frente a)]TJ
22.41947 38.65907 TD
-0.023 Tw
[(la tasa de v)15(erdaderos positi)25(v)19(os (sensibilidad). Es una)]TJ
0 -1.10455 TD
0.207 Tw
(manera \234til de mostrar la relaci\227n continua entre)Tj
T*
-0.03 Tw
[(sensibilidad y especif)20(icidad de una prueba o medida.)]TJ
T*
0.111 Tw
[(Cuanto m\207s se acerque la curv)25(a R)39(OC a la esquina)]TJ
T*
0.089 Tw
[(superior izquierda de la gr\207f)20(ica, mejor rendimiento)]TJ
T*
0.025 Tw
(diagn\227stico presentar\207 la prueba.)Tj
0.97758 -1.10454 TD
0 Tc
0.177 Tw
[(El \207rea bajo la curv)25(a R)40(O)-1(C)1( )-1(\()1(A)-1(B)1(C)-1(\))1( )-1(es)1( un v)24(alor)]TJ
-0.97758 -1.10453 TD
0.127 Tw
(num\216rico que nos da una medida de la capacidad)Tj
0 -1.10455 TD
0.05 Tw
(diagn\227stica de un test. Una prueba perfecta tendr\222a)Tj
T*
0.189 Tw
(un ABC de 1 \(100% de sensibilidad y 100% de)Tj
T*
-0.032 Tw
[(especif)20(icidad\), mientras que un test sin ning\234n v)24(alor)]TJ
T*
0.032 Tw
[(diagn\227stico tendr\222a un ABC de 0,5. P)15(ara establecer)]TJ
T*
0.01 Tw
(si hubo diferencias en las ABC se utiliz\227 el m\216todo)Tj
0 -1.10454 TD
0.025 Tw
[(descrito por Hanle)15(y McNeil (16).)]TJ
0.97758 -1.10454 TD
-0.014 Tw
[(T)80(ambi\216n se calcularon los v)25(alores de sensibilidad)]TJ
-0.97758 -1.10454 TD
0.034 Tw
[(de los par\207metros del GDx-VCC para especif)20(icida)-1(-)]TJ
T*
0.004 Tw
(des f)Tj
1.89956 0.00001 TD
(ijadas en el 85% y 90%, para discriminar entre)Tj
-1.89956 -1.10455 TD
0.025 Tw
(ojos normales y glaucomatosos.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 331.2948 396.772 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(RESUL)Tj
3.24195 0 TD
(T)Tj
0.57715 0 TD
(ADOS)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 271.5408 372.472 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.009 Tw
(En la tabla I se incluyen las caracter\222sticas demo)Tj
19.30526 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.108 Tw
[(gr\207f)20(icas de los grupos del estudio. La edad de los)]TJ
0 -1.10454 TD
0.078 Tw
(hipertensos oculares fue menor que la del resto de)Tj
0 -1.10453 TD
0.062 Tw
(los grupos, y la de los glaucomatosos mayor)Tj
18.11049 0 TD
-0.0001 Tc
(,)Tj
0.56159 0 Td
0 Tc
0 Tw
(sien-)Tj
-18.67208 -1.10455 TD
0.064 Tw
(do similares e intermedias la edad de los normales)Tj
0 -1.10454 TD
-0.0001 Tc
(y)Tj
0.88586 0 Td
0 Tc
0.136 Tw
(glaucomas preperim\216tricos. Los glaucomas pre-)Tj
-0.88587 -1.10454 TD
-0.004 Tw
(sentaron una mejor agudeza visual corre)Tj
16.09381 0 TD
(gida menor)Tj
-16.09381 -1.10455 TD
0.3 Tw
(que los otros grupos. La PIO, relaci\227n e)Tj
17.99599 0 TD
0 Tw
(xca)Tj
1.36792 0.00001 TD
(v)Tj
0.4751 0 TD
(a-)Tj
-19.83901 -1.10455 TD
0.084 Tw
[(ci\227n/disco v)15(ertical \(v)25(alorada en estereofotograf\222as\))]TJ
(y)'
1.0052 0 Td
0.255 Tw
[(los v)25(alores de los \222ndices perim\216tricos fueron)]TJ
-1.0052 -1.10455 TD
0.19 Tw
[(diferentes entre los grupos se)15(g\234n los criterios de)]TJ
0 -1.10454 TD
0 Tw
(clasif)Tj
2.14526 0 TD
0.115 Tw
(icaci\227n def)Tj
4.50934 0 TD
(inidos en el apartado de m\216todos.)Tj
-6.6546 -1.10455 TD
0.131 Tw
(Los hipertensos oculares presentaron c\227rneas m\207s)Tj
0 -1.10454 TD
0.025 Tw
(gruesas que el resto de los grupos. )Tj
ET
0 0 0 0 k
14.173 7.5279 29.435 12.314 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 14.1732 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(360)Tj
ET
0 0 0 0 k
137.36 10.6629 228.784 9.179 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.0444 14.3792 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 14.1732 672.6915 Tm
0 0 0 1 k
(BORQUE E, et al.)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
0 0 0 0 k
14.173 31.181 473.386 158.43 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9 0 0 9 14.1732 183.4652 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Tabla I.)-488(Caracter\222sticas cl\222nicas de la poblaci\227n del estudio)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
9 0 0 9 91.2424 164.1091 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Normal (n=60))-5710(HTO (n=218))-2991(Glaucoma preperim\216trico (n=68))-1658(Glaucoma (n=71))]TJ
-2.21083 -1.07533 TD
0 Tw
(Media)Tj
3.98121 0.00001 TD
(DE)Tj
4.21952 0.00001 TD
(p)Tj
3.38222 0.00001 TD
(Media)Tj
3.76044 0.00001 TD
(DE)Tj
4.1653 0 TD
(p)Tj
4.71352 0.00001 TD
(Media)Tj
4.90713 0.00001 TD
[(DE)-3121(p)-2697(Media)-1166(DE)-2431(p)]TJ
-35.48177 -2.15071 TD
0.025 Tw
[(Edad)-4575(59,85)-1120(10,78)-2193(H)-3048(53,21)-900(12,01)-974(N, P, G)-3216(59,57)-2046(10,18)-2426(H)-2863(64,83)-1359(9,23)-1737(H)]TJ
0 -1.07534 TD
[(MAVC)-4130(0,89)-1620(0,10)-2193(G)-3548(0,93)-1400(0,10)-2137(G)-4880(0,89)-2546(0,12)-2427(G)-3363(0,83)-1359(0,13)-573(N, H, P)]TJ
T*
[(PIO Basal)-2523(14,39)-1620(2,45)-1028(H, P, G)-1885(23,15)-1400(2,92)-1514(N, G)-3756(22,51)-2547(3,44)-1802(N, G)-2240(24,14)-1359(3,85)-573(N, H, P)]TJ
T*
[(E/D)-5519(0,29)-1621(0,17)-1028(H, P, G)-2384(0,41)-1400(0,13)-974(N, P, G)-3716(0,69)-2546(0,16)-1803(N, H)-2740(0,72)-1359(0,19)-1113(N, H)]TJ
T*
(DM PA)Tj
6.7969 0 TD
0 Tw
(-1,35)Tj
3.7031 0 TD
(2,41)Tj
3.94218 0.00001 TD
0.025 Tw
[(G)-3216(-0,26)-1399(1,06)-2138(G)-4547(-0,43)-2547(1,30)-2426(G)-3030(-6,10)-1359(5,43)-573(N, H, P)]TJ
-14.4422 -1.0754 TD
-0.0001 Tc
(DSM)Tj
2.4417 0 Td
0 Tc
0 Tw
(PA)Tj
4.688 0 TD
(1,51)Tj
3.3704 0 TD
0.025 Tw
[(1,61)-2192(G)-3549(0,96)-1399(0,76)-2138(G)-4880(0,97)-2546(0,72)-2426(G)-3363(5,03)-1360(3,62)-572(N, H, P)]TJ
-10.5 -1.0754 TD
0 Tw
(Paquimetr\222a)Tj
6.1296 0 TD
(551,5)Tj
3.8704 0 TD
0.025 Tw
[(20,24)-2192(H)-2549(572,6)-1399(27,38)-974(N, P, G)-2716(550,9)-2546(22,41)-2427(H)-2363(543,3)-1359(26,54)-1736(H)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 59.8013 Tm
0 Tr
0 0 0 1 k
0 Tc
0.019 Tw
(HTO = hipertensos oculares; DE = desviaci\227n est\207ndar; p= diferencias significativas con; MAVC = mejor agudeza visual corregida; PIO = presi\227n)Tj
0 -1.0754 TD
0.041 Tw
(intraocular; E/D = relaci\227n excavaci\227n /disco vertical valorada en estereofotograf\222as; DM = desviaci\227n media; PA = perimetr\222a automatizada con)Tj
58.8405 0.00001 TD
(-)Tj
-58.8405 -1.0754 TD
0.004 Tw
(vencional; DSM = desviaci\227n est\207ndar de la media. N: Diferencias con el grupo normal; H: Diferencias con el grupo de HTO; P: Diferencias con el)Tj
T*
0.025 Tw
(grupo de glaucomas preperim\216tricos; G: Diferencias con el grupo de glaucomas.)Tj
ET
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 176.5149 m
487.559 176.5149 l
S
14.173 148.256 m
487.559 148.256 l
S
0.417 w 
14.173 71.688 m
487.559 71.688 l
S
1.25 w 
14.173 70.021 m
487.559 70.021 l
S
Q

endstream
endobj
9 0 obj
<<
/Width 472
/ColorSpace/DeviceCMYK
/Filter/DCTDecode
/Subtype/Image
/Height 320
/Type/XObject
/Length 20718
/BitsPerComponent 8
>>
stream
ÿØÿà JFIF      ÿî Adobe e€    ÿÛ C 4"@.0&4KBONJBIHS^xeSXqZHIhiq{†‡†Qd“’‚œxƒ†ÿÛ C=""=VIVÿÀ @Ø" " ÿÄ           	
ÿÄ µ   } !1AQa"q2‘¡#B±ÁRÑğ$3br‚	
%&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzƒ„…†‡ˆ‰Š’“”•–—˜™š¢£¤¥¦§¨©ª²³´µ¶·¸¹ºÂÃÄÅÆÇÈÉÊÒÓÔÕÖ×ØÙÚáâãäåæçèéêñòóôõö÷øùúÿÄ        	
ÿÄ µ  w !1AQaq"2B‘¡±Á	#3RğbrÑ
$4á%ñ&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz‚ƒ„…†‡ˆ‰Š’“”•–—˜™š¢£¤¥¦§¨©ª²³´µ¶·¸¹ºÂÃÄÅÆÇÈÉÊÒÓÔÕÖ×ØÙÚâãäåæçèéêòóôõö÷øùúÿÚ    ? ã¨¢Šùä:Š(¢Š)öò˜&Y#r½×+ùS¯¨QBÃ#H#Hœ¹ş §?•	®Ì©³/,ª¤•­Û§œÜj’[—ûAHNcûÛH]ØÇ¾Ú–ôŞ¤*Ö~hº2Eçùyİ»Ê\gû¿ô~£›»Ñöókÿ m4ä
)Äœ±´Ã¦skš¢µ.k«êB¡UwÙıß½UZêd;JÅŸe³xJp‚”äúíìíİÇMSŒç&¯ıÛş¨msMÂµËlŠBJîPT¯­#_J§+oÂ$5VŠ±öÙ»ığ(ûl¿İşøŸ³Ã;ÿ Àà‹Ùáÿ ÿ à?ğJ”U¯í	ç•¿ıù_ğ£ûB_ùåoÿ ~Wü*½cí²ÿ v?ûàQöÙ»ığ(öxoçøüöxçøü­kûB_ùåoÿ ~Wü(şĞ—şy[ÿ ß•ÿ 
¯EXûl¿İşø}¶_îÇÿ |
=ùßşÿ =ùßşÿ «EZşĞ—şy[ÿ ß•ÿ 
?´%ÿ Vÿ ÷åÂ«ÑV>Û/÷cÿ ¾m—û±ÿ ßg†şwÿ €ÿ Ág‡şwÿ €ÿ Á*ÑV¿´%ÿ Vÿ ÷åÂí	ç•¿ıù_ğªôU¶ËıØÿ ïGÛeşì÷À£Ùá¿ÿ à?ğCÙáÿ ÿ à?ğJ´U¯í	ç•¿ıù_ğ£ûB_ùåoÿ ~Wü*½cí²ÿ v?ûàQöÙ»ığ(öxoçøüöxçøü­kûB_ùåoÿ ~Wü(şĞ—şy[ÿ ß•ÿ 
¯EXûl¿İşø}¶_îÇÿ |
=ùßşÿ =ùßşÿ «EZşĞ—şy[ÿ ß•ÿ 
?´%ÿ Vÿ ÷åÂ«ÑV>Û/÷cÿ ¾m—û±ÿ ßg†şwÿ €ÿ Ág‡şwÿ €ÿ Á*ÑV¿´%ÿ Vÿ ÷åÂí	ç•¿ıù_ğªôU¶ËıØÿ ïGÛeşì÷À£Ùá¿ÿ à?ğCÙáÿ ÿ à?ğJ´U¯í	ç•¿ıù_ğ£ûB_ùåoÿ ~Wü*½cí²ÿ v?ûàQöÙ»ığ(öxoçøüöxçøü­kûB_ùåoÿ ~Wü(şĞ—şy[ÿ ß•ÿ 
¯EXûl¿İşø}¶_îÇÿ |
=ùßşÿ =ùßşÿ «EZşĞ—şy[ÿ ß•ÿ 
?´%ÿ Vÿ ÷åÂ«ÑV>Û/÷cÿ ¾I×w²è‘gãGİ£7ÿ €ÿ Ág‡şwÿ €ÿ Á*ÑV¿´%ÿ Vÿ ÷åÂí	ç•¿ıù_ğªtV‘ô¶şºGş4yw¿İµÿ ¿‘ÿ iõJÍ/üş{,?ó¿üş	VŠ·öùç•·ıùOğ£íòÿ Ï+oûòŸáY´V——{ıÛ_ûùøÕwºš7(ËTàíU#ó}V—óKÿ  ÿ ‚ThQ—Ã&ÿ íßø%J*ßÛåÿ Vß÷å?Â·Ëÿ <­¿ïÊ…U¢¬}¶_îÇÿ |
>Û/÷cÿ ¾/ªÒşiàğJú­>òÿ À?à•(«_Úÿ Ï+ûò¿áGö„¿óÊßşü¯øUz*×ÚgÙ»d[}Õiîf8TŒŸ@‚ŸÕ)÷—şÿ #†¥-#)àğJ´U¯í	ç•¿ıù_ğ¥ò“…†ÜŸúà¿áU¨«rÈe±ŞÊ ‰6ü«ÕR¹ëÑ'WtÕûõ©F“+ºjıŠ”Ué¥óô³#G²Ì«”W§Ò¨ÑEV!EQEPEQEPEQEPEQEPEQEPEQEPEQEPEQEPEQEPEQEPET©sqŞrO*KÓz¹ùÑÕÄ.ïòÆÏÃr}}j**¹äº…Ã4dÑEX´û“ÿ ×#UêÍ–6ÏœãÊ9ÅV8ÉÛÓ¶k¦²ıÅ/ŸæuVş/Ÿæ[Óşåßı{ŸæµR­éØÙwŸg?Íj¡ëÅQEr¡EQEPEQEPEQEPEQEPEQEPEQEPEQEPEQV¢³E%º!†UævËÛñ"ªÖ„Öæsï#‰#¶Ff|àíşOR+jQNï–åBœ¹bµ
(¥UÎyÍBe±_•-$`;´¼ŸÈQçYÿ Ï›ßÓş}’úÚÿ ß2ñ}’úÚÿ ß2ñ­Òz¸ıÑ:–)ë5÷ÇüÄ¢µ¾¿­&Õşúş´yÖóæß÷ôÿ …:¶šE;,z;Ò­¬RÅ$÷–òBDY2Ê*>AÏâ(K¦aˆ–Ö'*FV2ç·¥mN{¤½ywSzxJ\¼Õ*ÿ ¡T±Âõ§„P‹)R}é~P…•ãw?Ê§X9ŠÒÌ¿m÷ˆÿ ’†ıj»ÍspV)fU„°Ìhè¨?à+ÅWØ‹°¤É¹NsƒşŠˆI•8>‡ü*•8Û•ËîqF>Â”¬á+/6¿àØÙÿ ¾…%9[9‘SëŸè)Â4Ïúèÿ &ÿ âjÍÒÚÇ¹b„¯µO›¸²óÏ·j«¾/ùåÿ S\‚ìAÈÍ%c*´a¤cüÿ ‘&r ›m6ü­şC\*±U`÷¦ÒÈA‘Šœ‚M%JP:‚Š‹õS|–õşû_ñ¦QJXŠrûÿ Àù¼E=£/—ëÇ¬LÊ)Ï«¨ş´¾KzÇÿ üj:)şKzÇÿ }¯øÑä·¬÷Úÿ 2•³Q’{Tª°nÊúOÿ "%ZÙCÿ Iÿ äI<–õşş/øÑä·¬÷ñÆ£¥U,ÁTd‚èÄÅÍ·R943,jcŒäŸ¼Ş¾ÃÚ†eLqœ“÷›×Ø{TuU«rû±ßòé÷÷$jòû±ßå§İ×»û‡4D2"ÌGE óšVeJFrOŞaü…Ë”ŒäŸ¼Ãù
¬ùúëÿ ²Õz°?äë¯şËUêq;Sÿ 
ıE‰ÚŸøWæËkÿ  †ÿ ®ëÿ  š©V×şAÿ ]×ÿ A5RŠ(¢¹NP¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š*Å§ÜŸş¹¯Vl‰Uœ¯Dj±$’OS]u­ì)|ÿ 3ªµ½…/Ÿæ[Óşåßı{ŸæµR­éÄª]pE¹şkU	ÉÉ¢Š(®C”(¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢§†ÊêuÌ6Òºúª~u­:RÛBŸ6¯H…QPQVÆëşº{h~²?’äÓeŠÒ&QçI)æ
›Sş²¡Ëòıîß†ãæ¥†7õÿ %şaEUjtq¼±ÆŒîxUQ’k^ÖòÚÒÆIm-ÙxŠZG,s†?Ã·*Œú…Ä®J² ÏQTş$šÓ–•%ÌÚ¿÷nÿ 6ãN1”c«õÓ§p¢ŒÉ;NG óŞ˜I''“RCi3yw9–oá‚<ò}	È~b¦Ô.š=Ğ#ÅXÕQ”6A<ÿ õê’ß]¬~ZÜH©»Cv¨¢ùUØuUÈ>œŠÚ5oxÛ–:÷¾ÏÏ·Èé‡3…§)+ÿ •ôWü@N Éô§»òg SC¸]¡˜/¦iñp²0ê«•>œ­/Ÿ'÷¿Jkî;YwŠwÚ%ÿ Lwg9bI÷®iâ#ÊÔ[ş¾oò9ı­8Eû=ş»ş„t¥J…'ø†E;Î—şz¿ıôi¬ìç,Åˆõ9¥Gdû§¾t˜ÆïÒ™Eaíª3ûÎyJRw“¸”QEQEdHQEQE QEQE*)f
£$ö¦“nÈi6ì‚Š)UK0U' ¡³Q’iìË˜ã9'ï7¯°ö¡™cSg$ıæõöÕlÚ¢¹cñu}¼—êÍ›T—,wü¼—êÁT³Q’z
{2Æ¥#9'ï0şB†eJFrOŞaü…GEQXQVüƒıuÿ Ùj½Xò?õ×ÿ eªõÕ‰ÚŸøWêubv§şù²Úÿ È!¿ëºÿ è&ªUµÿ C×uÿ ĞMT¢Š(®S”(¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(«ú=Œw²Ê²,¯åÇ¹bˆª³rSÀÆjÌÚuœ“§¸h–Q,{C)Ú	Ïc·8ã­uC	RTÕO²ÊPv¸QJ‹“ĞŸ¥Q×5BÈeg÷G“UˆÁ#9úUãnm.om˜äÄ¬™õÁª5UãËFœZ×_Ìè­ü_?Ìµ§r—c8ÿ G<ş+UZ·a÷.ÿ ëÜÿ 5ª”QEÆr…QEQ@QEU«±¤÷ÁpÈRYW8ïŒÕBÎÀQENœ d0ÅœI*)çıœäQöH—¾ƒèŠìô~µYÙË»f9$œ’hD.p¸õäâ´NÚ¿¯ü QEumì•A3Nùÿ aù·ô£6±ÿ «³V?ôÚàÿ íª³pQr§ÚsQ×CtâÚåµ¿®±eÂŸ2»vAEUÖ¹œ©H’Úÿ ¦jŠï®¿­C+\Îs4ÆCêòƒıj
}¼Fiâ‰A%ÙTîiN´j5O[zéÿ ¤šI¹Ê4áı=Š)Ñ*´¨¬p¤€iÉï_¹×ûëş5q­#‚9¥¹TwóR5ç9$0¿6+6IQÙ@R	?kÿ Šª·n²]Ìèr­#>£4ùiÂ=ãëşqGM: ½¥EÃ§œuR,[AßŒƒ»ÔS¾Oùä¿÷ò£ƒ#r	4ı²ˆå„gW?:õ ßÜÔgÊÙ6ÁÆwu¨è¬ş³Ëü8Ùÿ Û¯ÿ mFOãğ+?Hşêå¾Ò¹çï¯øÒ0”‚ÛIVş”Ê*Mğÿ Ïÿ }R4€¦ÄM‹ßœæ™EdëMßÏÉºÓwóòCóüóûì…ãfÄ]ªzó’i”QEVFAEQEPEQEPEQE¨¥˜*Œ“ÚšM»!¤Û²
(¥U,ÁTd‚„RÌFI§³,jcŒäŸ¼Ãùj–51ÆrOŞo_aíQÖÍª+–?WÛÉ~¬ÙµIrÇËÉ~¬K0U' §³,jQXıæÈPÌ±©HÎIûÌ?¨è¢Š+ ¢Š(¢Š( ¢Š*Àÿ qÿ ®¿û-W«şAÇşºÿ ìµ^º±;Sÿ 
ıN¬NÔÿ Â¿6[_ù7ıw_ıÕJ¶¿òoúî¿ú	ª”QEÊr…QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QVì.`†)à¹F†`¹10VR§#­[“S´¸ÌwV²˜¡ˆ$ƒwÊ¡pÄrVMÑUHAAmè¼ÿ Í”¤ĞªGCÒŒ©ê%ynæâòâE¤Vr¿SœU&*NUvLÕ‹%%gU&#ÀªÄ$‚;Vµå'B›}où5›öş™oO?-Ù#?èçÅj«NB…ökN¥ØQ’mÏóZ¨FQEqEQEPEQV­ÆË§o•]V5÷;”ãò¬q2Æ¤(êÌz"¤Ó®çY]R V†ØÔõÇ©÷?ç¥kr.oĞŠ(¨)ñ}É?Üş¢„+ìª~^1ß­0É+…İ³ü9&®07®ı¿ãŒ[vˆQEi•%´ât…HRÇ©íW4Èš)Ì„¼l°ÈÊBıßİ¶}iP¹Fé‡÷K·?­hè|0“K¾«üÏCêĞŠ‚¨í®»y_¯Ëäª¹`¾µ$HªAbÊJ’¸\öúÓ£‘Õ¼ÙN;mÿ ëÒK4ÑÁ¼pÍ”Ë»ÇÉmÇ×Ûm1uFVtu9VX†TúŠªÌÎrÌXûœÒVq”SnùCMÊœ©[ğCäTÛ´†\ò¾äJhr;/ıò)™ÎY‹RsIEQXÊr–œ’©)+6QEQEIEQEPEQEPEQEPEQE¨Œì$ÓŒ[vCI·dQJŠY‚ª’OaB)f
£$ÓÙ–51ÆrOŞaßØ{PÌ±©3’~óAíQÖÍª+–?WÛÉ~¬ÙµIrÇËÉ~¬K0U' §³,jQXıæÈPÌ±©D9c÷˜!QÑEVEQEPEQEPEUÿ  ãÿ ]öZ¯Vüƒıuÿ Ùj½ubv§şúX©ÿ …~l¶¿òoúî¿ú	ª•mäßõİôU(¢Š+”å
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢¬Z}Éÿ ë‘ªõbÏgÎ@òJ®q“·¥uÖ_¸¤ı3ª²ıÅ'ëù–ôÿ ¹wÿ ^çù­T«zv6]çösüÖª¼QEW!ÊQE*–!TO ôUÈ$6ÚyšWÇ¿º®ßáôëÖ®œ» QE—èEÇšÜÎ}dü;ûı*ª#1Â©4•5³"ow…%
¿u‰¯û$WTiBv”İ•´K{+Q¡Â2©.[ôµØQE**Ö¦Í‘@dfuE¤Šã·Êicº¶·SkÄrºlW2—{(ô¨§œÜ$(‘ü¨S8@Q×ØUzuªÁYÂ-_ÏÍùÄB”cKF·Ó]Z¿Â9{	*r¿íuı)C¢+lVRF3»§éJ­º9N áxL×—N…æfR0T¹ Ô4Q\®TŞéıÿ ğ9T„·Müÿ ûQÆG ‚ìA÷¦ÑEQEzrÅY
U=ŞX+/ëêÁEQEVfAEQEPEQEPEQEPEQE¨…Ø*Œ“N1mòÄq‹nÈ(¢•»Q’hD.ÁTdš{2Æ¦8ÏûÍëÿ Ö¡ÙQLqœçï7¯ÿ Z£­›T—,wêÿ Eú¿’Ó}[T—,wêÿ Eú¿»MÄBìFI§³*)3œıæõÿ ëPÌ¨¦8Îs÷›×ÛéQÑEV!EQEPEQEPEQEPEUÿ  ãÿ ]öZ¯Vüƒıuÿ Ùi¦\™•Oqší¯NR6¿•yw;+ÓrŒşUú–×şAÿ ]×ÿ A5R­¯ü‚ş»¯ş‚jWné£RUN0İÆ»PÑRùQÏÂß'ü(ò¢ÿ Ÿ„ÿ ¾OøW?±—u÷ÇüÎe//½™'”ŸóŞ/É¿øš<¤ÿ ñ~Mÿ ÄÔTT¾T_óğŸ÷Éÿ 
<¨¿çá?ï“ş{w_|Ì=”¼¾õşdtTRÏx¿&ÿ âhò“ş{Åù7ÿ QQRùQÏÂß'ü(ò¢ÿ Ÿ„ÿ ¾OøQìeİ}ñÿ 0öRòû×ù‘ÑRyIÿ =âü›ÿ ‰£ÊOùïäßüMEEKåEÿ ?	ÿ |Ÿğ£Ê‹ş~şù?áG±—u÷ÇüÃÙKËï_æGEIå'ü÷‹òoş&)?ç¼_“ñ5/•üü'ıòÂ*/ùøOûäÿ …Æ]×ßóe//½™'”ŸóŞ/É¿øš<¤ÿ ñ~Mÿ ÄÔTT¾T_óğŸ÷Éÿ 
<¨¿çá?ï“ş{w_|Ì=”¼¾õşdtTRÏx¿&ÿ âhò“ş{Åù7ÿ QQRùQÏÂß'ü(ò¢ÿ Ÿ„ÿ ¾OøQìeİ}ñÿ 0öRòû×ù‘ÑRyIÿ =âü›ÿ ‰£ÊOùïäßüMEEKåEÿ ?	ÿ |Ÿğ£Ê‹ş~şù?áG±—u÷ÇüÃÙKËï_æGEIå'ü÷‹òoş&)?ç¼_“ñ5éËr™Î;Ók9EÅ¸²%ÊÈè§KŠB„©Çu¦ÑE:(ŞY8‘ØáU$şkû'Rÿ  ußıøoğª…)Í^l,ÂŠ)vŸîš§EƒƒE@„¢Š(¢Ÿ2Ï G=’OÎæI(í¦gï¢ÆIO¨íUIü(,P9éF¥:ÓîOÿ \W«6dªÎ{ˆQU‰É$÷®šÖö¾™ÕZŞÂ—Ïó-éÿ rïş½ÏóZ©Vôãµ.Ïı;ŸæµPòsEQ\‡(QE<­4M'™h¤.]±“RÎ©‘	¢‘üÒØŒçh¦ù·ıw_ıÔ®éQvädfºéÆZ®šıæÔ)Ær÷¾¸QEëså†•­Òh×
wîÚ¤ôû¤sòšW¢d[@Ç£9?NI©o®eV¹V$‰'ÂªÂ‹Ópš¥qÌÍZÔ”c{_§ßÌubêFñŒvóK»ë¸«Ç;Aô£k¸T÷æ¦fØ’íTù\(ùúÕz$eE1¢®0¹aMGEÅR£›¹ÅRnnä²2¢˜ãU …ËóşMEEQEQEQ@QEQ@QEQ@QEQ@QERª–`ª2Oji6ì†“nÈ(¢•T³Q’z
K0U'µ=ÈLhrOŞaßÛéJÌ±)HÎXıæş‚¢­›T—,~.¾^_ç÷¶©.XïùyŸÜ
¥˜*Œ“ĞSØˆÔÆ‡$ıâ;û}(fX”¢±á˜!QÑEV!EQEPEQEPEQEPEQEPEUÿ  ãÿ ]öZeÏúÑşâè"?äë¯şËL¹ÿ Z?ÜOıW~#ø1ôşÜwWş=#ÿ ·×şAÿ ]×ÿ A5ÏúÅÿ ®iÿ  -L¿òoúî¿ú	¨nÖ/ısOıj**ÊıƒhÏÚ3ßiâ_ÿ O?øír{/4p‘QEV¥´€ÜİÃn¤)•Ö0OlœT¿ñ/ÿ §Ÿüv“L–85KIdm±Ç23E	ª§N>Ò1“Ñ±Çp rh u©F—0»ÙÙ¡]Ùê¬¹Púä’].İ'ñê1I?˜"òÄN9ÎÓÉâ¬Øê6ÆÚT¹}³F›!|grS´ı1‘õ5ú¬—²eCl—AÔˆ•~Pİx\ô®åOEïÍøk×Ukz>åZ!´æ—o¸¡HÇ=hÎHÍeÈ†92rP•¦Óî^âFS•.H?2¼Ç¾„	EQER ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š*KõÍø*¤¸ÿ \ß‡ò¨ëZÿ Å—«5­üIz²[¯õçıÕÿ ĞEERİ¯?î¯ş‚**U%H*J‘ĞŠéì x­/	¹W‰,^tjŒã«dƒŸ”çšæaE’TF‘"RpY³µ~¸®Ö(£’Ú9.,¤‘–#ù’.æLùgîqÁÆ;×~YäÜ¶Ó­µéÜTĞS•~\çğâš:úS¶¯÷—õ®]¾ñé×µ%+}ãõ¤¯,ÌmQZúß²ßmŠYdØ˜ÚÌ¹ç¸û½*íäWÛpÓùÑ´‹œ¼yv+ıŞFMs‘»FÁ£bŒ:84å–Dfd‘Õ›†!OÖ½
XÈÂ”i8íÛÕ¾ŞÕËRÒÂ¯ ğOÒ”ƒü9ëM¢´.¼·Õ5/'o–Yöàñ÷«5”¡Úvÿ ÀNj{O¹?ır5^£%*TİµwüÙÑY¯aO¾¿™sO[°1ş ÿ èKUJ¿ÍZÓşåßı{ŸæµRŠ(«V6’Í,R" Vá^™ü…rÓƒœ¹QÍóIG¸QE:#¶T'³
Y”Å§AÓ™¤o§İ_äßOËi¦îó&·&oàÊ’6ıE>KÛHõ8å†)äHYB(ÊãiÆÎøıjŒŸi”#»ÓsgèT¼%$İ·ù[·Şzrœ0´¹!+·{ş*@èjXØ,\»§'î¿­l?YS_ÿ ­Q³3}æ'êhw3I_fîç®}ê)YZBËœZyFKvÜ1–\~F¢®ZÒ—*Rİêşöy“œ¦ù¥¸ù¥i‰f*X	¨è¢Š(¢¹‰
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¥U,ÁTdÔÒmÙ&İQE*©f
£$ô*–`ª2Oj‘™bR‘œ±ûÌ?¡™bR‘œ±ûÍıE[6¨®Xü_—’ıY³j’åÿ —*–`ª2OAOfX”¢±á˜!C‰J!Ë‡òQE``QEQE QEQE QEQE QEQE QEQE QEXò?õ×ÿ e¦\ÿ ­î'ş‚)ãşAÇşºÿ ì´ËŸõ£ıÄÿ ĞEwâ?ƒHÿ íÇuàÃÒ?ûqmäßõİôPÜÿ ¬_úæŸúÔËÿ  †ÿ ®ëÿ  š†çıbÿ ×4ÿ Ğ¢¢¤GõùŸñ£Ìşx'æÆ¹}œ~?ü‰ËìãüËñÿ "*)á×ê“ó?ãFôÿ 1şgüj:Â¹¾¶·bUe•#$u œS<Èÿ ç‚~güiö¥¶¡mpêJE*9×
Aª§
q©fœo®ÿ ä„ãµ­şñ”´ıéÿ <cüÏøÓZ½&›o-´Ïh.‘âd]³¢…l¸Ö¡5ù•¢òWr»2&ŠNzñ÷zÓ£s-ÌOss<ÑG på±Ï`MN·¶S}¦+´b’s2¶îïò}t¯ªÔ}¿ò_ÑÛ·ËÌ=Ö;j‘òçñ¤ÚÉ£qÈ$“Š1ƒPÃ¤_Ê…£·?+2`²©Ü½Wç>Ô¥^¤ĞÂ`ËÌ	@¬§8ëÈ<c¾zUÇÖ"’òÖá£uò®^fUçå%p©ùj;N+XàãfU2¬Ÿ*Ÿ•ÕGàŸ—½?eƒ¿/3õÿ Àz[ÍıÁh€RhÚsŠ3üè_û*÷íG’7ìßë³o®ìíÆxëSÜhòÄ«qJóÚ
à38ÿ ÇzÔÒêvrî¶uœÚ´[7$q£)İ»!WlÓ×Y´3ÂÄ˜b3µQĞóëóqZFhåıkåé¯P´iÎ(ÛFGJ3YWvWL‹<awŒ©VVSô+Å][}+ìäµç#+òuÛŸÊ ¾¸¶kx-lÖ_*"Íº\%¶öÊ*!pŸÙ†×ko3	3ÛH®kÒ§9F6jÚ_]h„*W­;äÛŞšz`QÚ¯K¥ÛAh+Ü«<AÖe‹0ä®väsşÎ}j;-c²´¹ŠBë"¯š½ã$¿Áüª{]JÊÕ<ÈEÜnSk[+¸9ÉÎ\cñ¨aÔÒ)í–Ï
@°Íş5É'¡âº%.ÎÚö¾Ò½¾E{¢•sÏåÅ|¹£8éŸ¥ ?•M&™co{´Ò\5Ù¦Ş1#'9ÿ tV}üv±Nc´3„«y»zç¶*İæ¥ú…­Â$!‘$øçĞÖtî$G\íf$gëXbeG—–š[ş‹õ¹2k íªi§n~\ş4¤äæ’–ãıs~Ê£©.?×7áüª:ç¯üYz²ë^¬–ëıyÿ uôQT·_ëÏû«ÿ  ŠŠ¥´„\\Å	İó¶ß‘A?€$WOii$vĞù–òˆĞ*Êm‘š<tÁŞÇbV¹Xd1J’*£9ÚêOÔèlå¶H­-$·‰§š5)'Ù#d\ôÎFN;Ÿ¯¥zk¤¯Ìµõû¾bƒ@N*@Ÿ/ çıßş½GNcş•Î·~½é(o¼zuíEyFch¢Š(¢Š (¢Š±g³ädyF«œdãV->äÿ õÈÕzë¬ÿ qIzşgUgûŠK×ó-éØÙw‘‘ösÓêµPõâ­éÿ rïş½ÏóZ©EYb­¦Â”2Ë! úOğ4ÆÛ"˜±9'#õ§Ì¨tø$TZY…éÂ§øÕÑ§mó=tÓ^ñò
TáNkë¦šùy9c%7åUzrzÓØ,JŠcRÅrrNG?Zc¾åUªªIùsş{T6ÿ ññûëüé•%¿ü|Eşúÿ :°©ËÉ^ïô1©ÉÍî¢Š(¢Š+0¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢ŠURÌFIíM&İÒmÙRª–`ª2OAB©f
£$ö©–%)Ë¼Ãù
–%)Ë¼Ãù
Š¶mQ\±ø¿/%ú³fÕ%Ëÿ  U,ÁTd‚Ì±)D9cÃ0şB†e‰J!Ë‡òQE``QEQE QEQE QEQE QEQE QEQE QEQE QEXò?õ×ÿ e¦\ÿ ­î'ş‚)ãşAÇşºÿ ì´ËŸõ£ıÄÿ ĞEwâ?ƒHÿ íÇuàÃÒ?ûqmäßõİôPÜÿ ¬_úæŸúÔËÿ  †ÿ ®ëÿ  š†çıbÿ ×4ÿ Ğ¢¢Š+’Ôû¿»ş	ÍËK»û¿à‘QEU­*î5;Xe]Ñ¼Š¬¹ÆFj­Mepm/!¸TbpÛIëŠªnœjE¿†úéÿ L”¹_áÿ …ÔQ@àæ®&Zİíp,œ";·lOLv<Rk–ö¶—QÛÚl!#]ì¥²ÄŒóŸéëQ. ÊèŞRü–Æß¯b¥súÔ¯z”s%å­««åÈ[?*úWL½Œé¸RŠ½×Ü¼Ø{¯D.ßqC`)3ÏáJ ?ÄëIe¥}ª¤7PBfÅ>rÌ6ú~´.“'‘¸Ï
Îc2-¾Nâƒ9=1ĞŒô¡®~Äö‘FğÎ¶²™ƒÆNÖ'oËÈİ§kf,›XşĞ#1,ÛUGİéœ3M,*\²İzöWùŞöû=Ãİ ¹@£oGÒƒÇÍãîóëJtm®è×¶êÑÄ%“!¾E;q:üİ6çIh!•ÅÔ4H²lLäÆqµºcºñÖ£—Qid¹s>ˆó÷vìçÿ ıiEñ–GB©šíËpv|ßøå)<+ºŒ{Û;í¿{ùèm÷ÇqI¾ôf©Äd‰eRÄ.XíQõ=«Lèr„EsÇ.õßµ•T¢î=W¦;Ó!¶ŠÊTºP±•¡!Ö?Ÿæ+Î>íJúŞvíBª?4¬ÄîB‡$ÑJ•
qışú}×]´î	En»zr9£hîSùĞ[=ª8ôV–0Ñ]BÆLùµ—o§Ëòó3ŒÔqéM%‹ÜGq2Gæ4J•_®6çÛ4û]]à³Hæ DMæ2…Ï<¨8<šöÏú€Ú®ã[ÌlÆ2 >¾µvÁ¸ß¯/öÿ ?•¼ÃÜ¾â¿.sJ…ÛıieqŠÊ¢Š+Í J(¢¤¸ÿ \ß‡ò¨êKõÍø*µ¯üYz³ZßÄ—«%ºÿ ^İ_ıTU-×úóşêÿ è"¢©m&û5ÔS|ß»lü´ş}«¦²Ô/¦‚<ÃtÌcVÜ×Û7äà`êOA\¥tPÜÛ[ÛZ-ÅÌqÊ¨’|¶ìùÂ‘Nà>Pk¿.«(]srÇşİ_Ÿõ¹0`84íÌGVüé´¹ÿ ëW<Ç,O½%ËœóÖŠòÈŠ(¢Š( Š(«dªÎTàˆ"£€Ÿ4¶rv±Ï¾ÓRÙ¬ãb=MEÄŒ=¿ô^ŒoÉCµÿ SĞWä¡ëú–ôâU.ÊœnyU¨ 'ÍİÜ+ûí5>œ2—cşÏóZ‚$#ı†ÿ ĞM3–nå‰üMiÜY­¶—wr¤ó$`Š›ˆùcàò0z~u6¡'0\œãhªË4³e‘ä#€Y‰¬pñIsK¯ù¯ëï'Nö“ïøŞ>~dg$äòM8"„Ë§$cm­NqƒšFfo¼IÇ©¥·ÿ ˆ¿ß_çQÔ–ÿ ññûëüê:Æ_Ã^¯ô8âQEQE‚Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š)UK0U'µ4›vCI·dQJªY‚¨É=
¥˜*Œ“Ú¤fX”¤g,~óä(fX”¤g,~óä**ÙµErÇâü¼—êÍ›T—,wüT³Q’z
{2Ä¥åÃù
–%(„<3ä*:(¢ŠÀÀ(¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š°?äë¯şËL¹ÿ Z?ÜOıSÇüƒıuÿ Ùi—?ëGû‰ÿ  ŠïÄ>‘ÿ Ûêÿ Á‡¤öâÚÿ È!¿ëºÿ è&¡¹ÿ X¿õÍ?ô©—şAÿ ]×ÿ A5ÏúÅÿ ®iÿ  -0E!·ıóKäÉÿ <ßşù5 ½»êûøhûußüıOÿ pû§5©wwü*)ÂY À‘¿:_6Oùèÿ ÷Ñ¨ü™?ç›ÿ ß&§ÒQ_V²GUdiãR¤d¸S>İwÿ ?Sÿ ßÃL¶–HnbšeÕ“ŒòEiJQ…HÉìš%ò&¹FP½E?Í“şz?ıôi•·qäËÁs=„’I"$?eˆ+'ÍÉ$*ñ¶«Ia§Âey..<˜¤ò2±®âüäõû¼}k8¬öò¤­FÁ·.åÇ#š³¡yoæÌ¨Ï¹¼Èƒ&îyMv{zs½†¿7÷ê¯ÿ Éî8óÁÛÿ ¤Â÷&phu4[d–;yîdË3ÁDr»pO·5:M½ËÛµ¼ò˜]dŞY0Ø;F{äU5ÔnŒĞÈ_t‘JeBW$±Æsÿ |Š|S_Ú¤E"tXK0Ì\|ÀœõÕL+zS÷ıŸ?P¼{
w4msÅ&hÉf]*ÖiiVÙ"ŞT*™İ·où«Ré°\F©Šì„—ò—%v;ëœ/LóYÇR½I.$ˆ§–#òDW9ÆÜc¯46«~e\6Ù3P±÷AÇ¦ñWØHéÈíÿ çøâ.ÕÏ^(Çô£&“&£½¶·n-$‘¡”²m‘B²²ã=>¢¯K§Ù¤I=ÜÒª•…a‰Š0}º~µFêkËı› ÂF>D†¨¹ç¢ô—7wOÃ:í°…)´ü«µJÇŒŸ&š[¶Îı{ŠñÔt£ßô¤'4g5{S†ŞÇJKhÁiÄˆîc_›aƒÔvık¬]^Íwş¸©ùŞN¶3üª½sâjB¤ïhÙ%÷
Nìqá1ïM ’h¢Š(¬QEIqş¹¿åQÔ—ë›ğşUk_ø²õfµ¿‰/VKuş¼ÿ º¿ú¨ª[¯õçıÕÿ ĞEEEu6+1°´DcS*¹Ú¨Êû±Ø*?/zç´ûtº¿··v*²:©#¯>•±iJ!¶’Öd²°Xy17cŒœäò?†»òå(·.OËÉõkşäÀ)ÃvŞø¦´áÓëúV}ãÎyëIA$g4W–@Ú(¢¦³¶k™Äa‚(ÏDQÔš¿&›im5ÇÚ§•asf4’:“ì8üê­ûYÇ,bŞ	’]»„ªOİúş@«÷:…ôóı¦c…¦2Çäªäö!²{àr+Ğ¡?²Õ®o;ÛúıK-€RíPNIëŠ@qØR’¤œúöª_gkYïmÜ‚Ñ+!#¾UƒïŸ÷ÿ A5oíêêöåÓ™9\úœâ’U#[­Ğ®U¶BwØöÇëZòF^ÉÁè›û¹Ô—-êå«¹wÿ ^çù­WƒïŸ÷ÿ A5cO?-ÙÆÑÏŠÔ1d$*¯ÈÜ÷M+¼PéPÅåe¦Ë³nÇ •P1úÕ»'™mfû3|¨»Gß5U#Ên.¨	ÀÎ ÷®}9"ã­¾Kì…IB8>«ÿ ‘ıÿ ¯A¬Q>^Jç9÷ÿ ëS)ï÷"ÿ wúše:±¨”®â¬1ÍER6Å‡bº±İŸ”ëQÖ]”`yáEQEV QEQE QEQE QEQJˆ]‚¨É4ãß,G¶ì‚Š)Q°U&„BìFI§³,kåÆsıæõÿ ëPÌ¨¦8Îs÷›×ÿ ­QÖÍªK–;õ¢ı_Éi¾­ªK–;õ¢ı_İ¦â!v
£$ÓÙ•ËŒçûÍëì=¨fTSg9ûÍëíô¨è¢Š+¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š*Àÿ qÿ ®¿û-2çıhÿ q?ôOò?õ×ÿ e¦\ÿ ­î'ş‚+¿üúGÿ n;«ÿ ‘ÿ Û‹kÿ  †ÿ ®ëÿ  š†çıbÿ ×4ÿ Ğ¦_ù7ıw_ıÔ7?ëş¹§ş€´ÑÖ?ûíÆ—ÈoXÿ ïâÿ GEr^Ÿò¿¿ÿ µ8H¨¢Š“ÈoXÿ ïâÿ XÑ¿ä3cÿ _ÿ èB©Ô–±K5ÌQ[çÍf0vóÛšºRŒjAÂ/F¿­‡ÂÔQ@ëÅkB/E½ù¾óşÍäœyÙÛ¿#fÜ÷ş™«’$Ó,‘È—v®°º6ûfP‡îƒìO5ÎËq4À	¦’@½718©ç†ò†ÚY
¬JÆe\ôÈÏË×½vSÅ{­(·¿?»},ÿ 2Ô…ÁÚsŸÆƒƒG…0’zšR×Şª)*AS‚:Z—7/¥X©¸ïy·9ÁåzûTr^Z)dşÉµer²Èöj§2KØ¥¿(eRzÏâ1\Ñ~Æ2Q•ÓÓK÷Oª]‰ØJ2qÖ—pşâş´•ĞŞ¬ÓÅyæ¥å¤‹gVmöíËŸ»ŸáëRÅ²÷[¶ˆí[‹V‰£=7ÇµI_ªõÙ®a§™¢XšW1¯İBÇhü)²	ÛxèÙçó®¯íó_–ú«ü¯şesê8çiÈ#ùP¼²úŠnh­èæ–=fÒ4•Ñ¬dª± şæ°d’I[t®ÎŞ¬rhó$Ü{nQ´òJmqÖ®êG—Í¿¾Ä7qAçğ¤¢Š(¢ŠçQEQE QE%Çúæü?•GR\®oÃùTu­âËÕšÖş$½Y-×úóşêÿ è"¢©n¿×Ÿ÷Wÿ A r©ÍíÑwss)ic±rK/÷Iô¨(¨Œ¥…™>´QEQREQEPEU‹0JN'Ê5+‚--Aàì—úÔV|$äÏ#V e†Ñ]Š¯•31Q“…ÿ Jõ)[ÙÒş¾Ò=G™PŠŞÿ ûqoO¥Ø$ÛŸæµ#¸ßú	©ôÿ ¹wÿ ^çù­WƒıaÎq±ººjœÓ,–öÑ¨9‰
œû±?Öšßñïûíü–’_+îK”ÿ l i[ş=£ÿ }¿’×,´æh¯ı´çÄ·Î¢ŞÊ+ğ˜AıÕÇêi´­·?.qïIQÑEÊs…QEQ@QEQ@QER¢`ª2M8Å·h1mÙR¢`ª2M…Ø*Œ“OfTSg9ûÍëÿ Ö¡™QLqœçï7¯·Ò£­›T—,wêÿ Eú¿’Ó}[T—,wêÿ Eú¿–Ûˆ…Ø*Œ“OfTSg9ûÍëíô¡™QLqœçï7¯·Ò£¢Š(¬BŠ(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(«şAÇşºÿ ì´ËŸõ£ıÄÿ ĞE<È8ÿ ×_ı–™sş´¸Ÿú®üGğcéı¸î¯üzGÿ n-¯ü‚ş»¯ş‚jŸõ‹ÿ \Óÿ @Z™äßõİôPÜÿ ¬_úæŸúÔTQErsÇùWãşg7<‘~?æEEQW4VTÖ,ÙˆU®I=9ªtS…E	Æj?¹2’{FßxP½EVôwacŠÛ÷OØÈ¹ŞŠœõÎ@¨uƒqâGFEh†p¸ÆŸSXôWD±³”T_tşîÎÇg·Å&rÃ4”WF×H³Áj¿gò$Šo3äS“ºM¼õì¸¬ı~Y'¹·•İŞ=…vÿ tg§NsÖ³(¢®2Ui:mu]{+XNM«ÏÊ)äş”QEW!EQEPEQEPEQEPET—ë›ğşUIqş¹¿åQÖµÿ ‹/Vk[ø’õd·_ëÏû«ÿ  ŠŠ¥ºÿ ^İ_ıTTQE‘QEQE QEQE QEfËgÉÀò5nÔ¯—«¶Şãÿ @j§i÷'ÿ ®F¬[˜­­RAéfUÜ[î¥z~5éFÎ8÷Oÿ J=J0Œ£I¿³¯şMbŞ—yà}œÿ 5ªÉ÷:m?Ê¬éÿ rïş½ÏóZ†%^˜ä£ş³À$áFI©dFH#WR§spF;-6ßırÓ+š|±…û¤¾åpUø¾Qÿ ÒQQEQ\ÆAEQEPEQE¨…Ø*Œ“N1mÚ#Œ[vAE¨…Ø*Œ“B!v
£$ÓÙ•ÇÎ~ózÿ õ¨fXÔÇÎ~ózû}*:ÙµIrÇ~¯ô_«ù-7ÕµIrÇ~¯ô_«ı7°U&Ì¨¦8Îs÷›×ÛéC2¢˜ã9ÏŞo_o¥GEQX…QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QVüƒıuÿ Ùi$NAhß;UxqØcÒ?äë¯şËUë¶½IB0QşUÑ>ıÎÚÕ%Á/å]ïÜ¶¿òoúî¿ú	¨šHih¤ÜTíÀÇ÷jUÿ C×uÿ ĞMT©3üó“şûüM‡şyÉÿ }ş&£¢¹ı´»/ü?äsûiv_øÈ—u·üñ—şşş&ÖßóÆ_ûø?øšŠŠ“0ÿ Ï9?ï±ÿ ÄÑ˜çœŸ÷Øÿ âj:(öÒì¿ğÿ {iv_øÈ—u·üñ—şşş&ÖßóÆ_ûø?øšŠŠ“0ÿ Ï9?ï±ÿ ÄÑ˜çœŸ÷Øÿ âj:(öÒì¿ğÿ {iv_øÈ—u·üñ—şşş&ÖßóÆ_ûø?øšŠŠ“0ÿ Ï9?ï±ÿ ÄÑ˜çœŸ÷Øÿ âj:(öÒì¿ğÿ {iv_øÈ—u·üñ—şşş&ÖßóÆ_ûø?øšŠŠ“0ÿ Ï9?ï±ÿ ÄÑ˜çœŸ÷Øÿ âj:(öÒì¿ğÿ {iv_øÈ—u·üñ—şşş&ÖßóÆ_ûø?øšŠŠ“0ÿ Ï9?ï±ÿ ÄÑ˜çœŸ÷Øÿ âj:(öÒì¿ğÿ {iv_øÈ—u·üñ—şşş&ÖßóÆ_ûø?øšŠŠ“0ÿ Ï9?ï±ÿ ÄÑ˜çœŸ÷Øÿ âj:(öÒì¿ğÿ {iv_øÈ—u·üñ—şşş&ÖßóÆ_ûø?øšŠŠ“0ÿ Ï9?ï±ÿ ÄÑ˜çœŸ÷Øÿ âj:(öÒì¿ğÿ {iv_øÈ—u·üñ—şşş&ÖßóÆ_ûø?øšŠŠt¯¾BÛvçµ6Š+9IÉ¹=Ùœ¤äÜŸQó8’BÊ»Aè3šeQERQEQE QE±Æò0HÑ™ğ¨É¥X¤feXØ²ò@^V­éfğ¼©g)…JşöEãjçÔs×°ëZ“]]Énf°óÖcp‘»(!ßj(RØõ95ÙG	Óæmıß–¿×È¨Å0¢…Ïn)Ù=W=kÈíYÎÄG­K!Qalä€vÈêj[¤ûSRHBìÜáBôûÕŸ!*DçåOº¾™®–*tÛÖ1¿ş”z”¥ìèÂRWŠOÿ J^…8á.Ïı;Ÿæµ
UXgk¸õÍO§Œ­ØóÀÿ èKU;N8ô9§Dª…$gUëÎj*|Ÿêâÿ tÿ 3L®ó½£nßŠG—)9;±(¢Š(¢ŠÀ¢Š(¢ŠTBíµG4ã'ËÆ.O–!E¨…Ûjõ¡»m^´öuE1ÅÓø›×ÿ ­Cºªùqıßâoïõª:ÙÉR\°ß«ıêúúo«j’å†ı_è¿W×Óq»mQÍ=QLq}ßâníÿ Ö¡ÙU|¸şïñ7÷¿úÕQE`bQEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEXò?õ×ÿ eªõ`È8ÿ ×_ı–«×V'já_©Õ‰ÚŸøWæËkÿ  †ÿ ®ëÿ  š©V×şAÿ ]×ÿ A5RŠ(¢¹NP¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š(¢Š( ¢Š*kk»›RÆÚâXw}ï-Êçò§}¾ğJò‹¹üÇ]¬şaËBj½j¬â”SvC» JıÒE.ãœäÒQV->åÇır5^¬YãlùÎ<£Ò«œdíéÚºæ¿Ùàÿ ºÿ ô£ºKı?áúR-éÿ rïş½ÏóZ©Vôìl»ÏO³ŸæµPõâŸ'ú¸¿İ?ÌÓ)ò«‹ıÓüÍ2¹ªü_(ÿ é(à
(¢Š(¥D.ÛTsYÆ.O–#Œ\Ÿ,BŠ)Q¶ÕëB!vÚ½iîê«åÇ÷‰¿½ÿ Ö¡İQ|¸şïñ7÷¿úÕlÚ¤¹!¿Wú/ÕõôßVÕ5Ëú¿Ñ~¯¯¦â!vÚ£š{²ªùqıßâoïõ¨vU_.?»üMıïşµGEQX…QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QVüƒıuÿ Ùj½Xò?õ×ÿ eªõÕ‰ÚŸøWêubv§şù²Úÿ È!¿ëºÿ è&ªUµÿ C×uÿ ĞMT¢Š(®S”(¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š±i÷'ÿ ®F«Õ‹"Ug#¨ˆÕrI$¦»§o«Ãü/ÿ J;åo«Çü/ÿ JE½?î]ÿ ×¹şkU*ŞœJ¥ÙE¹şkU	ÉÉ§Éş®/÷Oó4Ê|Ÿêâÿ tÿ 3MD.ÛTs\õ"å5öäÅ·Ë¢ŠTBíµzĞˆ]¶¨æî¨¾\wø›ûßıjÕËîÿ {ÿ ­QÓmR\ß«ıêúúo«jšåı_è¿W×Óq»mQÍ=ÙU|¸şïñ7÷¿úÔ;*¯—İş&ş÷ÿ Z£¢Š(¬BŠ(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(«şAÇşºÿ ìµ^¬ùúëÿ ²ÕzêÄíOü+õ:±;Sÿ 
üÙmäßõİôU*Úÿ È!¿ëºÿ è&ªQEW)ÊQEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQW¬­¬şÈnoZ`'”‹Üç$ç°Èâ´¥IÔ|±W
(¥ÆMCf2³Œû£Ö£…Gšs´íV>£…5hÛµ¥Íí³˜•Ÿ\¯k;’£¬	ÏO”×£>Jpå×_ı(ïjøxÅ-y_ş”‹ZpÊ]Œãıÿ 5ª‡­[°û—õîšÕTRÌi™y™WåàvP R»ª/—ù‰¿½ÿ Ö¡İQ<¸şïñ7÷¿úÕqN|—Šwowú/Õü–›ò¶©®XïÕş‹õ}}7¶ÕÓİ•WËîÿ {ÿ ­C²ªùqıßâoïõª:(¢Šç1
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢Š(¢€
(¢¬ùúëÿ ²Õz°?äë¯şËUë«µ?ğ¯ÔêÄíOü+óeµÿ C×uÿ ĞMT«kÿ  †ÿ ®ëÿ  š©EQ\§(QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEUë+«Uµ6×Êñ¬b˜)Î0Tç±ãòª4UÓ¨é»ÄiØ)T®9ğ¤¢¯Ç3Ş]İÌP”3míÉéQµ­Ç—µ!Û»ï?ız©œt­;: ™c¸‘®m‘Zd)„Á §?ÂH¯Je:.2ƒv½Úq[ëÖ-ôgu,Lg(¾ªé¥»¿ò¿Ì½¥£H×(‰½ŒëÊÒ¾ŸyåíKV]ßyV¨R=yOìWóÈşb±\gıQüÅA“êhÉõ5ÉÏ…şIàKÿ 2çÂÿ $¿ğ%ÿ È†—{ŸøöqGö]ïüû=T¢¬}†ãê¿ZO±\ÿ Ï#ùŠƒ'ÔÑ“êhçÂÿ $¿ğ%ÿ È>ù%ÿ /ş@·ı—{ƒşôf^ÿ Ï³ÕJ*Á±¸ÿ Dş4%Œå†èˆ_¨ªù>¦´¢²´İ–©Zå"óHòñl®sœóéŒÖÔ£‡œ½ÚoNœÑÿ äJŒ°·¿³øÿ äKgK½òîæ•4»ÂØkwUõªt¸¼ÕO±\ÿ Ï#ùŠ_°Üc>Wášµ{a0Íö{‰$–ÕÂL¬›W'Œ©ÏLŒsY¹>¦•Haé>YAÿ àQÿ äEÍ†[Â_øÿ ä_Ù—¿óìôeŞíÏÙßéUH½%Oö+Ÿùä1Jlnÿ TOãUò}M>¦²çÂÿ $¿ğ%ÿ ÈŸü’ÿ À—ÿ  [şÌ½ÿ Ÿg éw ÿ Ç»Ÿ¥T¢¬ùåÆ“ìW?óÈşb Éõ5-´2\LÆy=ÉÀQÜŸaU†“Q9_üKÿ l3ûÿ À—ÿ  []éÿ —wf^ÿ Ï³ÕJ)æÆ}«ˆ{ò)>Åqÿ <æ*üºmµ´÷&âæ_³ÂÈŠÑ¦YË.zÀàÕØÒîHîØxaÆGcùVÕiP§¬©¾ßù¶eJXkßÙ¿ü	ò%Ã¥ŞmR-ß=Ç¥ Òïsÿ Î*®Ğ	Éèi±\Ï#ùŠQcpå?¯“êhÉõ5‡>ù%ÿ /ş@|/òKÿ _üléw¹ÿ g£û.÷Ÿôwª”Tÿ b¹ÿ Gó¿a¸ÀıßëUò}M>¦—>ù%ÿ /ş@9ğ¿É/ü	ò¿ìËßùöz?²ïxÿ Gz©EX[Ã1¹ç‘A²¸ÉÛÇÔUØ4ÈÚÀO4—
Ïu)	hã^@Ş{gm6]:Ñn$7qB²ºù6œ ç9 úWSÃÒP¿³}ş(ÿ ò%_Ëü7ÿ /şD¸š]áenásÉ¤şË½ÿ Ÿgª»~\Ñ¼ÕO°Ü`şëõ¤ûÏüò?˜¨2}M>¦¹yğ¿É/ü	òóá’_øÿ ä_Ùw¸ÿ wúQı™{ÿ >ÏU(«ÆàõYüh7şYcñªù>¦ŒŸSOŸ‚_øÿ äŸ‚_øÿ ägK½òîæ¥ŞŸùwqU(©şÅsÿ <æ)ÆÆ}ŠDgvNFGùõ§i–¢òíayWil"å›;Tw&®M¦[ÛË#Ï<éo#òÇš¥³„+œò“]¨Qœ9ãMÛoŠ>¿ÊTe†·ğßş¿ùßöeïüû=)Òï6öwİ“‘TÔdÒí½gıŠçşyÌR›€Hò³îÖæÒé¡Y7¦Õdlcr•N>†«äúšÂOàá+¯ï/ş@l2Ó’_øÿ ä_Ù—¿óìô.ô}Ï¸ª‡ƒEX7şë'Ø®ç‘üÅA“êhÉõ5<ø_ä—ş¿ù çÂÿ $¿ğ%ÿ ÈÆ—{Ïú;Š?³/çÙê¥`ØÜqû¯×¥*XÎ]CFBç“‘PÂ,«uMÇï;mQõ5¢Úl1]Ê²\¹¶†•¤9mÁpwnõ½(PŸ½n×şhúÿ /‘Q–÷öoÿ _ü‰léw¼£½*iw…Ô5»ªç“éTévó×Š­$/Ÿ¶EÚL¹ÿ Çj¥j¶›k
´÷2ıìòŠF¶àO œ`æ¨^[›K¹mËòÛ‡qØÔbá/uòòÆ>îé¾½­¿C<Dã7XÙE[{şˆ½5´ÖÚIY£1“:‘Ÿ÷MP¥Àõ¤<†Š(®œ(¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š(¢Š (¢Š+VêşÑâ¹–›í7H©"°•'iï’¢²¨­iÕ•8¸Ç¯üù64ì¤®8ÎM%QE‚Š(¢Š( Š(¢µ}=,+y®#(g_%q#S»îç¶+.ŠÖ•WNö[;/Ë·‚sô¤¢´ï¯lŞ“j³y·nEp6ÇÎJ©ïÏÓ¥fQE*µ]WvÜS·øsÍ%QE5¥¬÷“,6ñ—sÎaêj#'Ëv ¢Š ÏJ†­X_/7m¼,«±–U'Œç±Zé·Wp™aJ‚Urê¥ˆ!Aê~”©¦İ5™¹X×ËÚ[×qQÔ…ëzŞ:Ğjp‹ûº&Ô¡I£iÛš¿u©ØßK:OÁ˜ÙËeTƒO|úö™p.¯%P¢±ùTöQÀıvrŞ;¤>XØ›Ø»ª*®@ê~¢‹»G´(á}İ<©Uÿ =§ŠºÕ+U‡<£îß{zÿ ›m«‹•$ç {SOZdñÄĞWo\~ ¢Š+¢Š(¢ŠµŸ<ÊÌ†ˆŠÌÍ*ª®z“×ƒÅT)ÊnĞW\(¢”)>Ÿ_µÕaf•î¶±´kcË“9Æyã¯<â£–şÑ¢–dY¾×4)bğ °=yÓŞ²İJ;!*Jœ|§"œñ4n¨JUHÚÀõ®§‹ªãÊÿ §k}öş®W3½ò(%qÆri(¦QO·H$]¯aœàŠX`y–CäF›Û‹ÀşµËÈïËmI
(èqEGET€QEoK¹Öw2ùŠ’Dc/ŞL÷ç¡5z]BÊh¤¦äÀ#ES!e,A+Ÿ1^¾•EtÓÅNœ9ßÖŸÖ¥)5 ª}hÊqëIEXÔ.æé¤‰
Fª¨Šİvª…÷ÀªôQXNNrr{²^ y4QEQEHQEj}ºÖI¤I–U‚[h¡fE•‘Sœg‘•ık.ŠÖYSÒ?ÖëõcNÁK•'œã”V¼—Ö7µ¤Âá-£òü§ERß*r3r~•Ÿ}p.¯%Sb»|«ıÕíúTUUÄN¬m/ëşàäØ¹S×>Ô‡“EQE€‚Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢Š( Š(¢´4)ÚJóLq3|ãvàf³è­)Tt§®ƒNÌ(h¢¶´äY¡Ó¥Y¢,å-6÷
UwÈ¯§•(1»Ç¨¬±-ºZ¼l…×pm¬»võç ÖÕg,Tyvóê’KòØ®aW±ãŠ=óÚ’ŠÛÒ¾Éç\¥’K[òîŠ¢±ŞœdïßµIrC©Fe³²€´L¨°Î£'ÕI,¹ã8¬
(1F1÷ukw¿ò¿Ïä.aFÜü¼ıiGĞ¡¦Ñ]2ÆË=ù´–ŸËˆ©“Ëù<®~áoëSDöä¿ÖÆçz}¤«Dªß"çïpW;³¶¹hæ’8d‰É·zã®E2¶YŠ¹cøù·§ß«ë±\ã½pGjU#™ïÒ™Eo±Sbßb{8í{ç+•';Î¿1ùvíÇzš+µÂ(RXÕZî_—œîİü…sTVqÇÊñKoåo’ò‡Å öÏSh®‚ø“k/Ù¥´[M²yªÛ77`uÏİÁT¡Ç”Ÿb{E”$>w˜S˜ü¤õíÙ•ÍQOëúß—·^×Û¶ÿ Ÿpçø{b—<qzm×Åå5ÔÄËnÖòÏ7˜Æ£$ ç,{cëTCªérˆäµ¦ÍUßæewg¾sŸlb¹ê*¥˜óFÜ½ú÷_—[w1ùàôç4‡îöÆ)´QEW˜@QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEÿÙ
endstream
endobj
10 0 obj
<<
/Matrix[1 0 0 1 0 0]
/OPI<</2.0<<
/Version 2
/Type/OPI
/CropRect[0.059 0 944.97998 641]
/F(macline1:Users:macline1:Documents:TRABAJOS:SOCIEDADES INTERNET:SEO:06-junio-08 (internet):Imagenes junio:Fig.S07089.01.tif)
/IncludedImageQuality 1
/Size[945 641]
/Inks/full_color
>>
>>
/FormType 1
/Name/Fm1
/BBox[-1.14986 -3.18542 1.0625 1.36597]
/Subtype/Form
/Resources<</ExtGState<</GS1 2 0 R>>/XObject<</Im1 9 0 R>>/ProcSet[/PDF/ImageC]>>
/Type/XObject
/Length 35
>>
stream
/GS1 gs
q
1 0 0 1 0 0 cm
/Im1 Do
Q

endstream
endobj
11 0 obj
<<
/Matrix[1 0 0 1 0 0]
/OPI<</1.3<<
/Version 1.3
/Type/OPI
/CropRect[0 0 945 641]
/CropFixed[0.059 0 944.97998 641]
/F(macline1:Users:macline1:Documents:TRABAJOS:SOCIEDADES INTERNET:SEO:06-junio-08 (internet):Imagenes junio:Fig.S07089.01.tif)
/Resolution[300 300]
/ImageType[4 8]
/Position[260.78699 489.86899 260.78699 643.70203 487.55899 643.70203 487.55899 489.86899]
/Size[945 641]
>>
>>
/FormType 1
/Name/Fm0
/BBox[0 0 501.73196 700.15692]
/Subtype/Form
/Resources<</ExtGState<</GS1 2 0 R>>/XObject<</Fm1 10 0 R>>/ProcSet[/PDF]>>
/Type/XObject
/Length 63
>>
stream
/GS1 gs
q
226.7858 0 0 153.83369 260.773 490.0253 cm
/Fm1 Do
Q

endstream
endobj
12 0 obj
<<
/Length 8992
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.039 Tw
[(T)80(odos los par\207metros estudiados mostraron dife-)]TJ
-0.97758 -1.10455 TD
0.236 Tw
(rencias entre los glaucomas y los dem\207s grupos)Tj
T*
0.25 Tw
[((tabla II), e)15(xcepto el cociente superior/nasal \(no)]TJ
T*
0.133 Tw
(mostr\227 diferencias entre los glaucomas y los nor-)Tj
T*
0.04 Tw
(males\), la modulaci\227n de la elipse \(no se encontra-)Tj
T*
-0.034 Tw
(ron diferencias entre los glaucomas y los glaucomas)Tj
0 -1.10454 TD
0.372 Tw
(preperim\216tricos\), el cociente temporal/nasal \(no)Tj
0 -1.10453 TD
0.053 Tw
(hubo diferencias entre los glaucomas y los glauco-)Tj
0 -1.10455 TD
0.062 Tw
(mas preperim\216tricos\), el promedio temporal \(no se)Tj
T*
0.201 Tw
[(observ)25(aron diferencias entre los glaucomas y los)]TJ
T*
0.155 Tw
(normales y glaucomas preperim\216tricos\), y el pro-)Tj
T*
-0.002 Tw
(medio nasal \(no present\227 diferencias entre los glau-)Tj
T*
0.202 Tw
(comas y los glaucomas preperim\216tricos\). Ning\234n)Tj
0 -1.10454 TD
0.004 Tc
0.371 Tw
(par\207metro mostr\227 diferencias entre controles e)Tj
T*
0 Tc
0.025 Tw
(hipertensos oculares.)Tj
0.97758 -1.10454 TD
0.038 Tw
(La tabla III muestra las ABCs de todos los par\207-)Tj
-0.97758 -1.10454 TD
0.132 Tw
(metros del GDx-VCC para discriminar entre con)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.21 Tw
(troles y glaucomatosos. El par\207metro con mayor)Tj
0 -1.10454 TD
0.054 Tw
(ABC fue el NFI (0,876). Le siguen el \207rea inferior)Tj
0 -1.10455 TD
0.007 Tw
(normalizada (0,847) y el promedio inferior (0,822).)Tj
0 -1.10454 TD
0.229 Tw
(Las curv)Tj
3.67455 0.00001 TD
(as R)Tj
1.9392 0 TD
(OC de los seis mejores par\207metros)Tj
-5.61375 -1.10455 TD
0.015 Tw
(pueden v)Tj
3.63733 0.00001 TD
(erse en la f)Tj
4.38147 0 TD
(igura 1. Al comparar las curv)Tj
11.76404 0 TD
0 Tw
(as)Tj
-19.78284 -1.10455 TD
(R)Tj
0.6272 0 TD
0.093 Tw
(OC de estos seis par\207metros, el NFI present\227 un)Tj
21.79227 1.13061 TD
0.032 Tw
(ABC mayor que la del promedio TSNIT (p=0,012))Tj
0 -1.10455 TD
-0.0001 Tc
(y)Tj
0.77484 0 Td
0 Tc
0.025 Tw
(que la de la inte)Tj
6.41584 0 TD
(gral inferior (p=0,009).)Tj
ET
0 0 0 0 k
461.93 8.5039 25.629 11.338 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 469.559 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
(361)Tj
ET
0 0 0 0 k
137.614 10.57 228.784 9.178 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.2989 14.2856 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 345.0473 672.6915 Tm
0 0 0 1 k
(Diagn\227stico del glaucoma con el GDx-VCC)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
0 0 0 0 k
14.173 31.181 473.386 320.895 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9 0 0 9 14.1732 345.9297 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Tabla II.)-488(Media y desviaci\227n est\207ndar de los par\207metros del GDx-VCC estudiados en cada grupo. La columna p expresa)]TJ
4.29167 -1.07535 TD
(los resultados de las comparaciones m\234ltiples (ANOVA) entre los grupos)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
9 0 0 9 104.7627 316.8957 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Normal)-8964(HTO)-6246(Glaucoma preperim\216trico)-4663(Glaucoma)]TJ
-1.42147 -1.07534 TD
0 Tw
[(Media)-1679(DE)-2022(p)-2306(Media)-1593(DE)-2973(p)-2584(Media)-2353(DE)-3121(p)-2697(Media)-1165(DE)-2432(p)]TJ
-8.64403 -2.19755 TD
(NFI)Tj
8.85186 0 TD
(15,68)Tj
3.90741 0 TD
[(9,18)-1134(P,G)-2125(17,64)-1576(7,68)-1809(P,G)-2643(23,35)-2046(11,00)-1455(N,H,G)-1891(40,90)-859(21,93)-848(N,H,P)]TJ
-12.75927 -1.12223 TD
0.025 Tw
[(Promedio TSNIT)-1857(56,63)-1657(6,35)-1134(P,G)-2125(55,02)-1576(4,74)-2211(G)-3047(53,09)-2546(6,33)-1940(N,G)-2378(46,82)-1359(8,46)-847(N,H,P)]TJ
0 -1.12222 TD
[(Promedio superior)-1413(66,91)-1657(8,69)-1537(G)-2528(66,66)-1576(6,96)-1808(P,G)-2644(63,21)-2546(8,12)-1940(H,G)-2378(54,73)-859(11,60)-848(N,H,P)]TJ
T*
(Promedio inferior)Tj
8.85186 0 TD
0 Tw
[(66,48)-1657(8,78)-1135(P,G)-2125(64,24)-1575(7,27)-2212(G)-3046(61,44)-2547(9,45)-1940(N,G)-2377(52,07)-859(11,62)-848(N,H,P)]TJ
-8.85186 -1.12224 TD
0.025 Tw
[(Desv.est. TSNIT)-2079(22,63)-1658(4,92)-1537(G)-2528(22,91)-1576(5,04)-1808(P,G)-2644(20,33)-2546(5,38)-1940(H,G)-2377(16,32)-1360(4,73)-847(N,H,P)]TJ
0 -1.12223 TD
[(Raz\227n superior)-3246(3,21)-1658(1,25)-1537(G)-3028(3,44)-1575(1,25)-2212(G)-3546(3,00)-2546(1,13)-2426(G)-3364(2,26)-1359(0,89)-848(N,H,P)]TJ
0 -1.12222 TD
(Raz\227n inferior)Tj
9.35186 0 TD
0 Tw
(3,34)Tj
3.40741 0 TD
(1,23)Tj
3.28718 0 TD
[(G)-3028(3,45)-1576(1,21)-2211(G)-3546(3,03)-2547(1,17)-2426(G)-3363(2,31)-1359(0,83)-848(N,H,P)]TJ
-16.04644 -1.12223 TD
(Sup/nasal)Tj
9.35186 0 TD
[(2,31)-1657(0,58)-5287(2,54)-1576(0,74)-2212(G)-3546(2,44)-2546(0,75)-2426(G)-3364(2,02)-1359(0,50)-1333(H,P)]TJ
-9.35186 -1.12223 TD
0.025 Tw
[(Max mod)-5466(2,58)-1658(1,16)-1537(G)-3028(2,68)-1576(1,22)-2211(G)-3546(2,26)-2547(1,15)-2426(G)-3363(1,63)-1359(0,79)-848(N,H,P)]TJ
0 -1.12222 TD
[(M\207ximo superior)-1912(78,35)-1158(12,41)-1537(G)-2528(78,29)-1076(10,52)-2211(G)-3046(76,51)-2047(11,72)-2426(G)-2863(64,33)-859(13,90)-848(N,H,P)]TJ
T*
[(M\207ximo inferior)-2191(82,30)-1157(11,61)-1537(G)-2528(78,87)-1076(10,51)-2211(G)-3047(77,79)-2046(13,74)-2426(G)-2863(66,82)-859(14,63)-848(N,H,P)]TJ
T*
(Ell mod)Tj
9.35186 0.00001 TD
0 Tw
[(4,07)-1657(1,77)-1538(G)-3027(4,14)-1576(1,75)-2212(G)-3546(3,54)-2546(1,80)-6512(2,80)-1359(1,30)-1250(N,H)]TJ
-9.35186 -1.12223 TD
0.025 Tw
(\347rea sup norm)Tj
9.35186 0.00001 TD
0 Tw
(0,14)Tj
3.40741 0.00001 TD
(0,03)Tj
2.88423 0.00001 TD
[(P,G)-2625(0,14)-1576(0,02)-1808(P,G)-3144(0,12)-2546(0,03)-1454(N,H,G)-2392(0,10)-1359(0,03)-848(N,H,P)]TJ
-15.6435 -1.12224 TD
0.025 Tw
(\347rea inf norm )Tj
9.35186 0.00001 TD
0 Tw
(0,15)Tj
3.40741 0.00001 TD
(0,03)Tj
2.88423 0.00001 TD
(P,G)Tj
4.1528 0 TD
(0,14)Tj
3.32574 0.00001 TD
[(0,02)-1808(P,G)-3144(0,13)-2546(0,03)-1455(N,H,G)-2391(0,10)-1359(0,03)-848(N,H,P)]TJ
-23.12205 -1.12225 TD
[(Temp/nasal)-4687(0,80)-1658(0,32)-1537(G)-3028(0,79)-1575(0,26)-2212(G)-3546(0,85)-2546(0,21)-6512(0,97)-1359(0,28)-1251(N,H)]TJ
0 -1.12223 TD
[(Inf/nasal)-5854(2,42)-1658(0,59)-1537(G)-3028(2,55)-1575(0,71)-2212(G)-3546(2,45)-2547(0,73)-2426(G)-3363(2,09)-1359(0,46)-848(N,H,P)]TJ
0 -1.12222 TD
0.025 Tw
[(Integral total)-4191(0,53)-1657(0,06)-1134(P,G)-2625(0,52)-1576(0,04)-2212(G)-3546(0,50)-2546(0,06)-1940(N,G)-2878(0,45)-1359(0,08)-848(N,H,P)]TJ
T*
[(Integral superior)-2692(0,20)-1657(0,03)-1135(P,G)-2625(0,20)-1575(0,02)-1809(P,G)-3143(0,19)-2547(0,03)-1454(N,H,G)-2391(0,17)-1359(0,03)-848(N,H,P)]TJ
T*
[(Integral inferior)-2970(0,21)-1658(0,03)-1134(P,G)-2625(0,20)-1576(0,02)-2211(G)-3547(0,19)-2546(0,03)-1940(N,G)-2877(0,17)-1359(0,03)-848(N,H,P)]TJ
T*
[(Promedio temporal)-1135(27,27)-1157(11,24)-4787(25,54)-1576(8,03)-2211(G)-3047(28,83)-2046(11,09)-6011(30,84)-860(11,80)-1736(H)]TJ
T*
[(Promedio nasal)-2634(43,42)-1658(8,30)-1537(G)-2528(40,88)-1576(9,24)-2211(G)-3046(39,43)-2047(10,37)-6011(35,99)-1359(8,03)-1251(N,H)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 68.2335 Tm
0 Tr
0 0 0 1 k
0 Tc
0.037 Tw
(HTO = hipertensos oculares; DE = desviaci\227n est\207ndar; p = diferencias significativas con; NFI = indicador de fibras nerviosas; Desv est TSNIT =)Tj
0 -1.0754 TD
0.056 Tw
(desviaci\227n est\207ndar TSNIT; Sup/nasal = Cociente superior/nasal; Max mod = Modulaci\227n m\207xima; Ell mod = Modulaci\227n de la elipse; \347rea sup)Tj
T*
0.019 Tw
(norm = \347rea superior normalizada; \347rea inf norm = \347rea inferior normalizada; Temp//nasal = Cociente Temporal/nasal; Inf/nasal = Cociente infe-)Tj
T*
0.015 Tw
(rior/nasal. N: Diferencias con el grupo normal; H: Diferencias con el grupo de HTO; P: Diferencias con el grupo de glaucomas preperim\216tricos; G:)Tj
T*
0.025 Tw
(Diferencias con el grupo de glaucomas.)Tj
ET
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 327.9789 m
487.559 327.9789 l
S
14.173 299.054 m
487.559 299.054 l
S
0.417 w 
14.173 78.1529 m
487.559 78.1529 l
S
1.25 w 
14.173 76.4859 m
487.559 76.4859 l
S
0 0 0 0 k
260.787 484.7449 226.772 164.388 re
f
/GS3 gs
q
260.787 484.7449 226.772 164.388 re
W n
/Fm0 Do
Q
/GS2 gs
260.787 395.27 226.772 80.882 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 260.7874 469.3234 Tm
0 Tr
0 0 0 1 k
0 Tc
0.026 Tw
[(Fig. 1:)-500(Curvas ROC de los 6 par\207metros del GDx-VCC)]TJ
0 -1.1 TD
-0.007 Tw
(con mayor capacidad diagn\227stica para diferenciar entre)Tj
T*
0.025 Tw
(normales y glaucomas. )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
9 0 0 9 260.7874 437.6454 Tm
0 Tr
0 0 0 1 k
-0.01 Tc
-0.03 Tw
(NFI = indicador de fibras nerviosas; Inf Norm Area = \347rea infe)Tj
24.86408 0 TD
0 Tc
(-)Tj
-24.86408 -1.07534 TD
-0.01 Tc
0.125 Tw
(rior normalizada; Promedio Inf = Promedio inferior; Desv St)Tj
T*
-0.009 Tw
(TSNIT = Desviaci\227n est\207ndar TSNIT; Inf Int = Integral inferior.)Tj
ET
Q

endstream
endobj
13 0 obj
<<
/Length 7727
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
14.173 7.5279 29.435 12.314 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 14.1732 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(362)Tj
ET
0 0 0 0 k
137.36 10.6629 228.784 9.179 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.0444 14.3792 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 14.1732 672.6915 Tm
0 0 0 1 k
(BORQUE E, et al.)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
0 0 0 0 k
14.173 345.873 473.386 303.2599 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9 0 0 9 14.1732 642.9875 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Tabla III.)-488(\347reas bajo la curva ROC e intervalos de confianza de la curva de los par\207metros del GDx-VCC para)]TJ
4.68056 -1.07533 TD
(diferenciar entre sanos y sujetos con glaucoma)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
9 0 0 9 124.558 613.9535 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(ABC)-5328(DE)-5759(p)-8160(Intervalo de confianza del 95%)]TJ
21.00805 -1.07533 TD
-0.0002 Tc
(L)Tj
0.61084 0.00001 TD
0 Tc
[(\222mite inferior)-5114(L\222mite superior)]TJ
-33.88387 -2.15068 TD
0 Tw
[(NFI)-10558(0,876)-5022(0,03)-4393(<0,001)-6970(0,80)-9442(0,92)]TJ
0 -1.07532 TD
0.025 Tw
[(Promedio TSNIT)-5173(0,822)-5022(0,04)-4393(<0,001)-6970(0,75)-9442(0,89)]TJ
0 -1.07534 TD
[(Promedio superior)-4729(0,799)-5022(0,04)-4393(<0,001)-6970(0,72)-9442(0,87)]TJ
T*
[(Promedio inferior)-5007(0,831)-5022(0,03)-4393(<0,001)-6971(0,75)-9442(0,89)]TJ
0 -1.07533 TD
[(Desv.est. TSNIT)-5395(0,815)-5023(0,04)-4392(<0,001)-6971(0,73)-9442(0,87)]TJ
T*
[(Raz\227n superior)-6062(0,698)-5022(0,05)-4393(<0,001)-6971(0,61)-9442(0,79)]TJ
T*
[(Raz\227n inferior)-6341(0,621)-5022(0,05)-4675(0,002)-7252(0,52)-9442(0,72)]TJ
0 -1.07534 TD
0 Tw
[(Sup/nasal)-8280(0,737)-5022(0,04)-4393(<0,001)-6970(0,65)-9442(0,82)]TJ
T*
0.025 Tw
[(Max mod)-8282(0,762)-5022(0,04)-4393(<0,001)-6971(0,68)-9442(0,84)]TJ
0 -1.07533 TD
[(M\207ximo superior)-5228(0,642)-5023(0,05)-4674(0,001)-7253(0,55)-9442(0,74)]TJ
T*
[(M\207ximo inferior)-5507(0,760)-5022(0,04)-4393(<0,001)-6970(0,68)-9442(0,84)]TJ
0 -1.07534 TD
[(Ell mod)-8949(0,769)-5022(0,04)-4393(<0,001)-6970(0,69)-9442(0,85)]TJ
T*
(\347rea sup norm)Tj
12.16793 0 TD
0 Tw
[(0,792)-5022(0,04)-4393(<0,001)-6971(0,71)-9441(0,87)]TJ
-12.16793 -1.07534 TD
0.025 Tw
(\347rea inf norm )Tj
12.16793 0 TD
0 Tw
(0,721)Tj
7.27202 0 TD
[(0,04)-4393(<0,001)-6971(0,63)-9441(0,81)]TJ
-19.43995 -1.07534 TD
[(Temp/nasal)-7503(0,800)-5022(0,04)-4393(<0,001)-6971(0,72)-9442(0,88)]TJ
T*
[(Inf/nasal)-8670(0,847)-5022(0,03)-4393(<0,001)-6971(0,77)-9442(0,90)]TJ
0 -1.07533 TD
0.025 Tw
(Integral total)Tj
12.16793 0 TD
0 Tw
[(0,664)-5022(0,05)-4393(<0,001)-6971(0,57)-9441(0,76)]TJ
-12.16793 -1.07533 TD
0.025 Tw
[(Integral superior)-5508(0,811)-5022(0,04)-4393(<0,001)-6971(0,74)-9442(0,88)]TJ
T*
(Integral inferior)Tj
12.16793 0 TD
0 Tw
(0,794)Tj
7.27202 0 TD
(0,04)Tj
6.14297 0 TD
(<0,001)Tj
9.78451 0 TD
(0,72)Tj
11.19191 0 TD
(0,87)Tj
-46.55935 -1.07535 TD
0.025 Tw
[(Promedio temporal)-4451(0,815)-5022(0,04)-4393(<0,001)-6970(0,73)-9442(0,87)]TJ
0 -1.07534 TD
[(Promedio nasal)-5950(0,751)-5022(0,04)-4393(<0,001)-6971(0,67)-9442(0,83)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 374.1537 Tm
0 Tr
0 0 0 1 k
0 Tc
0.036 Tw
(ABC = \207rea bajo la curva ROC; DE = desviaci\227n est\207ndar; p = nivel de significaci\227n de la curva ROC; NFI = indicador de fibras nerviosas; Desv)Tj
0 -1.07537 TD
0.022 Tw
(est TSNIT = desviaci\227n est\207ndar TSNIT; Sup/nasal = Cociente superior/nasal; Max mod = Modulaci\227n m\207xima; Ell mod = Modulaci\227n de la elip-)Tj
T*
0.056 Tw
(se; \347rea sup norm = \347rea superior normalizada; \347rea inf norm = \347rea inferior normalizada; Temp//nasal = Cociente Temporal/nasal; Inf/nasal =)Tj
T*
0.025 Tw
(Cociente inferior/nasal.)Tj
ET
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 625.874 m
487.559 625.874 l
S
14.173 596.7479 m
487.559 596.7479 l
S
0.417 w 
14.173 385.4829 m
487.559 385.4829 l
S
1.25 w 
14.173 383.817 m
487.559 383.817 l
S
0 0 0 0 k
14.173 31.181 473.386 295.945 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9 0 0 9 14.1732 320.9807 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Tabla IV.)-488(Sensibilidad de los diferentes par\207metros del GDx-VCC para especificidades fijadas en el 85% y 90%, para)]TJ
4.625 -1.07533 TD
(discriminar entre sujetos normales y con glaucoma)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
9 0 0 9 172.2019 291.9466 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Especificidad 85%)-12895(Especificidad 90%)]TJ
-4.1939 -1.07533 TD
[(Punto de corte)-4117(Sensibilidad (%))-3913(Punto de corte)-4211(Sensibilidad (%))]TJ
-13.36484 -2.15067 TD
0 Tw
[(NFI)-13667(23,50)-7861(70,42)-8212(24,50)-8233(69,01)]TJ
0 -1.07532 TD
0.025 Tw
(Promedio TSNIT)Tj
15.27778 0 TD
0 Tw
(49,99)Tj
10.11111 0 TD
(61,97)Tj
10.4615 0 TD
(49,58)Tj
10.48295 0 TD
(57,74)Tj
-46.33333 -1.07535 TD
0.025 Tw
(Promedio superior)Tj
15.27778 0 TD
0 Tw
(60,73)Tj
10.11111 0 TD
(64,78)Tj
10.4615 0 TD
(57,41)Tj
10.48295 0 TD
(53,52)Tj
-46.33333 -1.07535 TD
0.025 Tw
[(Promedio inferior)-8117(57,00)-7861(67,60)-8212(55,02)-8232(61,97)]TJ
0 -1.07533 TD
(Desv.est. TSNIT)Tj
15.27778 0 TD
0 Tw
(17,11)Tj
10.11111 0.00001 TD
(60,56)Tj
10.4615 0 TD
[(16,84)-8233(56,33)]TJ
-35.85038 -1.07535 TD
0.025 Tw
(Raz\227n superior)Tj
15.77778 0 TD
0 Tw
[(1,96)-7861(47,88)-8712(1,70)-8233(33,80)]TJ
-15.77778 -1.07533 TD
0.025 Tw
[(Raz\227n inferior)-9950(2,01)-7862(52,11)-8711(1,85)-8233(33,80)]TJ
0 -1.07534 TD
0 Tw
[(Sup/nasal)-11890(1,72)-7861(32,39)-8711(1,61)-8233(22,53)]TJ
0 -1.07533 TD
0.025 Tw
[(Max mod)-11892(1,51)-7861(54,92)-8712(1,23)-8233(40,84)]TJ
T*
(M\207ximo superior)Tj
15.27778 0 TD
0 Tw
(68,00)Tj
10.11111 0.00001 TD
(54,92)Tj
10.4615 0 TD
[(64,33)-8233(50,70)]TJ
-35.85038 -1.07535 TD
0.025 Tw
(M\207ximo inferior)Tj
15.27778 0.00001 TD
0 Tw
(70,35)Tj
10.11111 0.00001 TD
(60,56)Tj
10.4615 0.00001 TD
[(66,46)-8233(53,52)]TJ
-35.85038 -1.07535 TD
0.025 Tw
(Ell mod)Tj
15.77778 0.00001 TD
0 Tw
(2,75)Tj
9.61111 0.00001 TD
[(59,15)-8711(2,14)-8233(36,61)]TJ
-25.38889 -1.07535 TD
0.025 Tw
(\347rea sup norm)Tj
15.77778 0.00001 TD
0 Tw
(0,12)Tj
9.61111 0 TD
[(70,42)-8711(0,11)-8233(66,19)]TJ
-25.38889 -1.07535 TD
0.025 Tw
[(\347rea inf norm )-9789(0,12)-7861(70,42)-8712(0,12)-8233(64,78)]TJ
0 -1.07534 TD
0 Tw
[(Temp/nasal)-11113(1,03)-7861(32,39)-8712(1,27)-8233(14,08)]TJ
T*
(Inf/nasal)Tj
15.77778 0.00001 TD
[(1,79)-7861(29,57)-8712(1,69)-8233(23,94)]TJ
-15.7778 -1.0753 TD
0.025 Tw
(Integral total)Tj
15.77778 0.00001 TD
0 Tw
[(0,48)-7861(64,78)-8712(0,47)-8233(56,33)]TJ
-15.7778 -1.0753 TD
0.025 Tw
[(Integral superior)-9118(0,19)-7861(67,60)-8712(0,18)-8232(52,11)]TJ
T*
[(Integral inferior)-9396(0,18)-7861(66,19)-8712(0,18)-8233(60,56)]TJ
T*
[(Promedio temporal)-7561(36,69)-7861(25,35)-8211(40,23)-8233(16,90)]TJ
T*
[(Promedio nasal)-9060(34,98)-7861(52,11)-8212(34,06)-8233(50,70)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 52.1467 Tm
0 Tr
0 0 0 1 k
0 Tc
0.039 Tw
(NFI = indicador de fibras nerviosas; Desv est TSNIT = desviaci\227n est\207ndar TSNIT; Sup/nasal = Cociente superior/nasal; Max mod = Modulaci\227n)Tj
0 -1.0754 TD
0.013 Tw
(m\207xima; Ell mod = Modulaci\227n de la elipse; \347rea sup norm = \347rea superior normalizada; \347rea inf norm = \347rea inferior normalizada; Temp//nasal)Tj
-0.0001 Tc
(=)'
0.8388 0 Td
0 Tc
0.025 Tw
(Cociente Temporal/nasal; Inf/nasal = Cociente inferior/nasal.)Tj
ET
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 304.0299 m
487.559 304.0299 l
S
14.173 274.8929 m
487.559 274.8929 l
S
0.417 w 
14.173 63.337 m
487.559 63.337 l
S
1.25 w 
14.173 61.67 m
487.559 61.67 l
S
Q

endstream
endobj
14 0 obj
<<
/Length 9307
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 641.6219 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0.031 Tw
[(En la tabla IV se encuentran los v)25(alores de sensi-)]TJ
-0.97758 -1.10455 TD
0.298 Tw
[(bilidad para especif)20(icidades pref)19(ijadas al 85% y)]TJ
-0.0051 Tc
(90%)'
2.13835 0 Td
(de)Tj
1.25445 0 Td
-0.005 Tc
0.076 Tw
(los par\207metros estudiados, para diferenciar)Tj
-3.3928 -1.10455 TD
0.15 Tw
(entre sanos y glaucomas. El NFI, el \207rea superior)Tj
T*
-0.01 Tw
(normalizada y el \207rea inferior normalizada presenta-)Tj
T*
0.051 Tw
(ron las sensibilidades m\207s altas \(70,42% en los tres)Tj
0 -1.10454 TD
0.073 Tw
[(par\207metros\) para una especif)20(icidad del 85%. T)79(odos)]TJ
0 -1.10453 TD
0.089 Tw
(los par\207metros del informe est\207ndar mostraron una)Tj
0 -1.10455 TD
0.003 Tw
[(sensibilidad mayor al 60% para dicho ni)25(v)15(el de espe)-1(-)]TJ
T*
0.183 Tw
[(cif)19(icidad. P)15(ara una especif)20(icidad del 90%, el NFI)]TJ
T*
0.139 Tw
(sigue siendo el par\207metro con mayor sensibilidad,)Tj
T*
-0.001 Tw
[(se)15(guido de nue)24(v)20(o por el \207rea superior normalizada y)]TJ
T*
-0.014 Tw
(el \207rea inferior normalizada, con unas sensibilidades)Tj
0 -1.10454 TD
0.025 Tw
[(del 69,01%, 66,19% y 64,78% respecti)25(v)25(amente.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 91.4504 445.3719 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(DISCUSI\356N)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 421.072 Tm
0 Tr
0 0 0 1 k
0 Tc
0.306 Tw
(En el presente estudio hemos demostrado, al)Tj
-0.97758 -1.10454 TD
0 Tw
(igual que di)Tj
4.69542 0 TD
(v)Tj
0.48511 0 TD
(ersos estudios anteriores, que los par\207)Tj
15.10232 0.00001 TD
(-)Tj
-20.28284 -1.10456 TD
0.037 Tw
(metros analizados por el GDx-VCC son \234tiles para)Tj
0 -1.10454 TD
-0.014 Tw
(discriminar entre sujetos normales y glaucomatosos)Tj
T*
0.115 Tw
(con defectos le)Tj
6.20212 0.00001 TD
[(v)15(es o moderados en la P)92(A \(6,7,17-)]TJ
-6.20212 -1.10455 TD
-0.022 Tw
(21\). La mayor\222a de los par\207metros presentaron dife-)Tj
0 -1.10454 TD
0.011 Tc
0.364 Tw
(rencias signif)Tj
5.85854 0.00001 TD
0 Tw
(icati)Tj
1.75203 0 TD
0 Tc
(v)Tj
0.48625 0 TD
0.011 Tc
0.364 Tw
(as entre sujetos normales o)Tj
-8.09681 -1.10454 TD
0.002 Tc
0.373 Tw
(hipertensos y glaucomatosos, no encontr\207ndose)Tj
0 -1.10455 TD
0 Tc
0.012 Tw
(para ning\234n par\207metro diferencias entre controles e)Tj
0 -1.10454 TD
0.025 Tw
(hipertensos oculares.)Tj
0.97758 -1.10454 TD
0.065 Tw
(Entre todos los par\207metros destaca el NFI como)Tj
-0.97758 -1.10455 TD
0.158 Tw
(el de mayor capacidad diagn\227stica. El NFI es un)Tj
T*
0.026 Tw
(indicador global del estado de la CFNR, se basa en)Tj
T*
-0.027 Tw
[(un a)20(v)25(anzado sistema de an\207lisis de redes neuronales)]TJ
T*
0.015 Tw
[(que v)25(alora el perf)19(il completo de la CFNR y obtiene)]TJ
0 -1.10454 TD
0.101 Tw
(un n\234mero que representa la inte)Tj
13.56603 0 TD
(gridad de la mis)Tj
6.71681 0 TD
(-)Tj
-20.28284 -1.10455 TD
0.108 Tw
[(ma. La clasif)20(icaci\227n diagn\227stica del NFI se deter-)]TJ
0 -1.10454 TD
0.022 Tw
(min\227 a partir de la distrib)Tj
10.2238 0 TD
[(uci\227n normal de sus v)25(alo-)]TJ
-10.2238 -1.10455 TD
0.101 Tw
(res en la base de datos incluida en el propio GDx)Tj
T*
0 Tw
(VCC. )Tj
0.97758 -1.10455 TD
0.123 Tw
(Otros estudios (6,7,17) han encontrado tambi\216n)Tj
-0.97758 -1.10454 TD
0.12 Tw
(que el NFI es el par\207metro de mayor rentabilidad)Tj
T*
0.121 Tw
(diagn\227stica para el glaucoma, con ABCs de hasta)Tj
T*
0.125 Tw
[(0,98 (7). L\227gicamente, el grado de la e)15(xtensi\227n y)]TJ
T*
0.045 Tw
(profundidad de los defectos del campo visual tiene)Tj
T*
0.029 Tw
(una gran influencia en la sensibilidad de los instru)Tj
20.28284 0.00001 TD
(-)Tj
-20.2828 -1.1046 TD
0.275 Tw
(mentos de diagn\227stico por imagen. Cuanto m\207s)Tj
0 -1.1045 TD
0.273 Tw
[(a)20(v)25(anzada est\207 la enfermedad mayor sensibilidad)]TJ
T*
0.041 Tw
(presentan estos equipos. Reus y Lemij (7) obtuvie-)Tj
T*
0.124 Tw
[(ron una capacidad diagn\227stica tan ele)25(v)25(ada para el)]TJ
T*
-0.026 Tw
(NFI porque incluyeron una poblaci\227n de glaucomas)Tj
0 -1.1046 TD
-0.025 Tw
[(con m\207s del 50% de glaucomas se)25(v)15(eros. Medeiros y)]TJ
0 -1.1045 TD
-0.0001 Tc
(col.)Tj
1.7354 0 Td
0 Tc
0.014 Tw
((6), encontraron resultados m\207s parecidos a los)Tj
20.68403 55.39542 TD
0.285 Tw
(nuestros utilizando una poblaci\227n de glaucomas)Tj
0 -1.10455 TD
0.238 Tw
(incipientes (ABC de 0,91 para el NFI). En otra)Tj
T*
0.001 Tw
(poblaci\227n en nuestro medio (17), los resultados son)Tj
T*
0.358 Tw
(superponibles, siendo el NFI el par\207metro con)Tj
T*
0.025 Tw
[(mayor ABC de nue)25(v)20(o.)]TJ
0.97758 -1.10455 TD
0.096 Tw
(El resto de par\207metros que ofrece el GDx-VCC)Tj
-0.97758 -1.10454 TD
0.049 Tw
(presentaron ABCs menores que el NFI, la mayor\222a)Tj
0 -1.10453 TD
-0.016 Tw
[(con v)25(alores por debajo de 0,80. Once par\207metros de)]TJ
0 -1.10455 TD
0.014 Tw
(los 21 ofrecidos por el polar\222metro presentan sensi-)Tj
T*
0.071 Tw
[(bilidades superiores al 60% para una especif)20(icidad)]TJ
T*
0.133 Tw
[(f)20(ijada en el 85%, aunque s\227lo 5 la siguen mante-)]TJ
T*
-0.003 Tw
[(niendo para una especif)20(icidad del 90%. Estos resul-)]TJ
T*
0.054 Tw
(tados son similares a los de otros estudios como el)Tj
0 -1.10454 TD
0.161 Tw
(de DeLeon (21), que presenta 13 par\207metros con)Tj
T*
0.135 Tw
[(sensibilidad mayor al 62% para una especif)20(icidad)]TJ
T*
-0.018 Tw
(del 80%, a pesar de que en este estudio la poblaci\227n)Tj
T*
0.359 Tw
(era de predominio afroamericano, que presenta)Tj
T*
0.012 Tw
(diferencias en la presentaci\227n y e)Tj
13.33488 0.00001 TD
(v)Tj
0.48023 0 TD
(oluci\227n del glau-)Tj
-13.81511 -1.10455 TD
0.025 Tw
(coma frente a la raza cauc\207sica.)Tj
0.97758 -1.10455 TD
0.021 Tw
[(En nuestro estudio tratamos de v)25(alorar la capaci-)]TJ
-0.97758 -1.10454 TD
0.077 Tw
(dad diagn\227stica de los par\207metros ofrecidos por el)Tj
T*
0.066 Tw
(GDx-VCC de manera independiente. Encontramos)Tj
T*
0.26 Tw
(que cuatro de los cinco par\207metros del informe)Tj
T*
0.113 Tw
(est\207ndar son los que mayor capacidad diagn\227stica)Tj
0 -1.10453 TD
0.107 Tw
(presentaron de entre todos los que el softw)Tj
17.81636 0 TD
(are del)Tj
-17.81636 -1.10455 TD
0.035 Tw
(aparato nos ofrece. Es f)Tj
9.5413 0.00001 TD
(actible que combinando los)Tj
-9.5413 -1.10455 TD
0.309 Tw
(par\207metros en f\227rmulas discriminantes podamos)Tj
0 -1.10454 TD
0.094 Tw
[(conse)15(guir una mayor capacidad diagn\227stica, como)]TJ
T*
0.169 Tw
[(se ha demostrado al e)25(v)25(aluar di)24(v)15(ersos sistemas de)]TJ
(e)'
0.41895 0 TD
(v)Tj
0.4751 0 TD
0.115 Tw
(aluaci\227n objeti)Tj
6.00462 0 TD
[(v)25(a de la CFNR (20,23-29). En la)]TJ
-6.89866 -1.10455 TD
0.106 Tw
(generaci\227n anterior del polar\222metro l\207ser)Tj
16.65439 0 TD
-0.0001 Tc
(,)Tj
0.60629 0 Td
0 Tc
(el GDx-)Tj
-17.26068 -1.10455 TD
0.062 Tw
[(NF)74(A, mediante la f\227rmula discriminante propuesta)]TJ
T*
0.037 Tw
[(por W)80(einreb (26), se observ\227 una mayor capacidad)]TJ
0 -1.10454 TD
0.002 Tw
(diagn\227stica que con el \307n\234mero\310 que aporta el ana)Tj
20.28283 0 TD
(-)Tj
-20.28283 -1.10455 TD
0 Tw
(lizador)Tj
2.72119 0 TD
-0.0001 Tc
(.)Tj
0.52497 0 Td
0 Tc
0.025 Tw
(Este \307n\234mero\310 es el equi)Tj
10.12779 0 TD
[(v)25(alente al NFI del)]TJ
-13.37394 -1.10455 TD
(polar\222metro l\207ser GDx-VCC.)Tj
0.97758 -1.10454 TD
0.044 Tw
(Hemos de ser cautos a la hora de generalizar los)Tj
-0.97758 -1.10455 TD
-0.035 Tw
(resultados del presente estudio para no sobreestimar)Tj
T*
0.083 Tw
[(los resultados del mismo. Los pacientes pro)15(vienen)]TJ
0 -1.10454 TD
0.149 Tw
(de una consulta especializada en glaucoma de un)Tj
0 -1.10453 TD
0.158 Tw
(hospital terciario (poblaci\227n seleccionada), por lo)Tj
0 -1.10455 TD
0.191 Tw
[(que los resultados del estudio en un conte)15(xto de)]TJ
0 -1.10454 TD
0.258 Tw
(consulta oftalmol\227gica primaria ser\222an, con toda)Tj
0 -1.10455 TD
-0.012 Tw
[(se)15(guridad, menores. A pesar de todo esto, encontra-)]TJ
T*
0.009 Tw
(mos en nuestro estudio una b)Tj
11.65962 0.00001 TD
(uena capacidad discri)Tj
8.62322 0.00001 TD
(-)Tj
-20.28283 -1.10455 TD
0.069 Tw
(minatoria entre controles sanos y sujetos con da\226o)Tj
T*
0.131 Tw
(glaucomatoso inicial o moderado mediante el uso)Tj
0 -1.10454 TD
0.065 Tw
(del polar\222metro l\207ser GDx-VCC. El uso de combi)Tj
20.28285 0.00001 TD
(-)Tj
-20.28285 -1.10456 TD
0.022 Tw
(naciones de par\207metros u otros m\216todos de an\207lisis)Tj
0 -1.10455 TD
0.189 Tw
(de la CFNR pueden apo)Tj
10.35645 0.00001 TD
(yarnos en el diagn\227stico)Tj
-10.35645 -1.10455 TD
0.025 Tw
(precoz de glaucoma y deben ser estudiados.)Tj
ET
0 0 0 0 k
461.93 8.5039 25.629 11.338 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 469.559 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
(363)Tj
ET
0 0 0 0 k
137.614 10.57 228.784 9.178 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.2989 14.2856 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 345.0473 672.6915 Tm
0 0 0 1 k
(Diagn\227stico del glaucoma con el GDx-VCC)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
Q

endstream
endobj
15 0 obj
<<
/Length 9998
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 70.711 473.386 578.4219 re
f
Q
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 78.809 640.2562 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(BIBLIOGRAF\352A)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
9 0 0 9 18.6732 613.2562 Tm
0 Tr
0 0 0 1 k
0 Tc
0.102 Tw
[(1.)-640(American Academy of Ophthalmology. Glaucoma Panel.)]TJ
1.38977 -1.11111 TD
0.13 Tw
(Preferred Practice Pattern. Primary open-angle glauco-)Tj
T*
0.214 Tw
(ma. San Francisco: American Academy of Ophthalmo-)Tj
T*
0.025 Tw
(logy; 2005. Disponible en: www.aao.org/ppp)Tj
-1.38977 -1.11111 TD
-0.003 Tw
[(2.)-640(Quigley HA. Neuronal death in glaucoma. Prog Retin Eye)]TJ
1.38977 -1.11112 TD
0.025 Tw
(Res 1999; 18: 39-57.)Tj
-1.38977 -1.11111 TD
0.201 Tw
[(3.)-640(Sommer A, Katz J, Quigley HA, Miller NR, Robin AL,)]TJ
1.38977 -1.11111 TD
0.067 Tw
(Richter RC, et al. Clinical detectable nerve fiber atrophy)Tj
T*
0.022 Tw
(precedes the onset of glaucomatous field loss. Arch Opht-)Tj
0 -1.11112 TD
0.025 Tw
(halmol 1991; 109: 77-83.)Tj
-1.38977 -1.11111 TD
-0.003 Tw
[(4.)-640(Weinreb RN, Zangwill L. Retinal nerve fiber layer evalua-)]TJ
1.38977 -1.11111 TD
0.025 Tw
(tion in glaucoma. J Glaucoma 2001; 10: S56-S58.)Tj
-1.38977 -1.11111 TD
0.201 Tw
[(5.)-640(Sommer A, Quigley HA, Robin AL, Miller NR, Katz J,)]TJ
1.38977 -1.11112 TD
0.018 Tw
(Arkell S. Evaluation of nerve fiber layer assessment. Arch)Tj
0 -1.11111 TD
0.025 Tw
(Ophthalmol 1984; 102: 1766-1771.)Tj
-1.38977 -1.11111 TD
0.067 Tw
[(6.)-640(Medeiros FA, Zangwill LM, Bowd C, Weinreb RN. Com-)]TJ
1.38977 -1.11111 TD
-0.006 Tw
(parison of the GDx VCC scanning laser polarimeter, HRT)Tj
T*
0.186 Tw
(II confocal scanning ophthalmoscope, and stratus OCT)Tj
T*
0.057 Tw
(optical coherence tomograph for the detection of glauco-)Tj
0 -1.11112 TD
0.025 Tw
(ma. Arch Ophthalmol 2004; 122: 827-837.)Tj
-1.38977 -1.11111 TD
-0.011 Tw
[(7.)-640(Reus NJ, Lemij HG. Diagnostic accuracy of the GDx VCC)]TJ
1.38977 -1.11111 TD
0.025 Tw
(for glaucoma. Ophthalmology 2004; 111: 1860-1865.)Tj
-1.38977 -1.11111 TD
0.139 Tw
[(8.)-640(Leung CK, Chan WM, Chong KK, Yung WH, Tang KT,)]TJ
1.38977 -1.11111 TD
0.211 Tw
(Woo J, et al. Comparative study of retinal nerve fiber)Tj
T*
0.314 Tw
(layer measurement by StratusOCT and GDx VCC, I:)Tj
T*
0.103 Tw
(correlation analysis in glaucoma. Invest Ophthalmol Vis)Tj
T*
0.025 Tw
(Sci 2005; 46: 3214-3220.)Tj
-1.38977 -1.11111 TD
-0.008 Tw
[(9.)-640(Weinreb RN, Dreher AW, Coleman A, Quigley H, Shaw B,)]TJ
1.38977 -1.11111 TD
0.196 Tw
(Reiter K. Histopathologic validation of Fourier-ellipso)Tj
22.97433 0 TD
(-)Tj
-22.97433 -1.11112 TD
0.005 Tw
(metry measurements of retinal nerve fiber layer thickness.)Tj
0 -1.11111 TD
0.025 Tw
(Arch Ophthalmol 1990; 108: 557-560.)Tj
-1.88977 -1.11111 TD
-0.003 Tw
[(10.)-640(Zhou Q, Knighton RW. Light scattering and form birefrin-)]TJ
1.88977 -1.11111 TD
-0.015 Tw
(gence of parallel cylindrical arrays that represent cellular)Tj
T*
0.004 Tw
(organelles of the retinal nerve fiber layer. Appl Opt 1997;)Tj
T*
0.025 Tw
(36: 2273-2285.)Tj
-1.88977 -1.11111 TD
0.088 Tw
[(11.)-640(Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glas-)]TJ
1.88977 -1.11111 TD
0.006 Tw
(ziou PP, Irwig LM, et al. The STARD statement for repor-)Tj
T*
0.072 Tw
(ting studies of diagnostic accuracy: explanation and ela)Tj
22.97431 0 TD
(-)Tj
-22.97431 -1.11112 TD
0.025 Tw
(boration. Clin Chem 2003; 49: 7-18.)Tj
-1.88977 -1.11111 TD
0.121 Tw
[(12.)-640(Chylack LT Jr, Wolfe JK, Singer DM, Leske MC; Bulli-)]TJ
1.88977 -1.11111 TD
0.035 Tw
(more MA, Bailey IL, et al. The Lens Opacities Classifica)Tj
22.97435 0 TD
(-)Tj
-22.97435 -1.11112 TD
(tion System III. The Longitudinal Study of Cataract Study)Tj
0 -1.11111 TD
0.025 Tw
(Group. Arch Ophthalmol 1993; 111: 831-836.)Tj
-1.88977 -1.11112 TD
0 Tw
(13.)Tj
1.88977 -0.00001 TD
0.246 Tw
(Tuulonen A, Airaksinen PJ. Initial glaucomatous optic)Tj
0 -1.1111 TD
0.053 Tw
(disk and retinal nerve fiber layer abnormalities and their)Tj
0 -1.11111 TD
0.025 Tw
(progression. Am J Ophthalmol 1991; 111: 485-490.)Tj
-1.88977 -1.11111 TD
-0.009 Tw
[(14.)-640(Caprioli J. Automated perimetry in glaucoma. Am J Opht-)]TJ
1.88977 -1.11111 TD
0.025 Tw
(halmol 1991; 111: 235-239.)Tj
-1.88977 -1.11111 TD
0.302 Tw
[(15.)-640(Zhou Q, Weinreb RN. Individualized compensation of)]TJ
1.88977 -1.11111 TD
0.368 Tw
(anterior segment birefringence during scanning laser)Tj
T*
0.132 Tw
(polarimetry. Invest Ophthalmol Vis Sci 2002; 43: 2221-)Tj
T*
0 Tw
(2228.)Tj
-1.8898 -1.1111 TD
(16.)Tj
1.8898 0 TD
0.057 Tw
(Hanley JA, McNeil BJ. A method of comparing the areas)Tj
0 -1.1111 TD
0.28 Tw
(under receiver operating characteristic curves derived)Tj
T*
0.025 Tw
(from the same cases. Radiology 1983; 148: 839-843.)Tj
25.51181 63.30349 TD
0.09 Tw
[(17.)-640(Ferreras A, Polo V, Larrosa JM, Pablo LE, Pajarin AB,)]TJ
1.88977 -1.11111 TD
0.152 Tw
(Pueyo V, et al. Can frequency-doubling technology and)Tj
T*
0.007 Tc
0.368 Tw
(short-wavelength automated perimetries detect visual)Tj
T*
0 Tc
0.375 Tw
(field defects before standard automated perimetry in)Tj
T*
0.006 Tw
(patients with preperimetric glaucoma? J Glaucoma 2007;)Tj
T*
0.025 Tw
(16: 372-383.)Tj
-1.88977 -1.11111 TD
(1)Tj
0.5 0.00001 TD
0.026 Tw
[(8.)-640(Da Pozzo S, Fuser M, Vattovani O, Di Stefano G, Ravali-)]TJ
1.38977 -1.11112 TD
0.186 Tw
(co G. GDx-VCC performance in discriminating normal)Tj
T*
0.049 Tw
(from glaucomatous eyes with early visual field loss. Gra-)Tj
0 -1.11111 TD
0.025 Tw
(efes Arch Clin Exp Ophthalmol 2006; 244: 689-695.)Tj
-1.88977 -1.11112 TD
0.16 Tw
[(19.)-640(Reus NJ, Lemij HG. The relationship between standard)]TJ
1.88977 -1.11111 TD
0.002 Tw
(automated perimetry and GDx VCC measurements. Invest)Tj
T*
0.025 Tw
(Ophthalmol Vis Sci 2004; 45: 840-845.)Tj
-1.88977 -1.11112 TD
0.011 Tw
[(20.)-640(Lauande-Pimentel R, Carvalho RA, Oliveira HC, Gon\215al-)]TJ
1.88977 -1.11111 TD
-0.013 Tw
(ves DC, Silva LM, Costa VP. Discrimination between nor-)Tj
T*
-0.003 Tw
(mal and glaucomatous eyes with visual field and scanning)Tj
T*
0.094 Tw
(laser polarimetry measurements. Br J Ophthalmol 2001;)Tj
T*
0.025 Tw
(85: 586-591.)Tj
-1.88977 -1.11112 TD
0.096 Tw
[(21.)-640(Kanamori A, Nagai-Kusuhara A, Esca\226o MF, Maeda H,)]TJ
1.88977 -1.11111 TD
0.104 Tw
(Nakamura M, Negi A. Comparison of confocal scanning)Tj
T*
0.284 Tw
(laser ophthalmoscopy, scanning laser polarimetry and)Tj
T*
0.002 Tc
0.373 Tw
(optical coherence tomography to discriminate ocular)Tj
T*
0 Tc
0.227 Tw
(hypertension and glaucoma at an early stage. Graefes)Tj
0 -1.11112 TD
0.025 Tw
(Arch Clin Exp Ophthalmol 2006; 244: 58-68.)Tj
-1.88977 -1.11111 TD
0.001 Tw
[(22.)-640(Dele\227n-Ortega JE, Arthur SN, McGwin G Jr, Xie A, Mon-)]TJ
1.88977 -1.11111 TD
0.182 Tw
(heit BE, Girkin CA. Discrimination between glaucoma-)Tj
T*
0.172 Tw
(tous and nonglaucomatous eyes using quantitative ima-)Tj
T*
0.069 Tw
(ging devices and subjective optic nerve head assessment.)Tj
T*
0.025 Tw
(Invest Ophthalmol Vis Sci 2006; 47: 3374-3380.)Tj
-1.88977 -1.11111 TD
0 Tw
(23.)Tj
1.88977 0 TD
0.053 Tw
(Bowd C, Chan K, Zangwill LM, Goldbaum MH, Lee TW,)Tj
0 -1.11111 TD
0.025 Tw
(Sejnowski TJ, et al. Comparing neural networks and line-)Tj
T*
0.209 Tw
(ar discriminant functions for glaucoma detection using)Tj
T*
0.002 Tc
0.373 Tw
(confocal scanning ophthalmoscopy of the optic disc.)Tj
T*
0 Tc
0.025 Tw
(Invest Ophthalmol Vis Sci 2002; 43: 3444-3454.)Tj
-1.88977 -1.11111 TD
0.004 Tw
[(24.)-640(Ford BA, Artes PH, McCormick TA, Nicoela MT, Leblanc)]TJ
1.88977 -1.11111 TD
0.094 Tw
(RP, Chauhan BC. Comparison of data analysis tools for)Tj
T*
0.072 Tw
(detection of glaucoma with the Heidelberg Retina Tomo-)Tj
T*
0.025 Tw
(graph. Ophthalmology 2003; 110: 1145-1150.)Tj
-1.88977 -1.11111 TD
0 Tw
(25.)Tj
1.88977 0 TD
0.073 Tw
(Weinreb RN, Zangwill LM, Berry CC, Bathija R, Sample)Tj
0 -1.11112 TD
0.195 Tw
(PA. Detection of glaucoma with scanning laser polari-)Tj
0 -1.11111 TD
0.025 Tw
(metry. Arch Ophthalmol 1998; 116: 1583-1590.)Tj
-1.88977 -1.11111 TD
0 Tw
(26.)Tj
1.88977 0 TD
-0.031 Tw
(Medeiros FA, Susanna R Jr. Comparison of algorithms for)Tj
0 -1.11112 TD
-0.002 Tw
(detection of localised nerve fiber layer defects using scan-)Tj
0 -1.11111 TD
0.105 Tw
(ning laser polarimetry. Br J Ophthalmol 2003; 87: 413-)Tj
T*
0 Tw
(419.)Tj
-1.88977 -1.11111 TD
(27.)Tj
1.88977 0.00001 TD
0.14 Tw
(Essock EA, Zheng Y, Gunvant P. Analysis of GDx-VCC)Tj
0 -1.11111 TD
0.004 Tc
0.371 Tw
(polarimetry data by Wavelet-Fourier analysis across)Tj
0 -1.11111 TD
0 Tc
0.219 Tw
(glaucoma stages. Invest Ophthalmol Vis Sci 2005; 46:)Tj
T*
0 Tw
(2838-2847.)Tj
-1.88977 -1.11111 TD
-0.009 Tw
[(28.)-640(Essock EA, Sinai MJ, Bowd C, Zangwill LM, Weinreb RN.)]TJ
1.88977 -1.11111 TD
0.237 Tw
(Fourier analysis of optical coherence tomography and)Tj
0 -1.11111 TD
0.057 Tw
(scanning laser polarimetry retinal nerve fiber layer mea)Tj
22.97431 0 TD
(-)Tj
-22.97431 -1.11112 TD
-0.003 Tw
(surements in the diagnosis of glaucoma. Arch Ophthalmol)Tj
T*
0.025 Tw
(2003; 121: 1238-1245.)Tj
-1.88977 -1.11111 TD
0 Tw
(29.)Tj
1.88977 0.00001 TD
0.06 Tw
(Medeiros FA, Zangwill LM, Bowd C, Bernd AS, Weinreb)Tj
0 -1.11112 TD
0.076 Tw
(RN. Fourier analysis of scanning laser polarimetry mea)Tj
22.97432 0.00001 TD
(-)Tj
-22.97432 -1.11112 TD
0.043 Tw
(surements with variable corneal compensation in glauco)Tj
22.97432 -0.00001 TD
(-)Tj
-22.97432 -1.1111 TD
0.025 Tw
(ma. Invest Ophthalmol Vis Sci 2003; 44: 2606-2612.)Tj
ET
0 0 0 0 k
14.173 7.5279 29.435 12.314 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 14.1732 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(364)Tj
ET
0 0 0 0 k
137.36 10.6629 228.784 9.179 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.0444 14.3792 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 14.1732 672.6915 Tm
0 0 0 1 k
(BORQUE E, et al.)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
Q

endstream
endobj
16 0 obj
<<
/Nums[0<</S/D/St 357>>]
>>
endobj
17 0 obj
<<
/Differences[32/space 40/parenleft/parenright 44/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/semicolon 61/equal 63/question 65/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T 86/V/W/X/Y/Z 97/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z 135/aacute 141/ccedilla 150/ntilde/oacute 231/Aacute]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
18 0 obj
<<
/Subtype/Type1C
/Length 9043
/Length1 9043
>>
stream
  UYBKMX+Times-Italic   @ø øøøøû=ûmú†ú
 ‹‹
 ‹‹  7  3  Ò»  ## ·ÃÈ003.001Copyright (c) 1985, 1987, 1989, 1990, 1993, 1997, 1998, 1999 Adobe Systems Incorporated.  All Rights Reserved.Times is a trademark of Linotype-Hell AG and/or its subsidiaries.Times ItalicTimes  L  " 3 $ )  4 0 & 1 ' 5 - .            	 S D I P T Q G U B M N 
  J H  V W E F È ( % Y 7 O Z Ø / *  C « [ X  2   , + 8 ; L # K : R   Î × 9 N   xYèëp¿NÆG™î}Ô§ñ^§ò(C±ô	9	 	ì

ÈEÚYÑY©^œÅ*á3º'ÂÅ5J "š x¾áXèFä• )À¨ês‘ sÜc  ±ü$d‹›÷f¯ø*wX÷ûøûû<÷<èøù0û¶üˆô9û ‚ˆe‚{÷O›]~¥¡‘˜™¦Ä÷÷pŸû}‹}‹Šcq…W‡{÷Š›Q…–Ñ-øÊûoü*÷)÷—Œ·û—d‹›ÿ6€ ÿ "€ ÷š©{›øwôØøË›U{®~®.÷‰÷#¦ÁÑÚ÷$û@‹gûŒ{º…£‰d‚hˆ€ûüNyL‰X‚{÷ˆ›U’}±“‹—¸Ã÷eÌ†÷ûØ÷(èû—øç’•¸ÄÉt5@f=û$pƒŒsœy¸øï¯Í÷ù øe°÷[v†…ntN£CûyûEûqûUû\÷&E÷÷&äô·°z™[\EDû‹ûTŞ÷÷'ñ÷†÷\÷#”ûoÓ‹›÷Êµ÷¡›ƒù›ù“ù!û‹{¶†¦ˆhy†s…w]û8û±Á÷WÍ»®›û¥{½‡¦†iy†s…wûüNzM|ˆZ‚{÷Š›_‘p­‘Œ“”Í÷ˆ÷±Jû€yKf‡]…{÷¥›]k¯‘Œ“”÷øuœÊ›¼”ü$û*y®€vù¬¾Éã÷â¼øhøh³÷[ty‚ƒtw‘’x‘ys‘^.<H*J€÷û'¬h°lKYh9-1SÚä“ŒŒ“w|iûs¼˜’Ÿ§­¾gĞ÷ÑóéÍv²/ç4à£ºÎ¾¬Â÷"RŒÓy¬øş¬ÇôøAôùOø;÷<ûÖûûGûxûnûqûR÷Tà÷t÷X÷„÷]üªû†÷ï÷Ö÷Zê¯E0û+ûãû_û‹÷#¢d‹¬÷»¬÷—¬{›øÜèùù!ü…Ø{¾‡¥†h€ƒcˆûüNzM|ˆZ‚{øÉ÷6{“D(`eûU‹q`ª—Ë÷{÷7†‹‹Z{ˆ{‡|Ÿ†Ï÷|yu‚x‚}ul…‚û5‰èÍ÷}‘Ÿ‘Ó‹÷2¦|MŠ~Š{ ‰d‹›÷µ°÷­©{›øŠòØ÷&ùµ†¨ˆf}c„tû
ü=yK~‰Xƒ{÷‰›W’{­œ‹‹—·À÷U¡†™ˆÑ‹÷\Ä÷Õè÷+û;Œ_ûŒ÷DQ—‘›©÷©aAû9û‹B~wd‹›÷É¯÷—¬{›øçØùù!ü†{¿‡¤‰fy„m‡}ûüNyK~‰Xƒ{÷›ia³–—‘¡É÷sŠ³‰¼‹œ¬ˆ_v†tˆ}œ†×÷~y]1‰‹û<ˆèÍ÷}’¢–Ê‹÷(¯~L}‰}Š} ‰-‹›øî®øÓ™ùù!ü¨aû.‡Å÷½‹÷‹û$ü¤yI`‡^‡{÷¶›@|Œ´™š“§÷ø†ÂË³{D€Š~‰|œ‰-‹¯øí›ƒøËø'ù!û¥{½‡¦†iy†s…wûüNzM|ˆZ‚{ø‘Å÷Gw‘Iû&:ˆû‹WY‹®‹Œ”±÷øOÍ»®÷K‹›ù›y÷ûúĞùıù!û;ûáü}ˆTø}ûI{ÂŠzv‚€l€cà!üjûw„^„{÷Z›kd³’£÷ø;Çü¬œøø½ûüb}WtzK…{÷¥›Rw°Ÿ‘ ÷øOœÊ—À”û*‹×ø£Ôøáø$÷gz{pIûR÷T÷T÷÷¤¸‹ÎÖSç!rû‡û0U „™¤±Ğå‹Ø¹OMj‡Qû û)ûfûtz÷÷½÷û*„§ù§«Ú÷ÇÚ÷÷0ìÓø÷)á‹%mûC5ûÔûkT÷ø÷¢íp÷,ûûû:ûbû¢#Ä$ó÷<÷÷÷Zû*„¡ù¢©Ï³Ù÷-ÖxÏô©÷1m û÷Gø÷ÛäáÙcÈ@ÖôÂ÷¯ì÷û ¬I-4Z$W¥\ÈJôs„û?Xû%Ïˆ÷÷Â¥“øì'¤qJ+=aUô5VÇÚ÷
øÎ±·ËÜ¥F[8PoTq,á‹ª¥ûÑ v÷Ş÷‹wñË{÷°¯ûÄ§ÔÊÎ¶r¨iƒa†a_¸Š‹ifTfw~È÷FøN ®›±«r¤lmrsjd­| û*„±øïµ÷ÙÛpâĞ÷FøËŸš®ºÊ±¼sHû û_'}Œ{’Œ“‹’‹àãÖaûû-iiSjÇ‹]fyv^Â}Æ÷Mæ÷"÷÷F©q—Ğô²½®×ŞCµAR@_OrûÑ•v‹÷÷z÷‹w½÷€÷˜õ€ ­›±X«q¤nlrql˜e­{¡¤î÷é ®›±«r¤lmrsjd­| û*„µøÄÒ÷òĞ÷‚øç÷z¢Òû”#ûn|÷ròuû-4Bû)UrÂ‹^xvno©oÓ÷Wö÷.÷÷1Óû¥û*˜vøíÔ•Öøb°ø­ù$…•Ğü:û™‚­³¦«Ó‹÷rˆüüêÑûÑ v÷TÊ¼÷}÷®÷“ûo}L÷pû*„¥øœz¯÷s›©×÷äÜøœùBûÅxûMûûbû8îVÜ÷>Ü÷=ğ¼÷"&µG{|‰‡|Ü|ˆ}†}„‡£½÷÷=÷D¢ûŸû—×µ[91Uû@û)‹÷¥›•÷‚÷û* v÷FÊøGwŒør÷©÷…ûh÷Ä÷ÒÛûÖ,÷øGbü5üCwH÷šZûFÚ¹÷DïûÑ vù"w®wµĞ°÷3ûC[÷‹ãÎÊœ÷³÷Ğ»÷¾Á»½°~šûJû/=û0‹û9K‹û&îû8û™ v÷èğJÌd—¸øÈ÷´÷™¸±Ó¨š“Ç÷ªÈ£|g‹¶–¯‹¿­rštL?û	Ijƒw‰¼÷[ˆ˜^„P~X„z–––ª{}‚…if:û¸ûb€¯ø4v©á÷râ÷òõcg\bONm¸ØëĞ÷E÷Ÿ†|z|…‹qtš}¤¤¡§ªr½7û(ûû-û!ûŞrÌôÅÖ«¤û*‚ºzvø¾ÿ Ç€ ÿ € ¡w÷´ÚÙ´øe÷	[eslwƒƒ’—j Ü÷”‹®Ì]’u1%û.Yl‰÷
øK†rWV‚W…{¥Œ¬Š“~‹|{R€aûü‰Ö¬÷šÂ¸ÏŸ§ß÷½‹›‹˜‹z´~9û³‹qp˜x«Í¶É¿¯û*•vøXv¦ß÷¥ß÷ÕøMû&û(û5û'8¸Nõ÷-÷÷I÷Ílİû„v»¡_W <ûcûYm¯Ä÷
æ÷[÷û™•v÷÷1÷…¢÷Ô¹×¥›œ¯÷&wû3›\–‘•™œ¨³x‹©Ãè¤÷àûä‹Ê¼«”¡Ì£QR®›œŸ÷}¬ƒ†…zœmwœ‹^!};l>÷+‹Ij{[S:{ç·„û*ûaš÷Gø¶‹w@÷!°™÷šåîø÷Íû1ûNûrr–¥²³÷¤ËÏ¥Å¹ºÌŒQpû×å¢Œ zv%üpûkƒ…pV{÷ašqe‹«Ÿ§÷”­¢Ÿ†¤÷÷4÷:÷/ÓmÆ29RBhs‰¦èŒŒ‹ˆŒ‰Şû/uüûNvøï«÷x¡û'×ø4Ú®ø å3ü8ƒcqûK‹„““–”‹‹œ£s˜}‰g‰‹eˆ]‘´~ª÷	Ã÷5÷§Ó÷Ô÷‘«û ¾”©÷Eİ˜•‡ƒ€‹‹u€‘p«¢ŸŸŸ{¸CûYû96q/ü€¼÷ú«°Ü:÷—Ğ÷¼ø@;§ò‹Œ‹‰‡‡ƒˆ„†‡àoh[^jzz‚o„…‚‰ˆŠˆ‹‡‹‰Œ‰‹‰ÕCû§‡{xN‹|m§Ÿ¿²·Ø¾~’rkh\w‹€†“”‹Œã÷áßû*€¼[¾ø!wŒ¡œß÷XÔ†œlød÷_^wr|ƒ…‘’ªç÷é—„šN„ˆˆ_‰§ˆj¥`ûû-ûOû'n2ïœÇÀ©÷Ş‰{N†u‹tz‹qµ¶­¯ÕÇü”åå÷p÷	š¨§x[))ûl!œpjÀü€¶øô›¡w´ØĞ÷x÷LZvor|‹™‘–“¦”°÷+ø×†ĞWW‚W…{™¤¨ˆuvû%ü‹voi·É²»Ø¾Ó‚ºzvø¿\›÷öØß×Ú¬ùE÷	\eqkxˆœj™Ü÷ ‹­³t¦gI:3ûE‰™³¢Ş‹™µv¢e7$û/Zm‰Ã÷\ˆZV€VU{¼š‰uu9û®{IÖ°÷ŸÍ³Çj³¦×ğ¸”˜‹pxFûŠq*Ö¨÷œÊ»×ª¼Óã´‹—‹”ƒ‹|¬w=û«‹p}‹hµÃ½Ã¾¯’ûÑ vù1w÷pĞ¨ûH÷(÷÷÷:÷Q÷p÷C÷	x†¥T¢(‹ 3{ûbû^ûQN_]ü$•v‹÷¦÷ İ€ ®œ°`ªq¥mmrrk e­{ ü€ºø ›¤w÷õ¼Ö¶ì¼÷r÷Qbnw‚„“’——³™ã÷ÖˆÜd„8{e‰{Â“†vo<ûŒ‹\y‹_ºÃ·ÂÆ²¨ø„¡z¬jstxhh¢z¤¬›ªŸû*ûb¡÷øv÷k²™¡“Â¬Ù÷+ÇjÚşølø)N„‚””zŞ”yr”b9ûQûF¶s¯{it`nlxš—‚7TjuRTÀS÷÷ÙÈà÷ûi{‹À˜¡¦™˜™‡‹˜ıãêİÕŸˆŸ…½Şû'ü[YZ^1|û è¢‹¦´®­¦‘“ìf‚‚¯z^İ¦øL8Y+I^z¬¸Î·ñØµšndû*‹šøö˜±w¼÷ü¼÷«š}`n§›˜°Ÿ÷#ø›•–‹“Šˆƒûmƒ\|Ä”‹¨‹‹kƒ‡}ˆ€ûü€~^cˆP…û*€ÀXº÷ş™w¨wµØ÷>ÙVøa÷	_hohx€Š–š˜·‘ŸÚ÷¿Ad uLZAWiL-`z†˜—‹Œæ÷ÿˆ¦YY‚Y…}´‹np?û‹__|¯åÕ÷÷ÏNt9w7y|f¸½¥¥æÊûbvø:—¤w÷Ò÷<¾Ø ø'Œ•“‹“¼u=™•Q˜û6Cz‹~”šŸÒÍ¸¬®÷)÷Fç°s¥jw{}|Uµ–‹dY;ûRPlk„÷…İm÷†ŠŒƒ‰†Z}€Bû*~ÀX»ø¢÷^œwšâ÷M×„šu÷7°N‹Äœæê÷l÷º‹_tû)ûR,®÷ÀÕ[awtwƒ’š›÷ø>¶÷B†uX€X„X†zÂŠ’†t}„rƒo`û3‰‰‡¡„¬S‹ûû>ûKû+W IŞv½Ãœ÷Ó‰ƒh‡t‹tv“r²¬ÌºÎ¶ûb€¸ø¢ªâ÷xÍ÷,÷ä°ÏØÁ¤•xvƒ†ûûba÷s(bYaiUaW¢ÏŸŸ §÷6¢éÜ‹Ú·l£Xû!û2û<û#L«=ôïæç›–û*€¼[¾ø!wŒ¡÷swœß÷XÔ†œnød÷_^wr|ƒ…‘’ªç÷é—„N„ˆˆ_‰§ˆj¥`ûû-ûOû'n2ïÇÀ©÷Ş‰{N†u‹tz‹qµ¶­¯ÕÇü”åå÷p÷	¨§x[))ûl!pjÀøø–’‘’š|œv€ƒ‡……û6û4®Óy°÷°›÷Í­¿÷ùXù*|}}wd‹qM­‹6ûjûSûYûy`¨ûk÷œÔé¡³Ë¼÷OœË¦À›û{Á†£ˆn{gûBnttnr€Xû>k÷Ù÷8í÷‹÷]Òïjû”ˆÓ‹©øå©{›÷cõ÷¨÷¸÷ù¾‡¥†iwƒlˆ€ûüNzM|ˆZ‚{÷‘÷º÷5÷M÷^ØôM÷5ûzûª÷KP™šÄ÷E­û&NjûÈûÏ\s‘¬›˜·”¬ûb€ÂTÅQØ÷ÂÔSÃf°pønŠø&÷mpwfvw„¤›‡…¤i÷‹Ï÷¨’¡’z‹££•Š£u—xW\N9W€Âyã|‹u‹kIs‚pF|«“™”‹¦}l”Œ†­û‚û1qiz*yy‹uuy{Šs›x¬ª—–œ­°µÁ»Í©ûV˜š}¨¢¨‹÷Òdvù#›øÉ÷ùDù!ûN{‰·‡no`A‚{û^ûñ†JøHŠ‘‹‹´©º›û…{Ã„†Ÿûàüœø	øû‘•©ª‹û*‚ºzvø¾\›÷³ÖŠÜ¨ø`÷	\frkw‰}šd©Û÷‹‹¶µt£]8/ûA\‰Ë÷eˆXU€UU{Á•€|vHû~lûÖ´÷˜¶¹ĞdÃ¯Êá»‘}y¨cAûˆ‹snm¹Á®¹Î½ûbûbÂTŞø£˜£wø³¨šø$—’ŒšÄ˜`0¦œUµûCepaZrnci~‚{Xy~§‹mvzzv˜a¶ˆ“÷÷¬øf÷¯w¥fq€v}]Á–‹bV<û`Ew÷~ÖP÷F~‹y={ƒ[û*•vøXv÷ˆw¦ß÷¥ß÷ÕøMû&û(û5û'8¸Nõ÷-÷÷I÷Ílİû„v»¡_W <ûcûYm¯Ä÷
æ÷[÷÷0÷H–’‘’š|œv€ƒ‡……û6û4®œ‘vš›ù›w÷ø~÷xùkù!û[{Â‡šdz„x‡}&üˆûbøƒû5{»ˆ {œfûü5fû€Tƒ{÷Z›nb³“’¥÷ø4¨÷xü´÷$ø‹­÷™Ì™ûÑ‹›ù›ƒøƒ÷ˆ›`r«£Ÿ‘Ÿ÷øOœÊ›¼”›û‹{¶†¦ˆhy†s…wûüNzM|ˆZ‚¤ v÷Í÷ÍáøŒøâøüŒIøŒûüŒIøŒû*€¢ø¼÷^œw¢á÷«àìø÷Ç7,ûgû\‹¥’ôë÷†÷Ê•Ulûª÷äÅŠ’†t}‚r„oûü‰‡uØlÀ÷-÷;÷A÷2ÔZ»E1L.Wj‰ŒÜ­÷¹÷N¡İ†ìWX„Y…d‹›÷f¯ø*wX÷ûøûû<÷<èøù0û¶üˆô9û ‚ˆe‚{÷O›]~¥¡‘˜™¦Ä÷÷pŸû}‹}‹Šcq…W‡{÷Š›Q…–Ñ-øÊûoü*÷)÷—Œ·û—÷0øº–’‘’š|œv€ƒ‡……û6û4®û™OvívøÇ÷ºĞÜ÷ÉÃ¡ ±÷&ûÊü”‚˜–š’œ‹ÑÓ5‹Ö¾¶°±«r‚t}zu™€‹€~{ˆx‹¬qWÎzI™÷¶÷ì–û°lûœvø:˜¢w w÷Ğø.»Ì›ø'ŸŒ–¬€G–”T”5H3}‹j˜š’ ÷@ì¸Ú£µ«¨ûĞŒ{‹}–‹–˜»³œ¹Á÷/÷Wâ¨{¦fn‚yzj¶†‹gW>*3û¬k÷ûŠ‹„‹…ˆ‡†ˆûSûÂ‰œ÷yğÁˆ…‚N{ƒRüvù@wJøW÷Íù.üı@Ôøù@ÓûJÏsÍÃ¬n¨øü¬ÇôøAô®÷«{÷t÷X÷‚÷]÷<ûÖûûGûxûnûq^û5ëLÛ|*6‚…DX•| ®¸•°®¾ó_‹âº÷¥öÒ|–cbih&‹ma–•an–ab•p‡rŠO÷’÷ï÷Ö÷Zê¯E0û+ûáû_û‹÷!¢û*v÷Š¹vø¥Ğã÷˜Ö¼¢z÷Á¯÷<÷}÷^÷(;Õ$û	ûûûÜûÍHà··¥³‰€`ûûYûJl÷ø/è»÷%÷î‹û dp{%rd`oSzl'‡ô«ü$û÷zÒËûÄ§ÔÊÎ¶r¨iƒa†a_¸Š‹ifTfw~œ‹›ÿB€ ¯ÿ€ ›’ù_ùfù!ûr{Â†‘ˆzr?KG[û$&…Œ¾÷PÍ½¬›û¥{½‡¦†iy†s…wûüNzL‰V‚{÷Œ›V‘x±™—”«Ç÷o“Š÷ûZ—v¥[‹ruv‰U…{÷§›P‘Œo¼ûB÷Ã÷À÷v’®¥¬ûbyªù›…èøù!û’{¸‡«ˆhwƒo‡|ûüe…w‚ii‹r™¤•Œ”‹‘¤u¡qnztlNÇpÀ÷²óõ¨òøË˜¾“÷Kvù#›ÿ¾€ ÿ Z€ ÷÷úù!ûM{·‡ ‰fwzg‡ƒûLûÿˆcø!Š‘‹‹º¦’´›û‚{ÇŠ”‘^”Fû>ûëˆ‡©døŠ‹‹¸¦¹›û€{Êƒ‹‹›ûÉü™÷røZ½üZŸ÷ÃøÛ¦¿—”¯–-‹¯øÙ¯…øøøòù!üz]û&†­Ğ¡¹÷-‹÷?üsüï}øÁ÷<xZ$fkû8‹û5øwøïûb€¿wvø0›÷h›¡w™øSû÷´ø2÷Ynyuqx¹÷?Cj÷÷±©¼›ûK{¦§‹xlû+T`‰÷øY†tWW‚W…{™¤¨ˆu‰uuA‚gûüwÖ»÷Hµ«´•m±3—t©Ptª‹·‹¨°±Ód‹©÷Áª÷™©{›÷cõ÷
÷ WğÒƒ÷®Ô÷÷É÷íE©V¢ÚéÙ¶å÷+­#û–{ºˆ©ˆfz†u…tûüNzM|ˆZ‚÷GÆ¿÷AšËÜÏŠ¹Š¤{©x£h‹X‹(R<û!‹Únj’±ê÷"øœš˜ÂÖ°gGûûy.€€Œ‹üûc¢ÿH€ ÿ € ¤w÷õûÜ÷rì¼Æˆ>xr#X‚€Œ•—˜‹‹  wšwf‡h‡Z¸|¬äÅÖ÷4´óø/ˆÜd„1{b‰{­Œ­ˆ„‹zŒ‰‹ˆˆ~†t€b÷%÷Ê¡z¬jstxhh¢z¤¬›ªŸ-‹›ù›Ùø¿û÷àæù¿ƒ“Š›RØû¡NûhxId‡\‡{÷µ›ExŒ°¨ Ê›Á¨ğĞ÷o÷¢«³–“¦˜›ûQ{¾†‰paû#û2^Ssç`÷¦«¥¹›ûƒû*ûe÷HÀø¡¤á÷¡™øûS|qj¥ŒŒ÷8øÕB}_‰¥‚~¬Sûû5ûRûG¥RØäÅÜØÀ‰5û±}^r‡T‡{÷…û¬÷Ù÷÷÷Oèª¨v^)û ûi"hvª¶û*òø»¡÷õUË÷*Õè÷l÷B’¨œÓÂ·¶®ğİ¬ªÑÕTÀ+ØDIdDnšy£•©©¡|’‹£ºÌ‹Ô’Prû'ûKb{ûVè²ûœ{¬fmttnn¢uª¯›¬Ÿûbûm®à­À®ø4v©áÓÕ×â÷òõcg\bONm¸ØëĞ÷E÷Ÿ†|z|…‹qtš}¤¤¡§ªr½7û(ûû-û!û
ÌjÇ…U5”ƒ•––‹£¡zs‹kTrt“’yzn«~­ƒ£‹¼ÔÏ¶g£_…Š‰‚±Ãë‘ÀÑ£©û*‚ºzvø¾\›÷Ç{Æ÷³ÖŠÜ¦ø`÷	\frkw‰}še©Û÷‹‹¶µt£]8/ûA\‰Ë÷eˆVU€UU{Á•€|vHû~lûÖ´÷˜¶¹ĞeÃ¯Êá»‘}yªcAûˆ‹snm¹Á®¹Î½qøœv„ƒtefeV¶‹UAzGe¨§’œ§¨€€¨j€§§€œ¸³°Î–d‹›÷¦vø›nù@ù#ù!ûd{²‡¡†pzû%û;P÷'„›ƒ¥‹–«¤’¹›ûœ{Æ‡›}œ`õû›û2ûLRKw|ou~…p…{÷j›ngŒ­›”›—™÷+÷@Îû9’{y‹}iv‰T‡{÷¥›L“|qË%÷–÷=÷VËÔ«—¨•yù!œû†˜÷’÷ üt}™ù*™ûv•÷s‹÷š“ü|Œ	«
×÷ù
endstream
endobj
19 0 obj
<<
/Descent -205
/Flags 98
/FontName/UYBKMX+Times-Italic
/CapHeight 653
/FontBBox[-169 -217 1010 883]
/StemH 0
/ItalicAngle -15.5
/FontFile3 18 0 R
/StemV 76
/XHeight 683
/Type/FontDescriptor
/Ascent 676
>>
endobj
20 0 obj
<<
/BaseFont/UYBKMX+Times-Italic
/Type/Font
/Widths[250 0 0 0 0 0 0 0 333 333 0 0 250 333 250 278 500 500 500 500 500 500 500 500 500 500 333 333 0 675 0 500 0 611 611 667 722 611 611 722 722 333 444 667 556 833 667 722 611 722 611 500 556 0 611 833 611 556 556 0 0 0 0 0 0 500 500 444 500 444 278 500 500 278 278 444 278 722 500 500 500 500 389 389 278 500 444 667 444 444 389 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 444 0 0 0 0 0 0 0 0 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 611]
/LastChar 231
/Encoding 17 0 R
/FirstChar 32
/Name/F0
/Subtype/Type1
/FontDescriptor 19 0 R
>>
endobj
21 0 obj
<<
/Differences[32/space 37/percent 40/parenleft/parenright 44/comma/hyphen/period 48/zero 53/five 56/eight/nine/colon 65/A/B/C/D/E/F/G 73/I/J/K/L/M/N/O/P 82/R/S/T/U/V 89/Y 97/a/b/c/d/e/f/g/h/i/j 108/l/m/n/o/p 114/r/s/t/u/v/w/x/y/z 131/Eacute 135/aacute 142/eacute 146/iacute 151/oacute 156/uacute 231/Aacute 234/Iacute 238/Oacute]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
22 0 obj
<<
/Subtype/Type1C
/Length 7206
/Length1 7206
>>
stream
  LYGIRE+Times-Bold   @ø øøøøû<ûnú|ú;
 ‹‹
 ‹‹  3  /  ¸Ä  í ·ÁÆ003.001Copyright (c) 1985, 1987, 1989, 1990, 1993, 1997, 1998, 1999 Adobe Systems Incorporated.  All Rights Reserved.Times is a trademark of Linotype-Hell AG and/or its subsidiaries.Times BoldTimes  A  $ " 1 * %  ( / » 4 5 & - Y 7 3 0 6 . # : ' C K F U J W P  B S M Z N Ï E T V ¶ Q I +  ² O D , X G Ø H È Ó   Ş 	 
 « [      C   h ÍAzÚİ[·'¬ÿqºL nÕAË7œø	]	°	ò
C
œ
æ¢ü)ªI·$šñE´e˜&’ÚXÖ*]ıHgô)^Ş(³ßT«ü$Óx»ù	¬ˆw¼÷Eø6¤Øù%÷,.8@m=l<šÓafË…ëÇ÷=²÷-÷&÷ßû	4®¤¸÷~pØr‚vpq>¼1ûfû$û0û_ûO÷û8÷}÷ÙÊŞÔÓ‹¤÷@²øZw”÷ûù<èùE¤‡^{®ó_ûsø¢oğûrü¸m@}iUƒr÷_¤i[±››´§Ó÷u™k«ApjyŠM†r÷Øüˆ÷€é÷‡ğû‡d‹¤÷ª®÷Ã®r¤ï÷6÷:÷@ì›÷â¤F”xÜ÷N÷Œ¾ŒË¯Û¸–Ò‹®‹÷=ûJš;‹ûÖÜrÀ†ªˆ7üNS}~‚„†‰ŠZƒì÷ŠøÙ¡Œ˜˜­İ¯eûûalû€û™‹¤ù¤÷÷6ø¤TcËøxÏ»Œº¤ûòr¹ˆº‰IüxMd‡U†r÷òÓ‹¤r®øó­r¤ì÷6÷•÷B¬™÷Ğ÷“÷ ÷0÷L÷.0÷Bû¬ûÅœr²‡·‰NüfwnLl÷‰øÎ“Ÿ‘Ã÷@¢ûi0ûƒ3Kû[‚³ü$÷x¬÷Œ¤ø¬ˆw°÷E÷¿÷0f¤ìù‡÷³ûërĞ‡«‰K"`{m3ûQ…÷Ò÷@³÷,÷%ê÷ßû	4®¤Ú÷~pêr‚vpq>¼1ûlûû6ûYûB÷ûE÷ìâ÷§­»÷İ£É’Óv¤ù¤ó·øC·x›÷w¤A“vÓø$¸øQü²§øá»‘¢Ó”¤ûkrÜ…—jOûÃ‰ûïø?ûgr˜›ˆFÃxünIo„O„÷x¬ù¬®÷E÷ö÷Eøù&÷ °ûDû&4…ûû?û?…÷â÷&°÷D÷ ¬ûUû5ûûnûf÷)û%÷a÷a÷)÷%÷f÷nû5÷ûU÷
÷£š›•§¯l“yx‰qtûû1Ã-x¬ùª®¨w÷÷…÷P©äøxøo÷mmx††|tn\¬;ØûRlûN]‹5÷?9ÎkÌlºs‹H~†(ûèûQ÷ğwnû‹¨› ª¸iê÷LË÷ã÷?Åiœû'ÔÔ7µx¡ÁÌÂ©¿÷
ÇûEœ‹¤øÿ«ÿ  € ÿ € ÷U÷6÷T§ø•¤Asàø£Ğ‡ò†Ÿû4¨‰÷]üìˆû]¨Ÿ÷4òÑü£7s‰B…r÷ùœ‹¤rª÷¾­÷«­r¤ó÷6÷6¥÷¤¯›ù¹ˆµ‰IüxMlˆR…wrøİ³÷doû+L%q)Jx—·÷†î¾mû—¥÷æqû|Zp.†÷|¶Â÷Òrû"¢¤÷]üÕœ‹¤rªù ¤ô÷6pù÷wnû]S8û+Hu“»ølãªŒÑ¤ûñr¸ˆ´‰I°üxNmˆS„prøÖû*‹£÷¡v÷9£—ølüj÷=÷÷<ğøx£~ƒ‚˜û(÷xìğ÷¢£—§£û<s²ˆ—Šv}‹‹A,|SÙœ›¢££ûs¦‡“‚œq÷ûYûû?ˆŠ_†s÷=£zŒj‹¤ŸÈÙ¢ªZœv”|—x‘{‹…‹{t‡uŠs÷…Óvù1¤øÒ÷ùQù8ûirÄˆ¨‡dw€q‚tûûİû÷Ğ¤wµ‹±¢‹Ê¤ûär¶„šˆ¥O÷”üë¦÷xøß¡Ã˜Â’Ó‹¤÷´«÷½­r¤÷÷6÷K÷?ì÷¨øìª–ÂÛ´`&ûWuûŠøKûÔ|Œ}û]÷±Áœòª‹÷÷<ûh“EûÖÜrÄ‡ª‰5üN:wˆGƒr÷æ¤I”uÛ÷X¦÷cûÍ÷a÷x¬ù¬®÷E÷ö÷Eøù&÷ °ûDû&4…ûû?û?…÷â÷&°÷D÷ ¬ûUû5ûûnûf÷)û%÷a÷a÷)÷%÷f÷nû5÷ûUÓx¼ù¤í÷3÷Ö·ùQù8ûprá‡—iNûÅK‰û-ûDû$‹÷Ä÷âãªŒÍ¤ûærÃ…¥‰7ûâû ¥h¶eRÌé…·ÇâÁ½µ¸™äÆ÷ÓÍ¢–Â“÷º‹¤ù¤ôµø§÷/ú-¤I”uÛøNá«Ã¤ûû\ülû\ølû‘rÒ†}WüoQ~|=„r÷~¤8y£Ñøe÷üá¦÷øğüŒInˆO…r÷àœ‹¤r«÷Ë©÷¥©r¤ó÷4÷0÷9û÷@n÷œ÷ë©uÌˆã|û#N~2ûay›¸øŒ¢ŒŒ¥¾vÜ¡PE%uaûûŒü	÷Öm÷gÑíß÷"½7™®µ˜÷¥÷÷0û`SûÉr¹ˆµ‰IüxNk‡S…Ó‹¤ù¤÷ª÷6÷÷ùOù8ûprºˆ°‰dpkT„€ûûMû÷|ƒ›{¤‹š§—‘Ğ¤ûãr¾ˆ£`‚÷Kûàû'8s‰F„r÷ï¤E’uŞ÷L÷S÷ËŸ«¨d‹¤÷Ä­÷«­r¤ó÷6÷-¤÷£Ş›ùºˆ´‰IüxMlˆR…r÷ü¤EcÍ÷}÷›B9–¤÷ær<}|Eû†î÷|¶Á÷@¦L#¡£÷]üË-}«ø%Á÷G£Ó÷÷7÷'œù ¯„‡\üó—ÚÃ¹^»ª‹÷9Ï÷÷÷BğûFgeyz÷—ûV÷VûĞ¡”š°¹â‘ûPû1hXOT~¾§ûÑû_ªøõ£Ö÷/R÷·÷/û"÷ô÷˜øaû^s®ˆ§ŠTünaƒicˆnŒ›š¢‹¤ y¬bawloAÙoÂ÷KŒ÷(Äøû,ø÷`ªi¹¶®¬·¶h®`^kgaûb}Ó÷O°÷4ª¤÷÷8÷®÷­¡°®˜ru‘“m‹WŒlóû1txh_P,uñàˆ÷Áˆ~÷BûBû0-û(û?ñAğÛÄ«èÈûÑÒ÷ú·Ó÷÷Åøa-÷=rG*^_V^p¿ûØvŒ7÷ å¯Ğ¶ r–€vzln‹eŠ°÷Ãéü‹£ø1£Ö÷/Ç÷/û&÷è÷“£dƒ¡ªøûTs±„š„^ûº[zˆg‚s÷ƒğûWøù`«i¹¶­¬·¶i®`^jgaû*’vøW£÷â÷+øyøaû+s¤Š©‹k~‡|„zCûJ<÷_‚¢‹‹¢ŸŒ¬£ûs¤‡‹—t‘©M¡U÷û¼¥÷4ø Ÿ½™£û*}ªø=ª¤÷'÷1÷'÷@÷y÷îÕÈœPû.ûƒ6F;‹ó÷ û'ûâû÷÷ä÷÷÷-ôûû4ûûûÑ~÷=÷'÷=İ÷=İÒ\¯f»º±¯»¹e²\[gc^÷Ñ\¯e»º±°»¹e±\[gd^û*}ËKÒø«¤÷&û÷÷÷¬ømËˆˆˆŠ‡‹u‹‘÷™é2¶ûûLNLGÁ‹—¿š±²m“‹ ›¢Ÿ¯Õ™fXBtû"`ûc#?Él»£ÑÌÌo‘“aÑ¸°£¬§ûWÄ{}tpig|¯ªâî¨¢ûb‹£÷Ä÷%5Õs£Ş÷˜÷»£NšÈ¨÷QÔ·¡šÈ«ŠP‹Å½™´¥£|ÁGJ^Olv‰˜ÚûQs©‡£†YûºYu‡k…s÷ü‹£ù£Î÷÷“£dª¨øäûRs¼\€ü’s€gcs÷ƒû*ûaÄøİ£›÷÷S÷+øtøaû+s¤Š©‹k|†~…zGûTC÷M‚¡€¥‹•£¦Œ¥£ûs¤‡‹—t‘©M¡U÷û»yV„urOi‹†—‹”€¬^O…X}k¦]Ìé Ä÷½÷)ø!½œ¡÷K‹£øÎg£Ò÷÷÷÷÷¼ùÂ£YŒ‹ª¤÷Ü÷<ªTQ^oP^«|rÂ07_Os}‰¼ÓûSs¨‡¥ˆWûºZu†j…s÷„£d„¡ªÜ÷Ÿ“³½¶Â‹Xkû†t‹l[ˆs÷~£e‚¡«÷Ÿ“µ½µÁ‹Wlû†s‹lZ‰s÷‚ûb}Ó÷O°÷4ª¤÷÷8÷®÷­¡°®˜ru‘“m‹WŒlóû1txh_P,uñàˆ÷Áˆ~÷BûBû0-û(û?ñAğÛÄ«èÈ;ø£š›•§¯l“yx‰qtûû1Ã-}Ãu¢ø
Ã÷G£¤÷(÷7÷|øª¶R‰¨¦øÓûksÂ‡ ŠVûK¥si¯O-(8ûB¼û&ç7ŞÖ§§±¯J|Éœ”Œ÷š¼ûZç€fP];‹÷Åì™åÒÃ¡NŠû™}­÷Æ÷€¬¤¤tï÷ë`¡²÷è÷Ú÷%uÒƒˆ‡y¬xb¡‹\/HP3û.÷‚‘‹/mvgY´ûsô¦…oû9¤Ÿ•‘“–”Ïn½èËÆê¬÷8û~t‹ñª§¥¯²Ä¹`D -}Ìø£Ì÷÷÷ø­¶^Œ€²÷üû]s­ˆ§ŠTû¯xxrreTŠ¶§÷çûPs´„“cûD­FñÎ¹´¤¨JÄ™Œ÷˜û™‹¤ù¤÷÷6ø¤TcËøxÏ»Œº¤ûòr¹ˆº‰IüxMd‡U†r÷òQùÎ£š›•§¯l“yx‰qtûû1Ã-ûLv÷TÂø
Äg£Ö÷÷6÷(ì÷j÷î™²Ã¸Ôû7Sˆû9TuÈ‹Ùû³\l”Ú÷!j­§pÃñåå÷9÷6(Ğ7;m^jz‰ÜÍûSs¹…“|eü‰b]„s÷¥-‹£øÎ÷G£Ğ÷÷÷øª£Z‹¶œ÷Œ÷<ªTW`uS[÷­ûTs²ƒ™ˆ\ü’Zz‡g„s÷…£]ˆ¨¢÷Ÿ”¶¼³ÁŒToû†f}zjˆs÷û*+¬ù^¤÷#İ÷6øsù8ûôrÄ‰·ŠGüÀl‹SJo{™œ§¦‰‹²ÂYŸunauTzû÷*ò÷±÷IøHâ«ŒÄü$…÷5÷/ÏÄûHÀ©÷Ì÷¿nÉB]gmWL¹{§—‹˜’S:Roxœ‹¤rª÷¾­÷«­r¤ó÷6÷6¥÷¤¯›ù¹ˆµ‰IüxMlˆR…wrøİ³÷doû+L%q)Jx—·÷†î¾mû—¥÷æqû|Zp.†÷|¶Â÷Òrû"¢¤÷]üÕøN÷*£š›•§¯l“yx‰qtûû1Ã-‹£øÎg£Õ÷÷÷¸ø¯£Z‹ª£÷Ø÷<ªT6`Os}‰¸ÓûSs³…˜ƒ^ûºZz‡g„s÷…£]ˆ¨¢Ø÷Ÿ”¶¼³ÁŒToû†f}zjˆs÷ûb}Îøª¤÷!÷÷ø0÷psqnR=NÜ÷ ¸’÷Ùš¥‚mU‹ZÃ“Ç‹ËÓ7°D-û"NûYûá!÷ÚÍ³Ì¹÷‹¤ù¤÷	÷6ù•¤wŒ}|ûÅø÷<÷@»¼ô‘¤ûµrÓ‡˜…tx‚‚ppûmûn÷já­Â¤ûær¹ˆ´‰IüxNk‡T…r÷å¤V’hÇ÷X¦¤÷Jûw›x“‹~{yˆN‰r÷äÓ’vøW£øĞ÷ùWøaûs§ˆŸ‰kuXûp?‰yÙa÷  ¡¥£û~s£ˆ–‹”v‘w•iGû?Y÷i× ¥£™£ûrs¥†„¥J÷(ü
£÷÷ÃïûÃ¢÷/ø%œ·™ûÑ‹£ø·÷[ªÒ÷Ä÷™÷ª£Jz“Ğ÷Îâ·4÷¦Œ½»—ˆ{|u{‹pwœiµ³¢¦®Ğ@ªNûIŠû*R_ÄûáVtˆi‡û*}ªø=ª¤÷'÷1÷'÷@÷y÷îÕÈœPû.ûƒ6F;‹ó÷ û'ûâû÷÷ä÷÷÷-ôûû4ûû÷ëø£š›•§¯l“yx‰qtûû1Ãû*ûb«÷ÿ w€ ÿ V€ §÷lÀ‚ª§ã<÷û÷÷,÷fÚò€øvø"Àûê€›ci‘gûG<;C»UÕp‰é@`AdLW¬|¸{‰ì@S†gmcSÕh÷÷÷¦÷÷û•ZŒñ€JŒAŒqŒ‹­©°Ÿì‹‹”¨Ó¢¬¿ÈÇm¨•ì@>üV¿§|gDû‹cz"Ë¡”˜¥ ê€¢÷ÿÊÏÈÍ‹5^RˆCLP„ÇĞû*}ËKÒø«¤÷&û÷÷÷¬ømËˆˆˆŠ‡‹u‹‘÷™é2¶ûûLNLGÁ‹—¿š±²m“‹ ›¢Ÿ¯Õ™fXBtû"`ûc#?Él»£ÑÌÌo‘“aÑ¸°£¬§ûWÄ{}tpig|¯ªâî¨¢Ïø£š›•§¯l“yx‰qtûû1Ãü‹£ø1£Ğ÷÷“£dƒ¡ªøûTs±„š„^ûº[zˆg‚s÷ƒ…øü£š›•§¯l“yx‰qtûû1Ãü$~÷=´÷=´Ò\¯f»º±¯»¹e²\[gc^ûÑ v÷?÷·÷‡÷³÷³û‡û÷‡-}Ìø£Ì÷÷÷ø­¶^Œ€²÷üû]s­ˆ§ŠTû¯xxrreTŠ¶§÷çûPs´„“cûD­FñÎ¹´¤¨JÄ™Œ÷˜û(øè£š›•§¯l“yx‰qtûû1ÃûÑû'vùòw¹÷÷ÆùJTrûaûû¸9§ûj÷|û§*ÆYÒ÷¤÷ÅË·ŞÃûÑû'vùòw÷B÷¦û<Â¤÷a÷÷¸İo÷jû|÷oìP½Dû¤ûÅK_8SÓ‹¤÷@²øZw”÷ûù<èùE¤‡^{®ó_ûsø¢oğûrü¸m@}iUƒr÷_¤i[±››´§Ó÷u™k«ApjyŠM†r÷Øüˆ÷€é÷‡ğû‡ãøâ£š›•§¯l“yx‰qtûû1Ãûb‹«ø!«ÿ )€ ÿ € ø8÷4o„loITvqƒl‰l‹n÷{ø'¥ü„û"¥¥÷º‹÷
Œû~ü(røû*~«ù¨§÷û÷÷9÷û÷Ô÷<øÖ´¬³¼ÕšDXOystlûÅèí÷û4H6.8ËNÖaèHv8dûûğQ÷ ÷#çÙ÷èKÑ5¾äÂÜ¯àÔÄcãû,èû	ü§Ô ª©¸Ï^Ì`9q‹02JmÍÓû*ƒÈ÷ª÷‹wğ÷ø	Ù¸÷)ø¹÷ª¶÷ûÖØ*ûíÓ†×†ÎmÀtÁYN9IuiLRâ‹F`xkoRÍlØ÷Jó÷÷íPÊ^¤H±M‘0÷ò}¹xv÷Â¹x¾÷i±“º™w÷÷÷V­Ğ÷	÷T¬•àù ç±Ç÷SÙ½Qz@FûEV‹³Ÿ•àû	¦D½Mİ÷&Ë÷HßÑi¿3)ûûû«à÷UøÑe„…ƒ„†„†O\5Tu™™x¥à˜wz™\Iû+<ûC=ÇWÎ÷%Ñ÷>÷mà‘Š‹‘ˆ–‰›­¼–™©‰ûîüüÂ¥à+ø%ÆÕ÷GÆ”•~†˜˜†›mAKû.;ky «û*“v÷Ÿ¸†v‹¥÷ş¦¥÷,÷÷1®ª~÷À©÷"÷T÷J÷„ûÄ1ûHeû>UÎû@÷eĞšŒš®š™š“XûQû	X'w÷'øÚ‹ÊÈÉšMûYt…Xˆ{ƒŠp†{F{×÷$û*~§ù§£÷2÷÷2÷Ò÷rI‚K†vw†€gfWzË÷#÷yŞ‹÷Î» Qû+ûºûû]íû$÷÷ á÷9÷H÷„û÷"&û#ûxù8šûz—÷ ’üu}™ù*™ûv•÷s‹÷š“ü|Œ	·
÷Œ
7’	÷ù
endstream
endobj
23 0 obj
<<
/Descent -203
/Flags 262178
/FontName/LYGIRE+Times-Bold
/CapHeight 676
/FontBBox[-168 -218 1000 935]
/StemH 0
/ItalicAngle 0
/FontFile3 22 0 R
/StemV 139
/XHeight 691
/Type/FontDescriptor
/Ascent 676
>>
endobj
24 0 obj
<<
/BaseFont/LYGIRE+Times-Bold
/Type/Font
/Widths[250 0 0 0 0 1000 0 0 333 333 0 0 250 333 250 0 500 0 0 0 0 500 0 0 500 500 333 0 0 0 0 0 0 722 667 722 722 667 611 778 0 389 500 778 667 944 722 778 611 0 722 556 667 722 722 0 0 722 0 0 0 0 0 0 0 500 556 444 556 444 333 500 556 278 333 0 278 833 556 500 556 0 444 389 333 556 500 722 500 500 444 0 0 0 0 0 0 0 0 667 0 0 0 500 0 0 0 0 0 0 444 0 0 0 278 0 0 0 0 500 0 0 0 0 556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 0 0 389 0 0 0 778]
/LastChar 238
/Encoding 21 0 R
/FirstChar 32
/Name/F1
/Subtype/Type1
/FontDescriptor 23 0 R
>>
endobj
25 0 obj
<<
/Differences[32/space 37/percent 40/parenleft/parenright 44/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/semicolon/less/equal 64/at/A/B/C/D/E/F/G/H/I/J 76/L/M/N/O/P/Q/R/S/T/U/V/W 90/Z 97/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z 135/aacute 142/eacute 146/iacute 150/ntilde/oacute 156/uacute 199/guillemotleft/guillemotright 209/emdash 231/Aacute]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
26 0 obj
<<
/Subtype/Type1C
/Length 8943
/Length1 8943
>>
stream
  BWGAKU+Times-Roman   @ø øøøøû<ûnú|ú
 ‹‹
 ‹‹  5  1  Ú»  "¿ ·ÂÇ003.001Copyright (c) 1985, 1987, 1989, 1990, 1993, 1997, 1998, 1999 Adobe Systems Incorporated.  All Rights Reserved.Times is a trademark of Linotype-Hell AG and/or its subsidiaries.Times RomanTimes  Q  # 0 3 2 6 &    ' " 4  1 - 7 + . ) / * F D J C E P        Q U B    S W G M N H Ó T O V Ï $ ; [ × % R  Ø ! È ( Y K Z  I Ş 	 
  5 X  L  j x 8 ‰  « S   • å`Ù9´·ï,vÈ8{Ï„îO…Ø/î	{	Ã

s

ó?pšfó,•|Ù'cØ4»-˜e¦ì£zõ¿jçxß^¿5¾ø2Üp6ÀäeçuŠ­ ;ü$œ‹x°÷µ³÷—°x÷ñ÷†ñ:÷®œùİ‡™AüPDz7‰x÷â­÷rŸ÷±ô;»4®¸–ã¡÷÷/ûC™4û¬÷Zûäë«†­u¿{¼j9ûû‚IQy°ø™š™Ÿ•™Œ‹ ¶Òóxûûû‰o,ŠÓ}¯øş¯­÷ø>÷÷ı}÷I÷&÷÷i÷zû7÷û8û8û7ûûzûi÷&û÷I¯û%ä÷p÷x÷Üññ÷:ûxûp%2ûœ‹÷´¯÷®°xññ÷~÷ìù'bsu¦ûb÷‘¾•÷£÷÷.û9 2û¨ÜxÑ„š‚AüE@‡v:†x÷©;Î÷YÃ÷‚ûÈ÷5ìü[øá¨”’À´÷ˆûû#û*‰7ŠÓûF÷,¨øş¯­÷ø>÷ùQû3/R©\°z™V¿‚œ÷ ˜÷.ó‹÷p‹÷zû7÷û8‹û8‹û7û	‹ûy‹ûi÷.èrºT2Ù÷j÷˜Ÿ‹Œ™ûèùÅñ÷:ûyûo%2ûû%ä÷o÷y÷ÜñÓ}·øùóñ÷ı·ùUù*û|xÑ‡£z û¢:j~u\nRk=ûB‹÷Ë÷ÔÒ—˜Ú‘û¯x×†™€AûÌO‹ûW÷Œ÷—‹÷PÛ÷™ôœšØ“d‹±÷µ´÷”±xîñ÷œ¢¬ÿ € îøé÷=o&_Ymûû)‹Œ´÷Œ÷.‰ŞŠš}—;¢÷|tD€s2û.÷r­—‹ ÷÷¥{2š¤ˆ÷#ü§ŞxÊ†£…<üP>t‚K‡xø°ü$û*‹šù)w÷iá÷
÷¨š@w–»øìƒûH0}¡Ã‹‹—­‹qvüYAf‰Q‰ü$…÷ 8v÷0² Şû!©•İÍÒŞQ˜trj|`c¯¥’ŒŒŒŒ`’’†‚x{^Ia-‹÷È´÷”±xîñ÷“¢µÿ € îøs÷{÷|t@yw9û%÷r©’¤÷÷¥{2š¤ˆ÷#ü§ŞxÊ†£…<üE9|@‡x÷¬Dw—Ö÷n÷%Ö‰£–7Ó‹÷Y´ø5wš÷ûùGèùV_}–kÔûøÌwûdüğx_lBtryxz‰{Šx÷Zv\‹µ–™˜¹÷	÷š´+‘}˜j‹{fjŠfx÷“ü~÷•÷÷§÷û§-}¯øù´Òá÷}ğøSù8v€‰†torU­O10Sû(Ë_çV÷'5›iRUcR;ûX÷ºxt©ûh¡›•œ ©¼i‹×÷#Ïëà÷aûâŸ‹÷*É¾ª½ôË19œ¤û*‹×ø¢Õ÷æáøo÷~dLxˆf‹ûƒ÷<÷D·ºßæ‹õ÷1Ï03-[û+m †¡Á©×æ‹÷
¤/X@`14.ûFûQø-‹÷¡³÷½°xïñ÷{÷Ü›ùÔ„–DüEC‹t7…x÷¬>zšÔ÷J‰£Š£ôË´¶œ›·´Ùì÷ûÀûûœ÷ND¬–Œ©·÷&‰û#û,û‹fvwŒxd‹²øğîñ÷ºù*û®xÊ†£…<üP>t‚K‡xø®»÷BrûRK‡û*8yŒ³ømÚ¤’ÏÓ•vù"øÉ÷ùMù*ûax±‰®ˆbvza‰…û'üû+÷æt¾y´‹š«Ãûxº‰´0÷Šü¹š÷røÅ©×™™»û™}±øÿ÷Dñ÷ªø½Õ™–Ùû³xÜ†—}DücW|}se¤ß‹Gnzmx}‘{›y–¤~µ¦÷!÷V÷ƒ‹ù÷·øñùóù*û[ûqüû{øûZxÕ‡ ƒ=ü*û v|?†x÷Bv¡òø#÷ü¶™÷’øÍüU9~|=‡x÷¬Kt”ØøPÚ£‘ÊÓ‹÷¼·÷°öñ÷Ãñ÷ª=Í÷b÷ÃûW@‡u7‡x÷ª=ÍøPÒ—˜×‘ûªxÕ…™AûVûÃ÷VÒ—˜×‘ûªxÕ…™AüE@‡u7‡Ó•v–ù÷·ø3·xùWù*ûxÏ†§ƒûûâ‰üøuû?x³›†Y´üMû v|?†x÷Bv¡òø¸øLü¸œø¢÷	«Ê’ûÑ‹ù÷ñ÷½As•ÙøPÛ¤’Ôû½xŞ‡™AüPDz6‰ûbĞ÷n«÷¯¤Ğ÷eñø,÷8ft`G2I:´÷E÷Ë÷€D¿-;ûNûMû"×9÷÷$Å÷ª•ûÛ÷,ã›²¦ÂÚ•H[’ûbÓø¨¤Øø"÷0Xif`C7F×÷÷'çª°Àym“‘u‘v›r£‹©›¢~ªm ›r^šgû û8û8û2öJÛÜÌ¶÷Áü‹šø–¿w¢w÷!ñÙñ6ßÚ›÷šF†œÍê÷÷‡WxXxWz|˜˜™›ŠPû|=z…MˆÜÉøıx™k¯©¡¡¨§u¢mh|kxû*«øÊ÷8š·wĞß÷wã÷-÷ÖÄË«æ¯$.I{ûûrD˜®7{fôp½÷MÆ÷2åöR÷û?VQt…‰÷Â†[zZ}[~{Œ‘•‹‘·‹vmû*¿ov¼šø§÷8š·w¦á÷wßŸ÷èñgƒdsaICÃ÷)÷Ï¼Ãº¼kG’?÷+û¦Š„…‹†Z‹Ÿ°øË†[zZ}Y~{Œ“•‹‘·‹vmû0¨jm™`û,ûûŸû`÷#w²Õ°°¦NˆÀ¹›»œû*§ø2§¨å÷™å÷‰ø`û9ûûûå$÷÷,Ñ÷î÷%-âûœüNût÷LÕóÂ¿Êç¾ûûû#HeXü•v‹÷÷Œ÷‹wÜ÷¨÷÷ğ ®œ°ªq¥mmrrke­{ ûû ®œ°Xªq¥mmrrk¨e­{ û*}¯øæÇ÷ÒÚeÓĞ÷-÷Ş¤¾¢…{ªËj—Ar@b<.PeÃ‹]{t„oWâ†£÷1÷ã÷"÷6®aàÍ¶¦¶Á´péûH2lûcš‡š§µÙæ‹Õ¯VX/@[0nü’vùFw‚÷¼÷³ù8HûyıFÏû*v÷ƒ¶ø§©ç÷„ìÆu÷’›÷&÷R÷h÷;+÷ûû;û û9¹û÷½À°·‰…rTûwû†c÷Æ÷ùyˆ~zvayj!u÷	×İ¢èß÷‹ûWPû*}¥ù¥£ë÷˜ë÷ù÷ûG<‰û„ûû‰÷‚ÜÏ÷÷¥ûLaûwû
ûµût÷L÷Lµ÷t÷÷
a÷wûLû*˜vøèÕŸøAøUù*ü{_`$œƒ¬¿¨Ì‹÷mûZüèÌ÷hù"ü$•v‹÷Ñ÷ ÷€ ®œ°`ªq¥mmrrk e­{ û*ûm÷Q«øš‚ÇÖß÷uáÜÖû`‡vI†z÷†C{–Ë÷1k¬§€³÷Ò÷ ÷÷?İ2>]Zov‰Ô…ì[x[z[|{Œ”•‹”®zcÜßˆ±‘Ã§¯÷û6tûB1xjT\¶¢ü¿ø«Ñß÷“øV&÷“‹„fV|ueduuu…‹‹ˆˆŠÀûÁ'´p¾¹º¬¶£~–€~yuk‹X‹Æª÷²ğûbÄ÷†v÷<£°ãFŞ÷(Üô÷³÷mˆl|†‚l~ufnªº­–Ã÷+½÷/û^‚€~vn‹¨¨÷WÇ‹ïû)ìû\Dc{—oª¥¡ ”†š‹šª±¬©º€CNôû7K4i'H¿fÁÂÀ³¬°CµŠ›ªŒ¼µû* v÷;ËøQw—³÷„Ùøl÷{%øQ_ûÎüQK÷­û;Ø÷;ñûHËû„÷‚÷èû*}°øÄÚ÷øÑ÷IøÛ÷X–”‹”±ä‚’€|‚€q‹ûeûûŠ‰‹‰‹Š†ˆ÷ ‡÷E\û4ûASJUpÉ‹Kc‹ngºsÚ÷2÷õ÷ä€¨`¿PÓ-œ;™û*}§ù§Ã×EÕ÷oĞT×ä÷h÷Ì÷9µmAE\aL:]ÌØèæ»²«¥û0û:=Í9÷ä÷:¬÷¿ÎvÅûëØÁ¨Ûµç×MÍû5&U&:³ißAè2Gbl4ØÛø%»«ÀÖØ®UT3Sferg¢2ÄÙûÑ‹š÷ïíI—‚Ê×ßÈ×ßS{ˆT|÷„šXiĞ˜÷u«·½£È£•h‹®£™¤¬w ieiwD\‰ä†¨ZwYyZ{{”–™›ŠPû*’vøUšøçøqøVû|¤Š¡‚tgDû0i+%÷”ˆ“…š‹—¤¡£šûX|ŸŠŸ…šm¯Dëû|£M›`‡”‹’‹”¢–¦÷÷Õ£Æ’›­ûÑ‹šø'«÷a§òß÷ÉøVû÷°¿Âº@‹µŸ¢˜¨­_¦SûH‹ûES9kİûÎ>z‚Iˆ|÷˜š/Š¥È÷Î÷ü‹šøö™·wíß ÷€šQz“Åøé‡VzV}V~{Œ—”Œ˜²‘{^üqTy~P‡÷‹šø˜„¿áß÷Lß÷Lß¼áàHm‰cŠ|÷ršhŒj¼÷®¹ÁĞ¿œdIûmJtˆ^ˆ|÷tšbŒl×÷­¡­¦ÂÓŒPXûgK{‰Y…|÷ošqa’Š¦‹¡÷eÕ}ó#<NOsvµ€lµJUbk^PÖ„Ü]z\|\~z“•™›ŠLû*ûnÄ÷Hv£v÷(¤÷j²§§ÑnŞ<Ç÷XØ¦§Ö í1© ª°º¡‹éˆÕ‰¼‰‹^‹VG_û	‹û‹g³‹ªµ`ÁøDÎ²¢¯á›ûou†AG=qäÚ¹ ÷Ò¹²>{y“vµ šcu“h?+[ûQ­]Æq´ 2<‹~zo¥¦~¶ Xg\b^VÖ_ñå÷:Ã÷§}Õ ¸àû‘mŒ[‹¢Ÿ³´Ÿ‘¯†‹—Ãò²÷ ½‚¢ü‹šø–¿w¢wêßØ›÷šF†œÍè÷÷‡û/T|˜˜™›ŠPû|=z…Mˆåø€÷.ì•‘Ÿ˜‹¢Š§k}„‹ttû'û(û™¡vø[w‘¢¾ÉN˜÷iÑ[˜¥÷Ï÷Î‡÷€™‡ˆ†„‚zlŸ_*`ISAÂfÉh–Åj«yŸs‹kR\{i)xâÀ{Uû0˜–”‘—§µy‹·ËÜµâÇh§Z©™û Ëf¡…¨‹Ÿ¥ ²Â·¸v%¡û*‹šø˜ÂÛß÷Dß¸ÛåP|~\ˆ|÷hšW}›¬÷­°±ªŸ©ÆgNûe?q†fˆ|÷dšZšº÷y÷D¦]Peh]ZÚ„Ø]z\|^~z–™›ŠLû*Åiv¶™øœÒß÷Fß<øs½„V‰¡®÷ëû2zÑ‰vcœûj„‚ƒupm}mI‚É™÷Úû&}©‰«‰Oû!Ùs´»²²|¶¶8‰ºœ±™Á™ûbĞ÷n«÷¯¤Ğ÷eñø,÷8ft`G2I:´÷E÷Ë÷€D¿-;ûNûMû"×9÷÷$Å÷ª•ûÛ÷,ã›²¦ÂÚ•H[’A÷Z÷.ì•‘Ÿ˜‹¢Š§k}„‹ttû'û(œ}·øò³§÷ù øW‚÷uvjƒj‹†uJ¬2û@û<ûûtû÷A+÷5÷Lá÷ŒylmCDû‹ûûâ÷h÷$·Ë²±´µÅŸ½÷Ó;"¤d‹±øŞ±”øàøÒ÷DBuxJûû•øDøõšü¢wû?¥Î˜—Í÷#÷qüIüõ|øÈ£÷Dûb‹©ø©ÿ 6€ ÿ € ø6÷y{=…l!‹û÷¡ø)šûïˆû
Á’­Ô÷ûü)|øû*‹šø˜ÂÓÃÂÛß÷Dß¶ÛåP|~\ˆ|÷hšW}›¬÷­°±ªŸ©ÆgNûe?q†fˆ|÷dšZšº÷y÷D¦]Peh]ZÚ„Ö]z\|^~z–™›ŠL÷Æ÷Àcz}p|v”‘®s—t—u‘v‹HmR_ƒ¨œ‘–¨±—˜†…—¶¢€¨} ª‹ÙÓ­”Ó‹°øà°xóñø÷Ø›÷°÷ÆÚ÷X÷÷tû3÷û„û¢¸xØ…–AüPE{?‡Ø÷RøËŸ‹º÷Ãp`»ĞM£:7û·ûŠ‹K[’­û*ûmœ÷RÈø§‡w£á÷{ßì÷üø=¡dt˜Xû)ûûû+ÖDäÈÑµ©œûNY}t@ˆz÷€™^•y»Üøé‡„ˆBûŞŠk‹{Wxy„z‰|‹2‹dê‹çì÷ÁÔÜêŒDoûÑ v÷VÊ²÷Š²÷•L÷ŠÊû*§ø2§¨å÷™å÷‰ø`û9ûûûå$÷÷,Ñ÷î÷%-âûœüNût÷LÕóÂ¿Êç¾ûûû#HeX^ø}÷.ì•‘Ÿ˜‹¢Š§k}„‹ttû'û(÷£}²÷
¬k¶÷©·÷ª÷ß÷Ò÷"Î÷<³¾€øĞø#û!~MDaho£Ç÷äÓ»Ş€©˜ta÷ûÚqRWu2ûBû÷÷#÷r÷÷
÷-÷Kôû+û5Zû
:ß€k…£Ÿ“Œ“ŒÌ÷’Fe~£§]‹ûMû>E¾€ûÊ|©ß€Å‘¹¹–Š}£SÌ÷Î÷ñ÷=û$÷ûLûZû;û%ûlû÷ûW÷™ÙÏ§¨ÊûbÄ÷†v÷<£°ãFŞ÷(Üô÷³÷mˆl|†‚l~ufnªº­–Ã÷+½÷/û^‚€~vn‹¨¨÷WÇ‹ïû)ìû\Dc{—oª¥¡ ”†š‹šª±¬©º€CNôû7K4i'H¿fÁÂÀ³¬°CµŠ›ªŒ¼µû‘øg÷.ì•‘Ÿ˜‹¢Š§k}„‹ttû'û(Ó}³÷Ê÷®³«÷ø ìd¥øùY÷öû“yÏ†ŸŠ8û6gFtGû/#÷÷I÷‘÷'Êêô÷ ¿(C¦¢ƒ÷guo…j†ƒk]¬&ûhûû;û<û©PÀQ>Ò÷mîø÷÷Å™÷]Ò¥·û*‹š÷©v÷8šœ÷%û%øbû`÷2è÷ÂÔ†—|v‚‡lŠ|÷]šzŒpŒeÅû÷XôŞ÷“˜©©¶Œšû2|œŠ¢Šv€…‚N3x¨bÈ ¤šûc|•¥™…U¯éû$ûû9k]}‰pˆ|÷%šzv‹‰–™ ‘”Ú÷üûn­øÖ—¾w¢w÷!ñçñ6ßÚ÷^9‹RYgÇ‹`xv|tf¹xº÷´ğ÷	êø]†WwWyW{{š˜™›ŠPÜz÷¾x™k¯©¡¡¨§u¢mh|kxû*ûnß7ñø»š™øaû÷¨øoøVû|¨šy‚~kp=ûrû÷‘ˆ’„›‹˜¦®Œ¢Œšûb}˜‰¥†—r÷ûŠ™l»/|{cûWp~l‹p]‰e…¨q¢k½Ö·Í÷¾÷.ø,š´Ÿ˜û*}§ø¹÷„›­è÷åøRù@û†ƒû>ûJû_ûfñ,÷
÷F¯÷3Ô÷=×!SvjT÷î÷÷F§ûbû²õ©'$û]WL@HÕ÷<Ç•£••£¤¯“­û*‹šøÁ÷8š·wÔß÷Nßø{šY”Ô÷[³Š÷ûOZkYh‰÷Â†[zZ}^~{Œ•‹‘·‹vmükB„U„|÷lšZxØ÷…»´²š¨Â¡dHûZ>x†Z†|÷hû*Åiv¶™øœÒß÷Fß<øs½„V‰¡®÷ëû2zÑ‰vcœûj„‚ƒupm}mI‚É™÷Úû&}©‰«‰Oû!Ùs´»²²|¶¶8‰ºœ±™Á™ûšøk÷.ì•‘Ÿ˜‹¢Š§k}„‹ttû'û(ûÑ vù8w»á÷»ù8û///û*û@û¬C¼C±SÍEÅl—›û>÷‹÷oñ÷’ëÙÕÆûÑ vù8w÷[á±ûE÷/çç÷*÷@÷jÓZÓeÃIÑQª{÷>û‹ûo%û’+=APü…÷ 8v÷ò÷‹wÜ÷²”öû!¬—ÚÌÑßP—v€[ˆTf©~«’ŒŒŒŒT’’†‚x{^Iah±øj ®œ°ªq¥mmrrke­{ d‹øíµ´v÷~ñ÷~v8øX7Ïø“Á÷§yû £…÷>üÈ…û>£÷¡¦÷ÁüˆAˆt0‡x÷¸Ó’v÷Àv÷>š ÷ø4÷øÏøV|£†Ÿ‡s…p€r1ûr;÷j|²…–‹¨¤¬šû_|´†–„°û0û[]÷P÷®§¢¢šûH|¤‰“~Ÿ[÷ûêi™’‘–§™÷÷„æû€™g„“‹“•²›÷÷îš°• ’š÷K“v˜©÷—­›«÷h¤£©™wÈ×÷r¤Ì×÷q¥Uàù+øû#û!F©Gè÷Ú÷*÷òB’gUà˜k³©gZ6Eû4K‹ÃŸµÁ÷Sì[àa÷ådmkbe7Wy™˜{uà™{}˜]û
*û'&Óh¸÷Ø÷/óà ˆ•‡™…š—‡²Á§š˜¢‰ûñı»uàY÷ädtÂŞÙ÷,Í~{{Ê‘x€zû;û
;û*‹šø8š÷C™·wİß’÷~šwŒju“‹´÷I÷ûL—z”‚‹„~~ˆƒx|÷nšpd’XËû-÷V¨¦÷÷§‹À‹šû`}µ“ƒ€‚ƒ€|}ciPTgl‰ø4‡VzV}Z~{Œ“”Œ˜²‘{^üvUƒ‰H€5˜v§øø¬Çü=÷Uø=÷UÏüûzMøûzû*Ávøwµø2µ÷w‰ÕK•‚SËÂL“‘’˜o³y£u©d·u©¡¨õ÷‹™‹’‰ƒ‹‡‹‹‹KLHPjo÷5p‰ÕK•‚SËÂL“‘’˜o³y£u©d·u©¡¨õ÷‹™‹’‰ƒ‹‡‹‹‹KLHPjoû*Ávøw·ø2ø^÷rAË”ÃKTÊƒ…†‡„~§cs¡m²_¡mun!û‹}‹„‡“‹‹‹‹——ËÊÎÆ¬§û5¦AË”ÃKTÊƒ…†‡„~§cs¡m²_¡mun!û‹}‹„‡“‹‹‹‹——ËÊÎÆ¬§÷º•vù"ù·÷ú8ù*ûZx­ˆ®‡dvƒmƒvûûçû÷é|²¡‹œ¯¹ªûŸxÀŠš…¬8¬9 û®û$ø†˜…œ‹™¥Ÿ‘¸û‰xÄ†™n«8±'óû°¾û-š÷.ø;¶ûİûf®#šÆ÷UÛ÷jĞ÷N™²›™¼“÷ò v÷]¼‹ú|÷Zú|¼5 v÷Í÷Í©øŒøªøüŒIøŒûüŒIøŒÓ‹÷Y´ø5wš÷ûùGèùV_}–kÔûøÌwûdüğx_lBtryxz‰{Šx÷Zv\‹µ–™˜¹÷	÷š´+‘}˜j‹{fjŠfx÷“ü~÷•÷÷§÷û§ûøb÷.ì•‘Ÿ˜‹¢Š§k}„‹ttû'û(}™ù*™ûv•÷s‹÷š“ü|Œ}™ù*™ûv•÷s‹÷š“ü|Œ	§
ß÷ù
endstream
endobj
27 0 obj
<<
/Descent -217
/Flags 34
/FontName/BWGAKU+Times-Roman
/CapHeight 662
/FontBBox[-168 -218 1000 898]
/StemH 0
/ItalicAngle 0
/FontFile3 26 0 R
/StemV 84
/XHeight 676
/Type/FontDescriptor
/Ascent 683
>>
endobj
28 0 obj
<<
/BaseFont/BWGAKU+Times-Roman
/Type/Font
/Widths[250 0 0 0 0 833 0 0 333 333 0 0 250 333 250 278 500 500 500 500 500 500 500 500 500 500 278 278 564 564 0 0 921 722 667 667 722 611 556 722 722 333 389 0 611 889 722 722 556 722 667 556 611 722 722 944 0 0 611 0 0 0 0 0 0 444 500 444 500 444 333 500 500 278 278 500 278 778 500 500 500 500 333 389 278 500 500 722 500 500 444 0 0 0 0 0 0 0 0 0 0 0 0 444 0 0 0 0 0 0 444 0 0 0 278 0 0 0 500 500 0 0 0 0 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 500 0 0 0 0 0 0 0 0 1000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722]
/LastChar 231
/Encoding 25 0 R
/FirstChar 32
/Name/F2
/Subtype/Type1
/FontDescriptor 27 0 R
>>
endobj
29 0 obj
<<
/Kids[30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R]
/Type/Pages
/Count 6
/Parent 36 0 R
>>
endobj
30 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R/F0 20 0 R>>>>
/Parent 29 0 R
/Contents 5 0 R
>>
endobj
31 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F0 20 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 6 0 R
>>
endobj
32 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 7 0 R
>>
endobj
33 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 8 0 R
>>
endobj
34 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/XObject<</Fm0 11 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F0 20 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 12 0 R
>>
endobj
35 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 13 0 R
>>
endobj
37 0 obj
<<
/Kids[38 0 R 39 0 R]
/Type/Pages
/Count 2
/Parent 36 0 R
>>
endobj
38 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R>>>>
/Parent 37 0 R
/Contents 14 0 R
>>
endobj
39 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R/F0 20 0 R>>>>
/Parent 37 0 R
/Contents 15 0 R
>>
endobj
36 0 obj
<<
/Type/Pages
/Kids[29 0 R 37 0 R]
/Count 8
>>
endobj
40 0 obj
<<
/Type/Catalog
/Pages 36 0 R
/PageLabels 16 0 R
>>
endobj
41 0 obj
<<
/XPressPrivate(%%DocumentProcessColors: Cyan Magenta Yellow Black\n%%EndComments)
/Producer(QuarkXPress(tm) 6.5)
/CreationDate(20080603125837)
/Creator(QuarkXPress(tm) 6.5)
>>
endobj
xref
0 42
0000000000 65535 f 
0000000015 00000 n 
0000000059 00000 n 
0000000111 00000 n 
0000000157 00000 n 
0000000204 00000 n 
0000009590 00000 n 
0000019254 00000 n 
0000029610 00000 n 
0000039389 00000 n 
0000060273 00000 n 
0000060808 00000 n 
0000061469 00000 n 
0000070514 00000 n 
0000078294 00000 n 
0000087654 00000 n 
0000097705 00000 n 
0000097751 00000 n 
0000098146 00000 n 
0000107272 00000 n 
0000107495 00000 n 
0000108213 00000 n 
0000108610 00000 n 
0000115899 00000 n 
0000116121 00000 n 
0000116830 00000 n 
0000117292 00000 n 
0000126318 00000 n 
0000126536 00000 n 
0000127264 00000 n 
0000127371 00000 n 
0000127597 00000 n 
0000127823 00000 n 
0000128039 00000 n 
0000128255 00000 n 
0000128505 00000 n 
0000129245 00000 n 
0000128722 00000 n 
0000128801 00000 n 
0000129018 00000 n 
0000129309 00000 n 
0000129378 00000 n 
trailer
<<
/Size 42
/Root 40 0 R
/Info 41 0 R
/ID[<FE17D168C8B27239B012BDA99E3598E6><FE17D168C8B27239B012BDA99E3598E6>]
>>
startxref
129573
%%EOF
